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ABSTRACT
Toxoplasma gondii is an intracellular obligate parasite of phylum
Apicomplexa. Toxoplasma is able to infect any nucleated cell including up to one
third of the world’s population.

Within its hosts, the asexual life cycle of

Toxoplasma consists of two distinct forms; a rapidly growing form called
tachyzoite and a latent cyst encapsulated form called bradyzoite.

Although

tachyzoites can be removed by the host’s immune system, parasites can convert to
bradyzoites thereby evading the host’s immune response. If the host’s immune
system becomes weakened, bradyzoites are able to reconvert to tachyzoites. Taken
together, these observations suggest Toxoplasma contains intricate gene regulation
mechanisms that could be shared by other intracellular parasites. MicroRNAs
(miRNAs) are crucial genetic effectors involved in numerous gene regulation
mechanisms in eukaryotes. Although a post-transcriptional gene silencing can be
observed in Toxoplasma the roles and functions of Tg-miRNAs are still elusive. In
this work an engineered dual luciferase reporter system was used to examine and
standardize the ability of long and short double-stranded RNA to control gene
expression in Toxoplasma. The effects of endogenous Tg-miRNAs were also
evaluated based on (i) their abundance and (ii) the number of binding sites within a
transcript. Tg-miRNA effectiveness can be altered by use of miRNA mimics and
inhibitors. Also a genetic knockdown system that exploits and directs Tg-miRNAs
for loss-of-function analysis of essential and non-essential genes was developed.
To further our understanding of miRNA induced gene silencing on parasite cell
biology, a model gene target was selected for the most abundant Tg-miR-60a. The
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locus of the Ubiquitin-like protease 1 (Ulp1) contains the highest number of
predicted Tg-miR-60a binding sites.

The antisense RNA expresses a likely

precursor of Tg-miR-60a suggesting TgUlp1 expression could be self-regulating.
Ulp1 activity is required for the first and last step in the SUMOylation pathway.
TgUlp1 is able to compliment the function of yeast Ulp1 and exhibits cleavage
activity in vitro.

Knockout of TgUlp1 is detrimental to parasite egress and

survival. Since a miR-60a inhibitor or antisense RNA can alter TgUlp1 expression
and activity, a TgUlp1-SF line was created to study the effects of miR-60a and its
effects on total protein SUMOylation to demonstrate the importance of proper
gene regulation by miRNAs.

Furthermore, Toxoplasma Argonaute, the core

protein of RNA-induced gene silencing that is required for a gene silencing effect,
is expressed as two isoforms from the same locus, suggesting alternative
translational starts sites. Overall, this dissertation reveals the importance of proper
gene regulation directed by non-coding RNAs in Toxoplasma that could lead to the
development of anti-Toxoplasma therapeutic.
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CHAPTER 1
General Introduction
1.1. Toxoplasma gondii, the one and only
Over 100 years ago in 1908, one of the most successful parasitic protozoans was
discovered in the tissue of a rodent, the gundi, at the Pasteur Institute in Tunis by Charles
Nicolle and Louis Manceaux, and in that same year in the tissue of a rabbit in Sao Paulo,
Brazil by Alfonso Splendore (Splendore 1908). It was originally mis-identified as
Leishmania, another unicellular eukaryotic parasite by both laboratories (Duby 2008).
However, Nicolle later realized that he discovered a new organism and named it
Toxoplasma gondii, based on the parasite’s morphology; toxo “bow” and plasma “life”
and the host.
Later Toxoplasma was isolated from birds by Sabin and Olitsky in 1973 and was
discovered to be identical to the human isolates. This lead to further investigations of
Toxoplasma isolates from humans and animals (Sabin and Olitsky 1973). Furthermore,
an in-depth study of the genetic differences among 275 isolates worldwide resulted in the
grouping of three dominant clonal lineages within North American called type I, II and
III. Type I parasites are highly virulent, while type II and III are most commonly found
within humans and animals, respectively (Dubey 2002, Montoya and Liesenfeld 2004).
Toxoplasma infection occurs worldwide with the largest range of hosts despite the fact
that Toxoplasma gondii is the only one species of its genus (Duby 2008). Although great
advances have been made in the last 50 years to prevent Toxoplasma infection, today one
third of the world’s population has been estimated to become infected by Toxoplasma
(Flint 2005).

Typically infection does not produce any clinical symptoms, however,
1

severe disease can be observed in congenitally infected children and immunosuppressed
individuals, including patients undergoing chemotherapy or by acquired immune
deficiency syndrome (AIDS, Dubey 1996).
1.2. The life cycle of Toxoplasma gondii
As an intracellular parasite, Toxoplasma spends most of its life cycle within the
cells of its host. The life cycle proceeds in two stages; sexual reproduction within the gut
of felines and asexual reproduction within its host. In the asexual stage, the parasite can
alternate between two forms called tachyzoite and bradyzoite (Figure 1.1.).
1.2.1. Sexual reproduction
In 1965, William Hutchison pursued the theory of a fecal transmission route for
Toxoplasma via cats after researchers reported no evidence of the parasite within canine
fecal samples ten years prior. Hutchison not only discovered the oocyst form of the
parasite but also its definitive host (Hutchison 1965).

Later it was discovered that

Toxoplasma undergoes sexual reproduction and genetic crossing within the epithelial
cells of the feline small intestine (Frenkel et al., 1970, Hutchison et al., 1970, Ferguson et
al., 1974). The oocysts are shed for up to 21 days in the feces of infected felines and able
to survive in the environment for up to 18 months (Frenkel 1975). Sporulation usually
occurs between 1-21 days, and the oocyst-containing sprorzoites have been found to be
the most significant source of infection for the intermediate hosts (Figure 1.1., Montoya
and Liesenfeld 2004). Despite the parasite’s promiscuous ability to infect any nucleated
cells including mammal and bird, felines remain the only definitive host for sexual
reproduction.
2

Figure 1.1. Toxoplasma gondii life cycle. Sexual reproduction takes place within the gut
of felines. Cats then shed oocysts that can be taken up by any warm-blooded animal.
Acute infection occurs by the rapidly growing tachyzoites. An attack by the host’s
immune system induces tachyzoite convert to a slow growing cyst-encapsulated
bradyzoite. Immune suppression allows the bradyzoite to reconvert to tachyzoites. If a
cat ingests bradyzoites cyst infected tissue, the parasites re-enter the sexual life cycle.
(Adapted from Black and Boothroyd, 2000)

3

1.2.2. Asexual reproduction: A tale of two forms
The proliferative form of Toxoplasma called the tachyzoite, was the stage
observed by Nicolle and Manceaux in the gundi.

Tachyzoites are crescent shaped

approximately 2 by 6 m with a pointed anterior and a rounded posterior end. This small
“banana-like” structure is the rapidly growing form of Toxoplasma. Tachyzoites are able
to divide rapidly by a process called endodyogeny, where two daughter parasites form
within the parent parasite (Glodman et al., 1958). Rapid parasite growth causes a strong
inflammatory response by the host’s immune system, and the tachyzoites can easily be
cleared (Figure 1.1). However, Toxoplasma is able to avoid an immune system attack by
converting to an encysted slow-growing, dormant form called bradyzoite. This form does
not cause harm to the host or elicit a host immune response. The cyst wall also makes the
parasite less susceptible to destruction. Although the parasite in the bradyzoite form
continues to grow, the growth is slower than that of the tachyzoite form that the parasite
remain intracellular and dormant (Montoya and Liesenfeld 2004). In individuals with a
weakened immune system, bradyzoites could be released from their cysts and convert
back to the rapidly growing tachyzoite form. When bradyzoite tissue cysts from infected
animals are eaten, the parasites are released within a new host and re-enter the asexual
life cycle (Figure 1.1., Dubey et al., 1998, Black and Boothroyd, 2000).
1.3. Lytic cycle
As an intracellular parasite, Toxoplasma must invade a host cell to survive.
Tachyzoites move through the extracellular environment by gliding motion until
attachment to a host cell (Figure 1.2.). Once attached, the parasite enters by penetrating

4

through the host cell membrane or by phagocytosis (Dubey et al., 1998). Once inside, the
parasite is surrounded by a parasitophorous vacuole (PV) derived from parasite and host
cell lipids and membrane proteins (Dubey et al., 1998). The parasite can then undergo
multiple rounds of replication while remaining within the PV (Figure 1.2.). Rapid growth
is achieved because Toxoplasma is auxotrophic and sequesters materials from the host
cell such as amino acids, nucleotides, sugars, cholesterol and lipids which requires less
energy (Laliberte and Carruthers, 2008). Growth rates have been shown to be directly
related to parasite virulence. Type I parasites are highly virulent where types II and III
are avirulent in mice (Weiss and Kim 2007). After multiple rounds of replication, the PV
fills with parasites and causes the host cell to lyse (Figure 1.2.), and allow the parasite to
initiate the next round of infection, the lytic cycle. The destruction of the infected host
cell is the serious consequence of toxoplasmosis (Blader et al., 2015).
1.4. Toxoplasma infection
Toxoplasma infection occurs through the ingestion of tissue cysts or sporulated
oocysts from infected meat or from the environment such as contaminated water or soil
(Dubey and Jones, 2008). Toxoplasma has been found in animals worldwide, regardless
of environmental or habitat (Dubey and Jones, 2008). This is especially a concern for
human health and consumption of contaminated animals and products. Tachyzoites can
spread throughout the hosts system and can be transmitted to a pregnant host’s offspring
(Montoya and Liesenfeld, 2004).

Congenital toxoplasmosis can cause severe

complications to fetal development including mental retardation, blindness, and brain
lesions and in the most severe cases, can cause abortion or stillbirth (Montoya and
Liesenfeld, 2004). Initial Toxoplasma infection mimics flu-like symptoms. Persisting
5

Figure 1.2. Toxoplasma gondii lytic cycle. Extracellular parasites attach and invade a
new host cell.

The intracellular parasites become surrounded by a parasitophorous

vacuole where they undergo multiple rounds of replication. Once the host cell fills with
parasites it ruptures releasing free tachyzoites that are able to invade a new host cell.
(Adapted from Gubbles, 2014)
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Toxoplasma infection can cause neurological and behavioral changes, and has been
linked to psychological disorders such as depression, schizophrenia and suicidal behavior
(Flegr, 2013, Dubey, 1996). The most interesting behavioral change has been found in
rodents, where infected rats display an attraction to the scent of feline urine thereby
leading them to be consumed by the parasite’s definitive host, completing its life cycle
(Berdoy et al., 2000, Dubey 1996, Montoya and Liesenfeld, 2004).
1.5. The model Apicomplexan
Toxoplasma is a member of the phylum Apicomplexa that includes other
important pathogenic genus such as Plasmodium, the cause of malaria, Cryptosporidium,
a water borne parasite and Eimeria, Neospora, and Theleria all of which are important
zoonotic parasites (Montoya and Liesenfeld 2004).

Among intracellular parasites,

Toxoplasma is the most experimentally tractable organism and is amenable to genetic
manipulation with reliable protocols for both forward and reverse genetics.

These

include high transient transfection efficacy and expression of epitope tags, reporter
constructs and heterologous proteins. The genomic sequences for type I, II, and III
parasite strains are available (toxodb.org) with regular updates (Gajria et al., 2008).
Furthermore, Toxoplasma can be used as an expression system to study biological
functions of other apicomplexan parasites that cannot be expressed in other organisms
(Soete et al., 1999, Weiss and Kim 2007). Toxoplasma has also been widely used as a
model to study host-parasite interactions, basic biology of host immune response, and
mouse models (Weiss and Kim 2007). Toxoplasma is a unique model organism for
intracellular parasitic research.
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1.6. Gene regulation
The regulation of gene expression is vital to the survival of all organisms. The
levels of gene products, both functional proteins and RNAs, can be modulated at the level
of transcription, post-transcription, translation and post-translation.

Transcription

regulation is the control of DNA expression orchestrated via chromatin modifications,
transcription factors such as enhancers and repressors, and promoter activity (Bell et al.,
2011, Bruce et al., 2007).

Post-transcriptional regulation is the control of gene

expression at the RNA level via RNA editing, intron splicing and addition of 5’ cap and
poly(A) tail; interactions with RNA binding proteins for nuclear export and processing;
and non-coding RNAs for mRNA degradation or translational repression (Bruce et al.,
2007). Within this complex network of controlled gene expression, my work focuses on
post-transcriptional gene regulation via non-coding RNAs, which is another layer of the
control of gene regulation. Thus this section is focused upon the current knowledge of
post-transcriptional gene regulation.
1.6.1. Post-transcriptional gene regulation by RNA interference
In 1998 Fire and Mello published one of the most influential discoveries in
science that described the RNA interference (RNAi) pathway in Caenorhabditis elegans.
The study began with an investigation of antisense RNA function in modulating the
expression level of endogenous genes at the mRNA level.

Double-stranded RNA

(dsRNA) molecules were found to be more potent and specific at interfering with genes
than antisense RNA (Fire at al., 1998). English and Jones (1998) described a gene
silencing effect caused by integration of T-DNA transposons in tobacco plants that
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caused heritable epigenetic changes to promote drug resistance.

Shortly thereafter,

Chuang and Meyerowitz (2000) reported that in Arabidopsis thaliana, RNA duplexes
were able to induce significant gene-specific down-regulation when compared to singlestranded sense or antisense alone.

The study confirmed the dsRNA-mediated

interference (Chuang and Meyerowitz, 2000).

RNA interference (RNAi) is thus

described as a biological process by which the expression of a gene can be altered by
non-coding RNA molecules. The pathway has been found in many single-cell and
multicellular eukaryotes. Not all eukaryotes contain the required enzymes or effector
RNA for a functional RNAi mechanism.

For example, some protozoa such as

Leishmania major, Trypanasoma cruzi and Saccharomyces cerevisiae lack the RNAi
pathway, while other protozoa such as Trypanasoma brucei, Tetrahymena thermophile,
and Saccharomyces castelli contain the canonical RNAi components (Kolev et al., 2011,
Aravind et al., 2000). The RNAi pathway is believed to be similar to an immune system
in cells that can defend against viral infection and transposons for chromatin integrity and
development (Matzke and Matzke, 2004).

It remains unclear for what purpose the

presence or absence of a functional RNAi pathway is among these single-celled
organisms. It has been hypothesized that select organisms might lose the need for an
RNAi mechanism thus the necessary genes for a functional pathway (Kolev et al., 2011).
The RNAi mechanism is initiated by the presence of long dsRNA. In the cytosol,
dsRNA molecules are cleaved into smaller 20-25 nucleotide duplexes with a 2-nucleotide
3’ overhang by a member of the RNAse III family called Dicer (Siomi and Siomi, 2009,
Bernstein et al., 2001). The RNA product is called either microRNA (miRNA) or small
interfering RNA (siRNA, Figure 1.3.). The RNA duplex is then transferred to an
9

Figure 1.3. RNA interference pathway. RNAi is initiated by the presence of long
dsRNA that is cleaved by Dicer. Within RISC, small RNAs are bound by an Argonaute
protein and guided to their target mRNA through either a perfect match or mismatch
complementarity (guide strand in red).

In the nucleus, the RITS complex controls

transcription through histone modifications or small RNA interactions with DNA or
RNA. An enhanced silencing effect can be observed by amplification of effector RNA
by an RdRp. (Adapted from Matzke and Matzke, 2004)
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Argonaute protein in the RNA-induced silencing complex (RISC). Within RISC, the
antisense strand of the RNA duplex guides the RISC complex to its target mRNA, which
gives its name as the guide strand. The sense strand, or passenger strand, is removed and
degraded (Preall et al., 2006, Okamura et al., 2004). Generally the outcome of gene
regulation occurs based on the complementarity of the miRNA or siRNA to the mRNA
target.

Perfect match interactions result in mRNA degradation, while mismatch

interactions result in translational repression (Figure 1.3.). MiRNAs generally function in
translational repression, as they rarely contain perfect match complementarity to mRNA
targets (Okamura et al., 2004). MiRNA binding sites can be found throughout target
mRNA structures (i.e. CDS, 5’ and 3’-UTR), but most often located within the 3’ UTR of
the mRNA (Lim et al., 2004, Friedman et al., 2009). The effects of these small noncoding RNAs can be amplified through the synthesis of secondary siRNAs produced by
an RNA-dependent RNA polymerase (RdRp). The RNAi mechanism also allows for the
maintenance and organization of the genome by transcriptional regulation via the RNA
induced transcriptional silencing (RITS) complex (Figure 1.3., Holmquist and Ashley,
2006).
Since its discovery, RNAi has quickly become the preferred methodology to
precisely, efficiently, and stably down-regulate any gene of interest for functional studies
(Saurabh et al., 2014). DsRNA can be easily generated and introduced into a cell or
organism. Since synthetic RNAs can be recognized and utilized by the enzymes involved
in the RNAi pathway, functional genomic applications such as mapping and annotation
have been possible in organisms where traditional engineering methodologies are
difficult (Saurabh et al., 2014, Kupferschmidt, 2013). RNAi has also been used to
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genetically engineer plants to produce lower levels of toxins, improve stress tolerance
and act as an insecticide (Grimm et al., 2006, Kupferschmidt, 2013).
1.6.2. Argonaute protein
Argonaute proteins are central to the RNAi mechanisms, where they direct small
non-coding RNAs to induce gene silencing. In eukaryotes, gene silencing can occur at
the transcriptional, post-transcriptional and chromatin remodeling levels by (i)
degradation of mRNA target, (ii) translational repression or (iii) by causing chromatin
modifications. Argonaute proteins were first discovered in plants and named after a
phenotype of A. thaliana mutant that resembled the animal Argonauta argo (Bohmert et
al., 1998).

Among eukaryotes, the total number of Ago proteins can vary among

organisms. Drosophila melongaster, Homo sapiens, and C. elegans, contain five, eight
and 27 paralogs, respectively, while Schizosaccharomyces pombe and S. castellii contain
only one (Jinek and Doudna, 2009). When an organism contains more than one ortholog
of Ago, each paralog may have a different function from one another despite their
sequence similarity. For example, one paralog of Ago could be found within the nucleus
while another in the cytosol to facilitate transcriptional or post-transcriptional gene
silencing, respectively. Organisms that contain a single ortholog of Ago, the protein can
be found within the nucleus and cytosol and participate in both transcriptional and posttranscriptional gene regulation.
Based on sequence homology and phylogenetic analysis, Ago proteins are
categorized in three subfamilies; (i) the Ago-like subfamily, whose members resemble A.
thaliana Ago1. Members of the Ago-like subfamily contain two conserved domains
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called PAZ (Piwi-Argonaute-Zwille) and Piwi (P-element induced wimpy testis). They
are typically ~100 kDa and interact with miRNAs and siRNAs. Their Piwi domain also
contains the canonical catalytic triad, DDH/E. (ii) The Piwi-like subfamily, whose
members resemble D. melanogaster Piwi protein. Piwi-like subfamily members contain
only the Piwi domain, are generally ~40 kDa and interact solely with PIWI-interacting
RNAs (piRNAs). (iii) The WAGO subfamily, whose members are only found in C.
elegans. For the purpose of this thesis I will be focusing on members of the Ago-like
subfamily.
1.6.2.1. The function of Argonaute in the mechanism of gene silencing
Ago proteins bind small non-coding RNAs and play important part in the
mechanism of gene silencing. Ago-bound small RNAs alone cannot catalyze the reaction
without first forming a fully functional RISC. The formation of RISC involves (i)
loading and (ii) subsequent unwinding of the small RNA duplex by Ago. Theoretically
either strand of the small RNA duplex could act as the guide strand, but
thermodynamically the termini of small RNA determine which strand is loaded or
discarded in Ago proteins. Generally, the less stably paired 5’-end of the RNA duplex is
loaded to Ago, and is known as the guide strand (Khvorova et al., 2003, Schwarz et al.,
2003). This reaction requires ATP hydrolysis to mediate a conformational change of Ago
to accommodate the small RNA. After the RNA duplex is bound, Ago reverts back to its
closed state, which drives the removal and degradation of the passenger strand
(Kawamata and Tomari, 2010). The exact mechanism of unwinding and discarding of
the passenger strand remains unclear. The complex between Ago and the single-strand
guide RNA, referred to as the miRISC, recognizes its target mRNA through
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complimentary base pairing. Although many software applications aimed to predict
miRNA targets have been developed and refined, the success in the identification of
mRNA targets is still limited. This, in part, is due to the lack of consensus rules
describing the exact base pairing or structure of small RNA to be loaded onto miRISC.
Single-molecule fluorescence resonance energy transfer (FRET) analysis showed that
human HsAgo2 initially scans for its target by using 2-4 nucleotides of the guide strand
sequence.

The stability of the interaction increases with base pairing of the seed

sequence 2-8 nucleotides from the 5’ end of the guide strand.

Perfect-matched

complementarity promotes mRNA cleavage, while mismatches in the central region lead
to translational repression of the target mRNA (Chandradoss et al., 2015). Translational
repression could still lead to mRNA degradation due to deadenylation and decapping of
the target mRNA (Nishihara et al., 2013, Arribas-Layton et al., 2013).
Under stress conditions Ago proteins have been shown to localize to the nucleus
to facilitate transcriptional regulation by associating with chromatin modifiers and
splicing factors (Ameyar-Zazoua et al., 2012). For example, the catalytically inactive
HsAgo1 and catalytically active HsAgo2 have both been shown to promote methylation
of the H3K9 histone to slow RNA polymerase II elongation rate (Wu et al., 2006).
1.7. Non-coding effector RNAs
Regulatory non-coding RNAs (ncRNAs) are single stranded or double-stranded
RNA molecules transcribed by either RNA polymerase II or III to produce a functional
RNA molecule (Morey and Avner, 2004). NcRNAs originate from intergenic regions as
antisense RNA or from overlapping protein-coding genes. NcRNAs are classified by
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their function as a housekeeping or regulatory RNA. Examples of housekeeping ncRNAs
include transfer RNAs and ribosomal RNAs while examples of regulatory RNAs include
microRNAs (miRNAs) and small interfering RNAs (Morey and Avner, 2004, Brosius,
2005, Palazzo and Lee, 2015).
1.7.1. Long non-coding RNAs
Long non-coding RNAs (lncRNAs) are grouped based on their length of 2002,000 nucleotides.

LncRNAs function to control gene expression by (i) sequence

complementarity for gene silencing, (ii) secondary structure formation of scaffolds to
assemble complexes, (iii) or act as a decoy for transcription factors (Yoon et al., 2013).
1.7.1.1. Antisense RNA
Long antisense RNAs are single-stranded RNAs that can be transcribed by either
RNA polymerase II or III or the product of spliced introns of pre-mRNA. Antisense
RNAs function by binding to the complementary nucleotides in mRNA gene targets. The
first studies of antisense RNA as an effector RNA is the hok/sok system of E. coli. The
R1 plasmid, which encodes for the hok gene (host killing), also encodes an antisense
RNA, sok. When the sok antisense is expressed, the translation of complementary hox
mRNA is inhibited by base pair complementation, causing an obstruction to the
translation machinery (Gerdes et al., 1985). Transcription of long antisense RNA is often
associated with the expression of its protein-coding gene (Engstrom et al., 2006, Korneev
et al., 2015). Xist and Tsix are perhaps the most well-known non-coding single-stranded
RNAs, involved in random X inactivation in female mammalians.
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Xist ncRNA is

expressed from one X chromosomes, and is regulated by the expression of an antisense
ncRNA Tsix to induce transcriptional silencing (Stavropoulos et al., 2001).
1.7.1.2. Long double-stranded RNA
In eukaryotes long dsRNA is formed by the transcription of complementary sense
and antisense RNA molecules or by transposable elements (Wicker at al., 2007). The
presence of transposable elements can cause truncated coding and non-coding transcripts
in both sense and antisense directions. DsRNAs are shown to involve in chromatin
remodeling, RNA editing, processing and nuclear localization (Meister and Tuschl,
2004). DsRNA can be acquired as a result of viral infection. RNA viruses use RNA
rather than DNA as its genetic material which can be present as long dsRNA that initiates
the RNAi mechanism (Blevins et al., 2006).
1.7.2. Small double-stranded RNAs
MiRNAs and siRNAs are the most pertinent small RNAs to be discussed here.
They are derived from long dsRNAs which are (i) exogenous dsRNA such as viral RNA,
(ii) endogenously transcribed as RNA-encoding genes, or (iii) spliced introns, called
mirtrons (Rother and Meisster, 2011). These small dsRNAs are central to the posttranscriptional gene regulation mechanism which alters gene expression by causing
mRNA destruction or translational repression. Conversely, small dsRNAs can also bind
mRNA targets to increase their activity via recruitment of transcriptional or translational
initiation machinery (Rother and Meisster, 2011).
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1.7.2.1. MicroRNAs
Lee and co-workers at Dartmouth College described the first single-stranded nonprotein-coding regulator RNA, lin-4 in C. elegans (Lee et al., 1993). The lin-4 locus
encodes for small RNA molecules with partial complimentary to several sequences
located on the 3’ untranslated region of lin-14 mRNA, which is important for larval
development.

lin-4 regulates the expression of lin-14 through an antisense RNA

mechanism (Lee et al., 1993, Wightman et al., 1993). let-7 is another excellent example
of functional small RNA. let-7 represses the expression of lin-41 which is important in
developmental transitions of C. elegans (Reinhart et al., 2000).

MiRNAs are well

conserved in both plants and animals. However, miRNA biogenesis are different among
organism kingdoms (Axtell et al., 2011).
1.7.2.2. Mammalian miRNAs
Mammalian miRNAs are able to recognize and bind their target mRNA via
Watson-Crick base pairing at positions 2 to 8 from the 5’ end of the miRNA, called the
seed sequence (Bartel, 2004). Thus, miRNA families are generally grouped based on
their seed sequence. By using transcriptome-wide mapping of miRNA binding sites
(Ago HITS-CLIP), Soek et al (2016) showed that miRNA target binding occurred
through non-canonical sites and interactions.

Canonical miRNA target interactions

would be the 2-8 nt seed sequence of the guide RNA. These non-canonical interactions
may include a near perfect match (1 nt mismatch), a 1 nt bulge, or a wobble (G:U nonWatson-Crick base-pairing).

Another contributing factor is the central nucleotides

termed seed-like motifs. The interaction with the seed-like motif negates the need for
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perfect match binding within the seed region (Soek et al., 2016). These above described
interactions induce translational repression, which may eventually lead to mRNA
degradation rather than direct cleavage of target mRNA. Noteworthy, a miRNA family
could have hundreds of different mRNA targets, and a target could be regulated by
multiple miRNAs (Bartel, 2004).
Mammalian miRNAs can be transcribed by either RNA polymerase II or III from
intergenic regions or from spliced introns (Lee at al., 2004, Faller et al., 2008). Multiple
miRNAs can be produced as ploycistronic units by one long dsRNA primary miRNA
(pri-miRNA). A single pri-miRNA, ~80 nucleotides, may contain one up to six miRNAs.
Pri-miRNAs produced by pol II result in a transcript that is capped at the 5’ end and
polyadenylated.

The resulting pri-miRNA folds into a secondary double-stranded

structure (Figure 1.4, Lee et al., 2004, Altuvia et al., 2005). RNA polymerase III can also
transcribe pri-miRNAs, but these RNAs are not capped or polyadenylated (Faller at al.,
2008). A member of the RNaseIII family cleaves the pri-miRNA to form a single hairpin
structure, referred to as pre-miRNA (Figure 1.4., Murchison et al., 2004). Pre-miRNAs
produced from spliced introns are also called mirtrons. Pre-miRNAs are exported from
the nucleus by the nucleocytoplasmic Exportin-5.

Once exported, Dicer, which is

another RNAseIII family member, cleaves the pre-miRNA to produces a 20-25nucleotide miRNA duplex (Figure 1.4. B, Lund et al., 2006).
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Figure 1.4. MicroRNA biogenesis. Pri-miRNAs produced by pol II result in a transcript
that is capped at the 5’ end and polyadenylated. The resulting pri-miRNA folds into a
secondary double-stranded structure. Drosha cleaves pri-miRNAs to form pre-miRNAs
that are exported from the nucleus by Exportin-5. Dicer cleaves the pre-miRNAs to
produces a 20-25-nucleotide miRNA duplex with a 2-nucleotide overhang on the 3’ end.
MiRNAs and their target mRNA interaction cause either mRNA degradation or
translational repression (Adapted from Hoffmann, et al., 2012).
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Dicer cleavage creates a 2-nucletoide overhang on the 3’ end of each miRNA strand
(Lund et al., 2006, Murchison et al., 2004).
1.7.2.3. Plant miRNAs
Unlike mammalian miRNAs, plant miRNAs usually have a near-perfect base
pairing interaction with their target mRNAs. Plant pri-miRNAs are generally transcribed
by pol II from independent non-coding intergenic regions, by inverted duplication of
protein-coding or non-protein-coding regions. This accounts for the extensive target
complementarity required by plant gene regulation mechanisms. The majority of primiRNAs encode a single mature miRNA. Therefore, pri-miRNAs derived from intron
splicing are rare (Axtell et al., 2011). Processing of pri-miRNAs to a mature miRNA
duplex occurs in the nucleus by an RNaseIII Dicer homolog, Dicer-like 1 (DCL1). The
miRNA duplex is also methylated at the 3’ overhang by an RNA methyltransferase
protein called Hua-Enhancer 1 (HEN1); which has not been observed in mammalian
miRNAs. The duplex is then transported from the nucleus by an Exportin-5 homolog
called Hasty (HST, Axtell et al., 2011, Lelandais-Briere et al., 2010).
1.7.2.4. Small interfering RNAs
In 1999, Baulcombe and Hamiliton discovered small interfering RNAs (siRNAs)
while studying viral infection in plants (Hamilton and Baulcombe, 1999). However,
siRNAs can also be endogenous (endo-siRNA) generated by three mechanisms; (i) a
perfect match hairpin derived from inverted repeats, (ii) a cis-natural siRNAs (cis-nat
siRNAs) transcribed from the same genomic locus as their target but from the opposite
DNA strand or (iii) trans-natural siRNAs (trans- nat-siRNAs) transcribed at different loci
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that encode for a gene and a pseudogene (Figure 1.5A, Elbashir et al., 2001). EndosiRNAs are generated by a similar mechanism as miRNAs mentioned above (1.7.2.2.).
However, exo-siRNA precursors originate from viral infection generated by an RNAdependent RNA polymerase and processed by a cytosolic RNAseIII member (Figure 1.5,
D.). On the other hand, endo-siRNAs are first transcribed and processed within the
nucleus by an RNAseIII member then transported to the cytosol by an Exportin-5
homolog, as observed in mammalian miRNA biogenesis (Figure 1.5.). The resultant
mature siRNAs duplexes contain a phosphorylated 5’ end and a hydroxylated 3’ end with
a two-nucleotide overhang (Bernstein et al., 2001, Elbashir et al., 2001).
1.8. MiRNA and siRNA structure leads to function
When Dicer processes long dsRNA RNA molecules, the PAZ domain binds to the
3’ end of the RNA substrate to aid in stabilization of the dsRNA for cleaving.

Upon

binding, dsRNA interacts with the intermolecular dimer of two RNAseIII domains of
Dicer. Each RNAseIII domain cleaves one of the two-dsRNA strands and creates the
canonical 3’ 2 nucleotide overhang (Tomari and Zamore, 2005). This interaction and
subsequent enzymatic reaction yield products of 20-25 nucleotides long. Argonaute
proteins preferentially bind and keep the stand with the less stable paired 5’ end of the
small dsRNA. The passenger strand is degraded from the complex. Thermodynamically,
the unwinding of A:U bonds are preferred to G:C bonds because of the fewer hydrogen
bonds necessary to disrupt, hence, A:U rich 5’ ends are preferred. Binding of the small
RNA to Argonaute requires ATP for conformational changes to accommodate the small
RNA (Kim, 2005). The “slicer” activity of Argonaute takes place within the Piwi domain
where the phosphodiester linkage between nucleotides of the target mRNA are cleaved.
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Figure 1.5. Origins of small non-coding RNAs. A. Endo-siRNAs originate from hairpin
derived from inverted repeats, cis-natural siRNAs, or trans-natural.

B. MiRNAs

biogenesis. D. Exo-siRNA precursors originate from viral infection. Dicer processes
small RNAs in the cytosol to produce effector RNAs.
Meisster, 2011)
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(Adapted from Rother and

Once the cleaved mRNA is removed from the complex the guide strand can remain
bound to Argonaute to engage another target mRNA (Tomari and Zamore, 2005).
1.9. Post-translation modifications by SUMOylation
In 1997, Melchior discovered a mysterious protein mobility shift that was due to
the addition of a novel protein modification that she would later name SUMO (small
ubiquitin-related modifier). This later lead to the discovery of the post-translational
modification pathway called SUMOylation described as the reversible addition of a
SUMO (small ubiquitin-like modifier) peptide (90-110 amino acids) to a protein substrate
(Mahajan et al., 1997). Unlike ubiquitination, where proteins are polyubiquitinylated and
sent to lysosomes for degradation, the addition of a SUMO peptide aids in protein
localization, stabilization and activity (Hay, 2005, Komander and Rape, 2012). The
addition of SUMO has been observed in proteins involved in DNA repair, transcription,
RNA processing, nuclear-cytoplasmic transport, stress response and progression through
the cell cycle (Hay, 2005, Liu and Shuai, 2008).
The pathway is initiated through the cleavage of a SUMO precursor by a protease
called Ulp1 (ubiquitin-like protease 1).

Ulp1 is a cysteine peptidase that is highly

specific for the SUMO peptide as it recognizes the tertiary structure of SUMO rather than
an amino acid sequence (Mossessova and Lima, 2000). To form a mature SUMO, Ulp1
cleaves amino acid residues from the C-terminal end of the SUMO precursor to reveal a
di-glycine motif that is required for attachment to target proteins (Figure 1.6, A.). Ulp1
cleaves peptide bonds via hydrolysis that involves a thiol group of a cysteine residue as a
nucleophile, a histidine and an aspartic acid, which forms the Ulp1 catalytic triad. The
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Figure 1.6. The SUMOylation pathway. The SUMOylation pathway is initiated by the
presence of a SUMO precursor that is cleaved from the C-terminal end to reveal a diglycine motif by Ulp1 (A). The mature SUMO is transferred to an E1 then E2 complex
(B, C).

E3 ligates SUMO to a protein substrate (D), which recognizes the KxE

consensus sequence (where  is a large hydrophobic residue and x is any residue). Ulp1
also removes SUMO from conjugated protein substrates (E). (Adapted from Hay, 2013)
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mature form of SUMO with its revealed di-glycine motif is transferred to the catalytic
cysteine of an E1 activating enzyme by the formation of a thioester bond (Figure 1.6, B.).
Next, SUMO is transferred to the catalytic cysteine residue in the E2 conjugating enzyme
which directly binds to a protein substrate. SUMO is then conjugated to the protein
substrate by an E3 ligase that recognizes a KxE consensus sequence (where  is a large
hydrophobic residue and x is any residue) on the protein substrate (Figure 1.6. C and D.).
The carboxyl group of the di-glycine motif is ligated to the –amino group of a lysine
residue on the substrate. Ulp1 is also responsible for the removal of SUMO from
SUMOylated proteins (Mossessova and Lima, 2000, Watts 2013).
1.10. Research Objectives
Toxoplasma contains all the canonical components of a post-transcriptional gene
silencing mechanism including RNAi genes Argonaute and Dicer as well as effector
RNAs. Although an RNAi-like gene silencing can be observed in Toxoplasma with long
dsRNA, the functions of the underlying mechanism are still unknown. The following
chapters describe my investigation towards the better understanding of RNA directed
gene regulation in Toxoplasma.
The first goal (Chapter 2) describes the development of a reporter system
allowing for the study of gene silencing in Toxoplasma. Using our dual luciferase
reporter system we investigated the ability of endogenous Toxoplasma miRNAs to induce
a gene silencing effect (Chapter 3). The Renilla luciferase transcript was engineered to
contain binding sites for the two most abundant miRNA families, miR-60 and miR-4.
The silencing effect caused by endogenous miRNAs could be altered by the use of
miRNA mimics and inhibitors. As the most abundant miRNA family, miR-60 was
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directed to down-regulate a gene of interest for functional studies.

This new

methodology proved extremely useful for fast and efficient down-regulation of an
essential and non-essential gene. We compiled a comprehensive review on antisense
RNA technologies and their current uses in Toxoplasma in Chapter 4. This review
outlines the applications, advantages and disadvantages of antisense RNA as a genetic
modifier. Although Toxoplasma miRNAs are functional, their underlying importance in
gene regulation induced gene silencing remained unclear. Chapter 5 describes my work
on the identification and characterization of a model gene target of Toxoplasma miRNAs.
This endeavor uncovered an interesting self-regulating gene (TgUlp1) by the miR60
family whose expression and activity could greatly impact overall parasite cell biology.
Disregulation of TgUlp1 expression created a cascade of events that can lead to parasite
termination. Chapter 6 describes my work on Toxoplasma Argonuate. Even though the
expression of TgAgo has been identified to a single locus, two forms of TgAgo are
expressed. Further investigation is still required in this area however these are the first
studies to suggest that multiple forms of Argonaute could arise from alternative
translational start sites.
Overall, this dissertation reveals the importance of proper gene regulation directed
by non-coding RNAs in Toxoplasma. These studies have led to the development of a
methodology that can be used as a genetic tool to quickly and efficiently down-regulate a
gene for functional analysis and to study its importance to parasite cell biology. Thereby,
this tool could also lead to quicker and more effective drug development studies.
Although the use of synthetic siRNAs in biomedical research to induced gene silencing
as a drug therapy is promising (Schiffelers et al., 2004), and Tg-miRNA mimics and
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inhibitors could be directed as an anti-Toxoplasma therapy, these studies were first aimed
at understanding the post-transcriptional gene silencing mechanism by miRNAs.
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CHAPTER 2
Evaluation of the ability of short and long double-stranded RNAs to induce homologous
gene silencing in the protozoan parasite, Toxoplasma gondii
2.1. Introduction
Since its discovery (Elbashir et al., 2001 and Fire et al., 1998), RNA interference
(RNAi) has become one of the most effective tools used in biological research for
altering gene expression patterns for studying functional genetics. The RNAi
methodology has expanded to serve many applications and purposes in both diagnostic
and medical sciences (Grimm, 2009 and Kim and Rossi, 2008). Fundamentally, RNAi is
a naturally occurring, evolutionary conserved, highly efficient and specific pathway by
which short double-stranded RNAs (dsRNA) trigger the inhibition of gene expression
(Carthew et al., 2009 and Meister et al., 2004). In metazoans, dsRNAs are expressed in
the form of long primary transcripts, called pri-miRNAs. Pri-miRNAs are single, foldback molecules that form dsRNA structures by intramolecular interactions, which are
then processed by one or more RNAseIII members (i.e. Drosha and Dicer) into short and
functional silencing RNAs, called miRNAs (Carthew et al., 2009 and Grimm, 2009). One
single strand of the miRNA, called the mature guide or antisense strand, is then loaded
onto the RNA-induced silencing complex (RISC), which allows it to bind its mRNA
target to induce gene silencing (Brodersen et al., 2009). In protozoans, such a mechanism
has been elucidated in Trypanosoma brucei, a parasitic and pathogenic kinetoplast (Ngo
et al., 1998), which has a more complex silencing mechanism than Tetrahymena, a
ciliated paramecium (Schramke et al., 2004).
The discovery of an RNAi mechanism in T. brucei (Ngo et al., 1998) has sparked
considerable interest in exploiting the mechanism for the study of pathogenesis in a
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variety of pathogenic protozoan parasites, including T. cruzi (Chagas disease),
Leishmania

spp.

(leishmaniasis),

Plasmodium

spp.

(malaria)

and

T.

gondii

(toxoplasmosis). Limited success has been reported (Kolev et al., 2011), and its possible
causes could lay in their evolutionary divergence (Ullu et al., 2004). The genome
sequence revealed the absence of RNAi genes in T. cruzi (El-Sayed et al., 2005) and oldworld L. major and L. donovani (Ivens et al., 2005), thus explaining their lack of response
to dsRNA. Enigmatically, P. falciparum, whose genome lacks conserved RNAi-genes,
was shown to exhibit homologous gene silencing, akin to RNAi, where dsRNA could
trigger down-regulation of gene expression (McRobert et al., 2002). Based on their
evolutionary divergence, only some species have conventional RNAi genes and
functions; while others retain only some homologs and/or functions. More investigations
are required to unravel the mechanism of homologous gene silencing and to render a
fruitful genetic tool for these protozoan parasites.
Among these evolutionarily distant protozoan organisms, T. gondii harbors an
ortholog of Dicer, Argonaute and RNA-dependent RNA polymerase (Al Riyahi et al.,
2006, Braun et al., 2010 and Kolev et al., 2011). T. gondii, an obligate intracellular
parasite of the phylum Apicomplexa, is one of the most successful parasitic pathogens
that has infected an estimated one third of the population and is a major threat in
immunocompromised individuals (Montoya and Liesenfeld, 2004). To gain a better
understanding of the biology and pathogenesis of T. gondii, a homologous gene silencing
via RNAi methodology offers an excellent genetic tool. Although the canonical RNAi
mechanism has not yet been demonstrated in T. gondii, it was shown that miRNAs in T.
gondii (Tg-miRNAs) are expressed in a high abundance in some lineage strains such as,
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RH (type I), PRU (type II) and CTG (type III) (Braun et al., 2010). Some of these
annotated Tg-miRNAs were shown to associate with translation machinery, suggesting
their functions in the regulation of gene expression similar to other eukaryotes. Moreover
the possible targets of Tg-miRNA were predicted to interact by perfect or partial basepair interaction similar to those of siRNA and miRNA of other eukaryotes (Braun et al.,
2010).
Despite a lack of a mechanistic characterization, our group is one of few
laboratories which successfully showed that homologous gene silencing, similar to RNAi,
is functional and can be used in the study of T. gondii biology (Al-Anouti and
Ananvoranich, 2002, Al-Anouti et al., 2003, Al-Anouti et al., 2004, Adams et al., 2005,
Ananvoranich et al., 2006, Yu et al., 2008 and Yu et al., 2009, Holmes et al., 2010).
However, these results have proved difficult to reproduce in other laboratories (Kolev et
al., 2011). Here, in an attempt to standardize homologous gene silencing in T. gondii, a
dual luciferase reporter system was employed so that the expression of Photinus (firefly,
Ffluc) and Renilla (Rnluc) luciferases, served as an internal control and a test target,
respectively. Such a reporter system would allow any interested laboratories to set up
comparable experiments to ensure reproducibility of the RNAi activity. A similar reporter
system was successfully used in the study of an RNAi mechanism in mammalian cell
cultures, including Hela, Cos-7 and Huh-7 cells (Choe et al., 2010 and Elbashir et al.,
2001). The reporter system would thus allow for an unbiased analysis of the silencing
capability and effectiveness found in T. gondii, in comparison to those of other
organisms. In addition, we have demonstrated that both long and short dsRNA are
capable of invoking homologous gene silencing in T. gondii with different silencing

36

abilities. Here we referred to the short dsRNA with perfect-matched central bases as
“siRNA”, and that with mismatched central bases as “miRNA”. This study was the first
to show the ability of miRNA to induce gene silencing in T. gondii.
2.2. Material and Methods

2.2.1. Cell and parasite cultures

Human foreskin fibroblasts (HFF; ATCC, #1041) were maintained using
Dulbecco’s Modified Eagle Media (D-MEM) with high D-glucose and L-glutamine
(Invitrogen, #12100046) supplemented with 10% cosmic calf serum (ThermoFisher
Scientific,

Hyclone,

#H3008704N)

and

diluted

(0.5x)

Antibiotic-Antimycotic

(Invitrogen, #15240-062) at 37 °C in 5% CO2. RHΔHX, T. gondii type I strain (NIH
AIDS Research and Reference Reagent Program, #2857) was cultured in confluent HFF
using Minimum Essential Media (MEM, Invitrogen, #61100061) supplemented with 1%
dialyzed fetal bovine serum (ThermoFisher Scientific, Hyclone, #SH3007903) and
diluted (0.5x) Antibiotic-Antimycotic.

2.2.2. Reporter plasmids
Expression plasmids, pTubRn and pTubFf, were derived from pRL-3xBulge and
pFL-Con (Pillai et al., 2005) and pTub_eGFP_mCherry_CAT which were gifts from W.
Filipowicz (Friedrich Miescher Institute for Biomedical Research, Switzerland) and J.
Murray (University of Pennsylvania, USA), respectively. In separate reactions, the DNA
fragments containing the coding sequence of Rnluc and miRNA-testing target sites and
the coding sequence of Ffluc were excised from the plasmids pRL-3xBulge and pFL-Con
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following (i) Not I digestion, (ii) Klenow Fragment treatment, (iii) NheI digestion and
(iv) gel extraction. The resulting DNA fragment containing either designed Rnlucsilencing target or Ffluc was ligated to prepared pTub_eGFP_mCherry_CAT. In the
preparation of pTub_eGFP_mCherry_CAT, the coding sequence of eGFP_mCherry
fusion was removed following (i) Afl II digestion, (ii) Klenow Fragment treatment, (iii)
Nhe I digestion and (iv) gel extraction to give the cloning vector carrying the T. gondiiTubulin (TgTub) promoter and the polyadenylation signal, contained within the 3’-UTR
of T. gondii dihydrofolate reductase (TgDHFR), flanking the Rnluc or Ffluc coding
sequence, and chloramphenicol acetyltransferase cassette. Resultant pTubRn and pTubFf
plasmids were subjected to restriction endonuclease analyses and nucleotide sequencing
reactions to confirm their identity and correct open reading frame.

2.2.3. In vitro transcription of long and short dsRNAs
In vitro transcription reactions were carried out using either 2 μg DNA amplicons
or 2 μM annealed primers as templates in the presence of T7 RNA polymerase (~5 units),
80 mM HEPES-KOH (pH 7.5) 24 mM NaCl2, 2 mM spermidine, 40 mM DTT, 10 mM
rNTPs, and ~1 unit pyrophosphatase in 50 μL reaction mixtures at 37° C for 16 hours,
similar to previously described conditions (Al-Anouti and Ananvoranich, 2002).
Resultant RNAs were extracted with one volume of phenol-chloroform mixture (1:1),
subsequently precipitated and quantified using a spectrophotometer (Thermo Scientific
NanoDrop2000). The DNA amplicons were prepared using oligonucleotide primers
containing a gene specific sequence and the sequence of the T7 promoter, as listed in
Table 2.1, under standard conditions for Taq DNA polymerase (New England Biolabs).
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Table 2.1.

Oligonucleotide primers used in the study.

The sequence of T7 RNA

polymerase promoter and its complementary bases are in bold and underlined,
respectively.
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For Rnluc-dsRNAs, pTubRnluc was used as templates for PCR amplification using two
sets of oligonucleotide primers: FW_RnLuc_1 and RV_RnLuc_1 to yield RnlucdsRNA_1, or FW_RnLuc_2 and RV-RnLuc_2, to yield Rnluc-dsRNA_2. The amplicon
used in the generation of control dsRNA was amplified from a plasmid containing T.
gondii uracil phosphoribosyl transferase (TgUPRT) and a pair of oligonucleotide primers,
called FW_UP and RV_UP.
For short dsRNA in vitro transcription, annealed oligonucleotide primers were
used as templates. The oligonucleotide primers were designed to contain a
complementary sequence of the T7 RNA polymerase promoter and the target sequences
to independently generate sense and antisense strands of the RNA. The templates for the
sense RNA strand synthesis were formed by heating a mixture of 2 μM T7promoterGG
and Sense_Tpl for 5 minutes at 70 °C and slowly cooling to room temperature. The
mixture was then used in the in vitro transcription reaction. Similar procedures were
carried out to create the templates for the antisense strands carrying a perfect or mismatch
complementarity by using T7promoterGG to anneal with Antisense_match_Tpl or
Antisense_mismatch_Tpl respectively. Following the in vitro transcription, resultant
RNAs were quantified. Equal amounts of sense and antisense RNAs were mixed and
annealed by heating the mixture to 70 °C for 5 minutes and cooled to room temperature
to generate double-stranded silencing RNA with perfect-matched central bases (siRNA)
or with mismatched central bases (miRNA) (Figure 2.1.). The sense and antisense strands
of the control RNA were generated similarly using T7promoterGG to anneal with
Sense_CTRL or Antisense_CTRL, respectively, to create templates for in vitro
transcription reactions.
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Figure 2.1. Sequences of short dsRNAs.
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2.2.4. Dual luciferase assay following transfection by electroporation
Freshly lysed parasites were harvested and counted. Approximately 2x106
parasites were used for each transfection via electroporation using a BTX ECM 630
(1500 volts, 25 Ω, and 25 μF). For each transfection, reporter plasmids with or without
tested RNAs were mixed with harvested parasites in an electroporation mixture (400 μL)
containing 120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 (pH 7.6) 2 mM
EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione in a 4 mm-gap cuvette and
electroporated (Roos et al., 1994). Following electroporation, the parasites were cultured
in confluent HFF monolayers grown in T25 flasks using MEM media with L-glutamine
without phenol red (Sigma Aldrich, #M3024) and supplemented with 1% dialyzed fetal
bovine serum and diluted (0.5x) Antibiotic-Antimycotic at 37 °C in 5% CO2 for selected
periods.
For dual luciferase assays, the infected monolayers were harvested and lysed with
100 μL of 1x Passive Lysis Buffer (Promega, #E1531) and incubated for 10 minutes at
room temperature. Lysates were cleared of debris by centrifugation (10,000 x g for 1
minute), and the supernatant was kept on ice and used in the dual luciferase assay, which
was carried out in a 2-step fashion. For a Ffluc assay, 20 μL of lysate was added to a
freshly made reaction mixture (100 μL) containing 200 μM D-luciferin (Sigma Aldrich,
#L9504), 20 mM Tricine, 10 mM MgSO4, 5 mM DTT, 250 μM ATP and 250 μM
Coenzyme A. The mixture was incubated for 10 seconds at room temperature. For a
Rnluc assay, 20 μL of lysate was added to a freshly made reaction mixture (100 μL)
containing 0.1 μM Coelenterazine (Santa Cruz Biotechnology Inc, #sc-205908), 100 mM
K2HPO4/KH2PO4 (pH 7.67.6) 500 mM NaCl, 1 mM EDTA, and 0.02% BSA. The
mixture was incubated for 10 seconds at room temperature. The luminescence signals
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from both reactions were measured with a 20/20n Luminometer (Turner Biosystems).
Rnluc signals were normalized to Ffluc signals for a direct comparison across
independent experiments. For each experiment, the reporter plasmid electroporation
without tested RNA, called mock electroporation, was carried out to allow for the
measurement of the dual luciferase expression under independently tested conditions. At
least two independent experiments were performed.

2.3. Results and Discussion
2.3.1. Strategy and dual luciferase reporter system
In the design of the dual luciferase reporter system for the gene silencing study,
we aimed to have an equal transcript production of both transcription units. Therefore,
the reporter system was engineered so that the expression of both Ffluc and Rnluc are
under the control of a strong and constitutive T. gondii promoter, called TgTubulin,
which also provides the necessary 5’-UTR for the protein’s expression. Furthermore, to
ensure similar levels of transcript stability and protein synthesis from both constructs, the
3’-UTR of TgDHFR (dihydrofolate reductase) were placed downstream from the coding
sequence (Figure 2.2a.). The transcript derived from Rnluc was used as the target for the
homologous gene silencing by three different RNA modulators, including long dsRNA,
miRNA and siRNA, while the Ffluc transcript served as an internal control for
transfection, expression, and detection.
Due to the parasitic nature of T. gondii, in a gene expression and silencing
analysis, the reporter system and silencing RNAs would be introduced into the parasite
prior to infection of a host monolayer. We viewed that the success of the subsequent
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analysis would rely greatly on the viability of the post-electroporated parasite and the
efficiency of transfection. The viability of the post-electroporated parasite was evaluated
using the ability of the viable parasite to exclude trypan blue and propidium idodide
(Jones et al. 1985). From three independent experiments we detected that 75 ± 10% were
viable and able to multiply when up to 60 μg of nucleic acids (RNA or DNA) were used
in the electroporation conditions (see Material and Methods). The efficiency of
transfection was evaluated by determining the amounts of remaining and internalized
nucleic acids following electroporation. Nucleic acids (RNA or DNA) were randomly
labeled with fluorescein during in vitro transcription or PCR amplification, and used in
the electroporation. Approximately 52% of labeled nucleic acids were internalized (AlAnouti & Ananvoranich, unpublished data). We thus concluded that under similar
controlled conditions, the electroporation of nucleic acids (60 μg, DNA plasmids and/or
RNAs) would allow sufficient numbers of viable parasites for gene silencing assays.
Next we assessed the expression of our newly engineered dual luciferase system
to allow for a sensitive detection of a broad range of different silencing activities, while
remaining within a linear range for a direct comparison. Based on a previous report
(Behnke et al., 2008) using a similar reporter system in T. gondii, when a promoter of
interest and a well-characterized promoter were placed to control the expression of Rnluc
and Ffluc, respectively, the transfection was carried out using 60 μg of the Rnluc and
Ffluc reporter plasmids (1:2 ratio). Keeping the total amount of DNA used at 60 μg, we
varied the ratio of Rnluc:Ffluc at either 1:1, 1:2 or 2:1. All ratios tested yielded
reproducible data (Figure 2.2b). Consequently, the plasmid ratio at 1:1 was kept for
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Figure 2.2. Dual luciferase reporter system. (A) Schematic representation of mRNA
reporters used in this study. Numbers indicate the first nucleotide of the start codon and
the last nucleotide of coding sequence. The transcript encoding Rnluc was used as target
for the gene silencing study and from which silencing RNAs were designed (see Table
2.1 and Materials and Methods). (B) Dual luciferase expression was assayed using three
different ratios of Rnluc and Ffluc plasmids, while the total amount of plasmids were
kept at 60 µg for the transfection. The graph is a representative of compiled experimental
results. (C) Dose-response of dual luciferase expression was assessed when the ratio of
Rnluc:Ffluc plasmids were kept at 1:1 ratio. The expression of the dual luciferase is
shown as relative Rnluc/Fluc light forming units. The assays were carried out 24 hours
post-electroporation. Values were obtained from at least two independent experiments.
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simplicity. Other experimental parameters, including the total plasmid concentration, the
number of extracellular parasites, and incubation time (post-transfection and conditions
luciferase assays), were evaluated in different combinations to establish optimization for
the study. When varied numbers of harvested parasites were used in the transfection,
~105-106 freshly released parasites were the most suitable for the study because the
parasites remained intracellular at 24, 48 or 72 hours post-electroporation under the
conditions tested (see Materials and Methods). These data indicated that both
transcription units were efficiently expressed and maintained during the testing period (3
days). Because lower amounts of the reporter system were used in other eukaryotic
systems (Choe et al., 2010 and Elbashir et al., 2001), we thus progressively lowered the
total amounts of plasmids from 40 to 0.2 μg (Ffluc:Rnluc = 1:1) so that the gene silencing
data could be directly compared. It was detected that within the amounts of plasmids
tested; both transcription units were still sufficiently expressed and allowed for detection
within a linear range (Figure 2.2.). In all succeeding silencing analyses, 1 μg of each
reporter plasmid (2 μg total) was used.

2.3.2. Homologous gene silencing by long double-stranded RNA
Long dsRNAs (ca. 300-800 nts) have previously been shown to induce
homologous gene silencing in T. gondii (Al-Anouti and Ananvoranich 2002, Al-Anouti et
al., 2003, Al-Anouti et al., 2004, Ananvoranich et al., 2006, Holmes et al., 2010). To test
our newly developed reporter system, two species of long dsRNAs were designed to have
homologous sequences to the Rnluc mRNA. Rnluc-dsRNA_1 (596 nts) was homologous
to nucleotides 12 to 607 of the Rnluc coding sequence, and Rnluc-dsRNA_2 (589 nts)
was derived from the Rnluc coding sequence at nucleotides 458-933 and the proximal
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region (113 nts) of its 3’-UTR (Table 2.2.). These long dsRNAs have an overlapping
region (149 nts) spanning the nucleotides 458 to 607 of the Rnluc coding sequence.
Using these dsRNAs, we aimed to evaluate whether dsRNAs derived from these regions
exhibited similar silencing inducing ability. This in turn would reflect inter-molecular
interactions formed between the mRNA target and different dsRNAs, given potential
structural preferences.
To determine the extent of dsRNA ability to induce gene silencing, varied
amounts of tested dsRNAs (0.25 to 4 μg) were co-transfected along with 2 μg reporter
plasmids (1:1) by electroporation. When 0.25 μg dsRNA was used, a negligible reduction
(<10%) of the relative Rnluc/Ffluc level was detected at 24 hours post-electroporation
(Figure 2.3, A). A clear silencing effect (~30-40%) was observed when 0.5 μg of RnlucdsRNA_1 and 2 were used and able to reduce the relative Rnluc/Ffluc level to 73 ± 4 %
and 61 ± 1%, in comparison with a mock silencing control (without dsRNA). The
silencing effects were slightly increased when higher amounts of both dsRNAs were
used. The maximal silencing ability was observed when 2-4 μg dsRNA caused the
relative Rnluc/Ffluc reduction to 52 ± 10% and 62 ± 1% for Rnluc-dsRNA_1 and
dsRNA_2, respectively at 24 hours post-electroporation (Figure 2.2a). Similar levels of
silencing were observed when the electroporated parasites were allowed to incubate
longer, and the dual luciferase assays were carried out at 48 hours post-electroporation
(Supplementary Figure 2.1.). The findings suggested that the transfection of long
dsRNAs at 2 μg or ~5.1 pmoles, despite their targeted regions, have saturated the
silencing machinery and reached their maximal ability to cause a silencing effect under
conditions tested.
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Table 2.2. List of silencing RNAs used in the study. Numbers of the nucleotides are
corresponding

to

the

Rnluc

transcript
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depicted

in

Figure

2.2a.

Figure 2.3. Gene silencing effect caused by (A) long dsRNA was detected at 24 hours
post-electroporation (B) and siRNA and miRNA at 24 hours and 48 hours post- plasmids
(1 µg of each Rnluc and Ffluc plasmid) in the absence of tested silencing RNAs.
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Figure Supplementary 2.1.

Gene silencing effect caused by Rnluc-dsRNA_1 was

detected at 24 and 48 hours post-electroporation.
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To evaluate the specificity of the homologous gene silencing, an unrelated dsRNA
whose nucleotide sequence is different from the intended target (the Rnluc transgene) was
tested under similar conditions. TgUPRT dsRNA (629 nts) did not cause any silencing
effect on Rnluc expression (Figure 2.3a, the lightest shaded bars), indicating that the
silencing effect is sequence specific. The presence of unrelated dsRNA (as high as 4 μg
or 10.3 pmoles) did not affect the activity of Rnluc or Ffluc. It thus indicated that in a
unicellular organism, such as T. gondii, the presence of long dsRNA in a large quantity (4
μg) did not cause a general cellular response affecting the transcription processes and/or
the degradation of gene products over the tested conditions.
In summary, we have confirmed that a homologous long dsRNA has the ability to
induce gene silencing in T. gondii. DsRNA exhibited the ability to induce Rnluc silencing
and to drop the relative Rnluc/Ffluc to 60% in comparison to a mock electroporation.
This silencing effect (~40% reduction of gene expression) was considered a mild effect in
comparison to when miRNA was used in silencing (~80% reduction) the expression of
Rnluc in mammalian cell cultures (Choe et al., 2010 and Elbashir et al., 2001). However,
such a mild silencing ability could be useful, when it is sufficient to produce a detectable
phenotype (i.e. the change in an enzymatic activity). However, when TgUPRT or
Toxoplasma lactate dehydrogenases (TgLDHs) were silencing targets, their homologous
dsRNAs were able to reduce their expression by ~90%. In those experiments, Al-Anouti
et al., (2003) detected the silencing outcomes by radioactive uracil uptake assays for
TgUPRT study and by in vitro and in vivo growth and differentiation assays for TgLDH1
and TgLDH2 experiments (Al-Anouti et al., 2004). It is highly likely that the level or
extent of silencing effect is gene-dependent, since here the silencing effect towards Rnluc
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was observed at ~40%, similar to that of Toxoplasma enolase experiments (Holmes et al.,
2010).
Despite its mild silencing ability, a homologous dsRNA-induced gene silencing
procedure offers a very easy-to-use method. One would require little information about
the gene target, such as the sequence of the transcripts or the exons, prior to initiating a
silencing protocol. Moreover, long dsRNAs can quickly be synthesized in a very costeffective way via in vitro transcription. One drawback of the system would be due to its
inherited long target region(s). When more than one species of transcripts are produced
from the same exon(s), the long homologous dsRNA would not be able to discern one
transcript over another. Considering its pros and cons, this homologous dsRNA-induced
gene silencing methodology is a valuable method-of-choice. Keeping in mind, with its
potentially mild silencing ability, the lack of a desirable phenotype might not indicate the
failure of the silencing procedure, but could be an indication of the critical level of gene
expression required for maintaining a phenotype.
2.3.3. Homologous gene silencing by short double-stranded RNAs
Due to their availability and reliability to induce gene silencing, gene-specific siRNAs
and miRNAs have become powerful reagents used in biological research. Recent
genomic and biochemical research has pointed that the T. gondii genome harbors both the
RNAi genes and miRNAs (Al Riyahi et al., 2006, Braun et al., 2010, Kolev et al., 2011).
It was thus crucial to investigate whether difference in complementarity could induce
gene silencing of designated gene target. Based on predicted secondary structures and
known constraints of short dsRNAs (Kim et al., 2005), we used the mfold nucleic acid
folding and hybridization prediction software (Zuker 2003) and SciTool RNAi design
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software (Integrated DNA Technologies, Inc., Iowa) to predict the most probable target
sites and to design short dsRNAs specific to the Rnluc transcripts. Twenty possible
targets and siRNA candidates were predicted and ranked from the most to the least
probable location for the interactions. We chose the three most probable sites located
between the Rnluc stop codon and the proximal region (103 nts) of its 3’-UTR (Table
2.2). Two silencing RNAs were designed and synthesized for the study. One contains
nucleotides perfectly complementary to its target, representing a siRNA interaction;
while the other, with five-central nucleotide mismatch, represents a miRNA interaction
(Figure 2.1). These silencing RNAs have three possible recognition sites located within
the 3’ UTR between the nucleotides 943 and 1022 of the Rnluc transcript (Table 2.2).
Varied amounts of siRNA and miRNA (0.25 to 4 μg, or 15 to 246 pmoles) were
independently tested for their ability to induce gene silencing using conditions similar to
those tested for the long dsRNA-induced gene silencing. At 0.25 or 0.5 μg, siRNA was
better than long dsRNA or miRNA (at the same amounts) to lower the Rnluc expression
(Figure 2.3b upper panel) at 24 hours post-electroporation. Both siRNA and miRNA at 1
to 4 μg exhibited similar ability to silence the expression of Rnluc (~60% reduction).
Interestingly, when the silencing assays were carried out at 48 hours post-electroporation,
the effect was more pronounced for all amounts of siRNA and miRNA tested (Figure
2.3b, lower panel). Both siRNA and miRNA (at 0.25 μg) exhibited similar silencing
ability (54 ± 2% reduction), which was higher than those at 24 hours. At higher amounts
used, miRNA seems to show slightly better ability than siRNA to induce gene silencing.
This silencing effect was not detected with an unrelated small RNA at either 24 or 48

54

hours (Figure 2.3, B, lightly shade bars), confirming the homologous nucleotide
specificity.
An enhanced silencing effect found at a longer incubation was not observed in
dsRNA-induced gene silencing (Figure S2.1.). It is possible that siRNA- or miRNAengaged machinery could be more stable than, or different from, that of a dsRNA-system.
Considering the nature of transient expression of the reporter plasmids, the more stable
the silencing machinery is, the more robust the machinery is to compete against the
expression of reporters. Another possibility could be due to the presence of an RNAdependent RNA polymerase, to which T. gondii carries a homologue, which would allow
for the amplification of short dsRNAs using the transcripts as templates. Thus, their
silencing ability would remain longer and could be enhanced as long as the transcript is
present.
In summary, our findings clearly indicated that small silencing RNAs (siRNA and
miRNA) are able to specifically induce gene silencing in T. gondii. This study is the first
to demonstrate the activity of miRNA in gene silencing in the Apicomplexan protozoan
parasites. More importantly, we showed that the silencing effect was within the range
(~80% reduction siRNA and miRNA tested (Figure 2.3b, lower panel). Both siRNA and
miRNA (at 0.25 μg) exhibited similar silencing ability (54 ± 2% reduction), which was
higher than those at 24 hours. At higher amounts used, miRNA seems to show slightly
better ability than siRNA to induce gene silencing. This silencing effect was not detected
with an unrelated small RNA at either 24 or 48 hours (Figure 2.3b, lightly shade bars),
confirming the homologous nucleotide sequence was required.
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2.3.4. Which silencing RNA (long dsRNA, siRNA and miRNA) is the best to induce
homologous gene silencing?
Using the dual luciferase reporter system, we demonstrated that silencing RNAs,
including long dsRNA, siRNA (perfect-match bases) and miRNA (central-mismatch
bases), were capable of inducing gene-specific silencing. Long dsRNA exhibited the least
silencing effect (~40% reduction of gene expression). The mild silencing effect was
maintained for 48 hours, which could be due to (i) additional processing steps required to
process the long dsRNA into small silencing RNAs, or (ii) a different silencing
mechanism being engaged. As stated earlier, long dsRNA-induced gene silencing could
be a useful tool when a quick assessment is required for evaluating a putatively essential
gene. In a shorter tested period (24 hours), siRNA and miRNA were equally effective
where the silencing effect was ~50%. When a prolonged and high silencing effect is
required, miRNA offers the best tool among these tested silencing RNAs. Tested miRNA
affected the Rnluc expression the most (80% reduction), which is equivalent to those
tested in different mammalian cell cultures (Choe et al., 2010 and Elbashir et al., 2001).
Therefore, we concluded that miRNA, with central-mismatch bases, is the best silencing
RNA to use when a homologous gene silencing is required for the study of a gene of
interest.
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CHAPTER 3
Utilization of inherent miRNAs in functional analysis of Toxoplasma gondii genes
3.1. Introduction
Toxoplasma gondii, a member of the phylum Apicomplexa, is one of the most
successful intracellular parasitic pathogens. It was reported that up to one third of the
world’s population has been infected, and could develop a disease called toxoplasmosis
(Montoya and Liesenfeld, 2004). In general T. gondii infection does not cause clinical
illness because the parasite in its rapidly growing tachyzoite form could easily be cleared
by the host’s immune system during the initial course of infection. If not cleared, residual
tachyzoites could differentiate into slowly growing bradyzoites, which could be very
resistant to an immune response and persist throughout the lifetime of the infected human
host. When the dormant bradyzoites reconvert to tachyzoites, they could cause a relapse
leading to fatality in individuals with weaken immunity (Cenci-Goga et al., 2011).
Throughout the life cycle of T. gondii, a tight regulation of gene expression is
required to ensure and sustain its viability (i) within its human and other non-definitive
hosts during its asexual cycle including tachyzoite –bradyzoite interconversion, and (ii)
within the gut of feline definitive host during its sexual reproduction to yield zygotecontaining cysts or oocysts (Montoya and Liesenfeld, 2004). To date, various molecular
and genetic tools have been generated and employed to modulate the expression of the
gene of interest at various stages of parasite development and aimed at gaining a better
understanding of its function(s) in the host-parasite interaction and pathogenesis (Roos et
al., 1994 and Boothroyd et al., 1997). An effective molecular manipulation of the
parasites could easily be achieved following a transfection via electroporation of the
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1994 and Boothroyd et al., 1997). In 2007, Meissner and co-workers reviewed and
cataloged molecular tools available for T. gondii to include reliable non-homologous and
homologous recombination, as well as an elusive RNAi-targeting technology. T. gondii
tool box has continuingly been expanded to include a tetracycline-inducible gene
expression system (Meissner et al., 2001, van Poppel et al., 2006 and Jammallo et al.,
2011), a site-specific cre/loxP-based recombination system (Heaslip et al., 2010), and a
ligand-induced protein stability system (Herm-Götz et al., 2007). Moreover, homologous
recombination events could be enhanced with the use of a permissive parasite strain
(Huynh and Carruthers, 2009) and well-designed plasmid systems (Upadhya et al., 2011).
The Miessner group later reviewed and cataloged advantages and disadvantages of
currently available controllable gene expression systems acting at either transcriptional
and/or post-transcriptional levels (Jiménez-Ruiz et al., 2014). In June 2014, two reports
showed that CRISPR (clustered regularly interspaced short palindromic repeats)
technology can successfully be applied to engineer the genome of T. gondii and to allow
for deletion, replacement, site-directed mutagenesis and epitope tagging (Shen et al.,
2014 and Sidik et al., 2014). Collectively these methodologies have enabled a selective
and specific down-regulation of a gene of interest and proven to be very valuable.
Although many sophisticated and varieties of genetic tools have become
available, RNA-based silencing techniques have not yet been explored and improved to
provide consistent outcomes. One contributing factor could stem from the lack of
understanding of how endogenous RNA effectors (miRNAs and/or siRNAs) and their
engaged machineries operate at molecular levels in T. gondii. The presence of hallmark
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RNAi genes have been repeatedly confirmed in T. gondii to include Argonaute (TgAgo),
Dicer, and an RNA-dependent RNA polymerase (Ullu et al., 2004, Al Riyahi et al.,
2006, Braun et al., 2010 and Kolev et al., 2011). Tg-miRNAs have been detected via
deep-sequencing methodologies (Braun et al., 2010, Wang et al., 2012 and Xu et al.,
2013). It was also shown that T. gondii harbors a chimeric RNAi mechanism containing
plant- and fungal-like effector RNAs, and metazoan-like RNAi genes (Braun et al.,
2010). Musiyenko et al. (2012) further demonstrated that TgAgo displays a weak target
RNA cleavage activity linked to its lack of canonical DDE/H catalytic triad. A greater
target RNA cleavage activity was observed upon the subsequent association of a Tudor
staphylococcal nuclease (TSN) and a protein Arg methyl transferase, PRMT1. The study
strongly suggested that the RNA-induced silencing complex of T. gondii utilizes the
slicer activity of TSN as for partially mismatched miRNA target pairs, and that of Ago
for a perfectly matched miRNA target pairs. With its unique silencing machinery and/or
mechanism, the RNA-directed gene silencing can effectively be achieved in T. gondii.
Taken together these findings, a consistent RNA silencing methodology for T. gondii
should be within reach.
The study here was aimed to gain a better understanding of how T. gondii utilizes
its miRNAs in the RNA silencing mechanism to give rise to eventual outcomes of down
regulation of gene expression. To do so, we used a dual luciferase reporter system to
evaluate (i) the extent of their silencing effect with the two most abundant Tg-miRNAs,
namely Tg-miR-60a and Tg-miR-4a, (ii) the nature of their interactions with target
transcripts, and (iii) the effect of Tg-miR-60a miRNA mimics and inhibitors on their
silencing effect. Furthermore, we explored the utility and versatility of Tg-miR-60a as a
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genetic tool in modulating the expression of a gene of interest. As a proof of concept, the
highly expressed Tg-miR-60 family was directed to control the expression of (i) DEADbox RNA helicase (TgHoDI), and (ii) a metabolically important lactate dehydrogenase
isoform 1 (TgLDH1). We showed that when the binding sites of Tg-miR-60a were
introduced into the parasite’s transcripts via homologous recombination at either locus,
the expression levels of the chosen genes can significantly be altered. It was thus proven
that Tg-miRNAs could be directed and controlled to assist in loss-of-function analyses.

3.2. Materials and Methods
3.2.1. Mammalian cell and parasite cultures
Human foreskin fibroblasts (HFF, ATCC-1041) were grown using Dulbecco’s
Modified Eagle Medium (DMEM) with high D-glucose and L-glutamine (Invitrogen,
#12100046) supplemented with 10% v/v cosmic calf serum (ThermoFisher Scientific,
Hyclone, # H3008704N) and diluted (0.5x) Antibiotic-Antimycotic (Invitrogen, # 15240062) and maintained at 37 °C in 5% CO2. RHΔHX, T. gondii type 1 strain, was obtained
from NIH AIDS Research and Reference Reagent Program (#2857); ∆Ku80 strain which
is a RHΔHX-derived strain, was obtained from Dr. Vern B. Carruthers (University of
Michigan). Unless stated otherwise, both strains were maintained in HFF using Minimum
Essential Medium (MEM, Invitrogen, #61100061) supplemented with 1% v/v dialyzed
fetal bovine serum (ThermoFisher Scientific, Hyclone, # SH3007903) and diluted (0.5x)
Antibiotic-Antimycotic.
3.2.2. Plasmid construction
The nucleotide sequences of primers used in the study are shown in Table 3.1.
The dual luciferase plasmid system, which was previously described in Crater et al.
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(2011), was adopted for the study. The system consists of two plasmids referred to as
pTubFf and pTubRnLet7a3x. The former was unmodified and served as an internal
control for transfection efficiency and expression assays. The latter was used as the
parental plasmid of all construction in the study to create multiple Rnluc expression
plasmids carrying one or three binding sites for any Tg-miRNAs. To replace the three
consecutive Hs-let-7a binding sites in the parental plasmid, Phusion High-Fidelity DNA
polymerase reaction (New England Biolabs, #F-530) was used according to the
manufacturer’s protocol with specific primer sets to reconstitute the desired binding
site(s). In addition, each primer of the set was designed to carry a partial sequence of one
chosen restriction endonuclease to allow for future restriction analyses of resultant
plasmids when they were reconstituted following construction. Once PCR reactions were
completed, the amplicons were purified, treated with T4 polynucleotide kinase
(Fermentas, #EK0031) and re-circularized using T4 DNA ligase (Fermentas, #EK0016).
pTubRn construct, which lacks the binding site for Tg-miRNAs, was generated using
FwRn and RvRn primers. For the construction of pTubRnMIR-60a3x plasmid to express
Rnluc transcripts carrying three binding sites of Tg-miR-60a, the primers named miR60aFw and miR-60aRv were used, and the newly generated EcoRI site was introduced
for its endonuclease analysis. Similarly, three primer pairs, including miR-4aAFw/miR4aARv, miR-4aBFw/miR-4aBFw, and miR-4aCFw/miR-4aCRv, were used in the
construction of plasmids to express Rnluc transcripts carrying three binding sites of TgmiR-4a with different complementary interactions, respectively. When the plasmids were
engineered to carry only one binding site, FwRn or RvRn primer was paired with another
primer with sequence encoding one or two binding site for Tg-miR-60a or Tg-miR-4a.
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Table 3.1. Oligonucleotide primers used in the study. The nucleotide sequence coding
for Tg-miRNA binding sites are in bold.
endonuclease recognition sites are in italics.
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Nucleotides corresponding to restriction

For example, FwRn was paired with miR-60aRv to generate a plasmid encoding for one
binding site of Tg-miR-60a. Following successful confirmation by restriction analyses, a
large scale plasmid preparation of reporter plasmids were prepared for a transfection by
electroporation, which the reporter plasmids (1 μg of Ffluc and 1 μg of Rnluc) were
introduced into approximately 2 x 106 freshly lysed parasites via electroporation using a
BTX ECM 630 (1500 volts, 25 Ω, and 25 μF) in a mixture (400 μL) containing 120 mM
KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4. pH 7.6, 2 mM EDTA, 5 mM MgCl2,
2 mM ATP, 5 mM glutathione in a 4 mm-gap cuvette.

3.2.3. In vitro transcription of miRNA mimics and inhibitors
Using partial DNA duplexes as templates, in vitro transcription reactions were
carried out in 50 μL-reaction mixtures in the presence of T7 RNA polymerase (~ 5 units),
80 mM Hepes-KOH, pH 7.5, 24 mM NaCl2, 2 mM spermidine, 40 mM DTT, 10 mM
rNTPs, and ~ 1 unit pyrophosphatase at 37 °C for 16 hours. Reactions were subsequently
extracted with one volume of phenol-chloroform mixture (1:1), and resultant RNAs were
precipitated and quantified (Thermo Scientific NanoDraop2000). As shown in Table 3.1,
oligonucleotide templates were designed to carry two parts of complementary sequence
(i) to encode for desirable resultant transcripts of the upper or lower strand of Tg-miR60a or Hs-let-7a, and (ii) to T7 RNA polymerase promoter (underlined, Table 3.1.). The
individual oligonucleotide template (2 μM) was annealed with an equimolar of
T7promoterGG following mixing and heating the mixture for 5 minutes at 70 °C and
slowly cooled to room temperature to yield partial DNA duplexes. One fifth of the
annealing reaction (or 400 nM of the partial DNA duplex) was used as templates for the
RNA synthesis. Resultant single-stranded RNA products, which were generated using the
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oligonucleotide template named miR-60a_upper or hs-let7a_upper, were referred to as
Tg-miR-60a inhibitor and Hs-let-7a inhibitor, respectively. When an equal amount of TgmiR-60a inhibitor was mixed and annealed with the single-stranded RNA products
obtained from the reaction using miR-60a_lower oligonucleotide template, the doublestranded RNA products was referred to as Tg-miR-60a mimic. Hs-let-7a mimic was
similarly generated from RNA products obtained from hs-let7a_upper and hs-let7a_lower
oligonucleotide templates. Quality of RNA products were verified by gel electrophoresis
to confirm their expected sizes prior to electroporation into freshly released parasites.

3.2.4. RNA isolation and RT-qPCR
Forty-eight hours following electroporation, total RNA was isolated from freshly
lysed parasites (approximately 3 × 106 parasites) using TRI reagent (Molecular Research
Center, Inc., #TR 118) according to the manufacturer’s protocol, and treated with RQ1
Rnase-Free Dnase (Promega, #M6101) for 60 minutes at 37 °C. RNA samples were
electrophoresed on a 1% agarose gel to verify for the presence of distinct rRNAs and
mRNA smear bands, and the absence of DNA templates. Samples were kept for future
use at −20 °C. Isolated total RNA (~500 ng) was annealed with 250 ng of an oligo-(dT)
following heating at 65 °C for 5 minutes and quickly cooled on ice. The reactions were
then divided in half. A half of each annealed reaction was used in a SuperScript III
reverse transcriptase (RT) reaction (Invitrogen #18080-093), while the other aliquot was
used in a control reaction in the absence of SuperScript III RT. The reaction mixtures
were diluted 1/10, and diluted samples were subjected to real-time qPCR using Kapa
Sybr Fast qPCR Kit Master Mix (2x) ABI Prism (Kapa Biosystems #KR0390) and
OneStepPlus thermocycler (Applied Biosystems). All test samples were analyzed to give
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technical triplicates. The expression level derived from the dual reporter system was
measured and calculated, so that the Rnluc expression from tested expression plasmid
was normalized by Ffluc expression using ΔΔCt protocol carried out by the StepOne
Software v 2.1 (Applied Biosystem). To generate a data set which allowed for
comparison across all technical and biological triplicates, the relative expression obtained
from the dual reporter system where Rnluc transcripts lack miRNA binding sites was
measured for each independent experiment set, and used for normalizing the effect of TgmiRNAs on the dual reporter expression.
3.2.5. Western blot analyses
Cell-free lysates were prepared by addition of an appropriate amount of RIPA
buffer to collected parasites, followed by sonication for 5 seconds. Protein concentration
was measured using the RC DC Protein Assay according to manufacturer’s instructions
(Bio-Rad Laboratories, #500- 0119). Approximately 10 μg was used for the analysis, of
which the lysates were denatured using 6x SDS protein loading dye and resolved on a
10% SDS-PAGE. The primary antibodies used were α-Flag mouse antisera (1:5,000,
Applied Biological Materials Inc., Richmond, B.C, Canada, #G191), α-tub mouse
antisera (12G10, 1: 1000, Developmental Studies Hybridoma Bank, University of Iowa,
USA), and α-TgLDH1 rabbit antisera (1:2,000, Yang and Parmley, 1997). The signals
were revealed using secondary antibodies: horseradish peroxidase (HRP) conjugated goat
anti-mouse antisera (Rockland Immunochemicals Inc., #610-1319) or HRP conjugated
goat anti-rabbit antisera (Rockland Immunochemicals Inc., #611-1322) at a 1:10,000
dilution, and a Chemiluminescent HRP Substrate Kit (Millipore, #WBKLS0500).
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3.2.6. Immunocytochemistry
HFF monolayers were cultured on coverslips until confluent, infected with ~1 x
106 freshly lysed parasites and incubated at 37 °C and 5% CO2. Infected monolayers on
the cover slips were rinsed three times with 1x phosphate buffer saline (PBS), fixed with
3% paraformaldehyde for 5 minutes and permeabilized with 0.25% Triton X-100 in PBS
for 10 minutes. Coverslips were then washed in 1x PBS and subsequently incubated in a
blocking solution (5% bovine serum albumin, BSA in PBS) with gentle agitation for 1
hour at room temperature. Coverslips were then incubated for 1 hour in a humidity
chamber with a specific primary antibody diluted in 2% BSA. The primary antibodies
used were α-FLAG mouse antisera at 1:500 dilutions and α-TgLDH1 rabbit antisera at 1:
5,000 dilutions. Coverslips were washed in 1× PBS (5 minutes, twice) and incubated for
1 hour with secondary antibody diluted in 2% BSA. Corresponding secondary antibodies
were used at 1:1000 dilutions. Cells were then incubated with Hoechst staining solution
(10 μM) at room temperature for 5 minutes, washed twice with 1x PBS and mounted on
glass slides. For the study carried out using extracellular parasites, the parasites were
collected and filtered through a 3-μm filtering set. Approximately 1 × 106 parasites were
transferred onto coverslips and further incubated for an hour to allow for adhering onto
the surface of coverslips. The coverslips were rinsed in 1x PBS, fixed with 3%
paraformaldehyde for 5 minutes and permeabilized with 0.25% Triton X-100 for 10
minutes. Subsequent blocking and antibody interaction steps were as same as those of
intracellular parasites. Image acquisition was carried out using a Leica DMI 6000B
inverted fluorescent microscope using HCX PL Apo 100×/1.40–0.70 objective and a
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Leica DFC 360FX camera with Leica Advanced Fluorescence Application Software
V.2.3.0. Post-acquisition image processing was performed with Adobe Photoshop 7.0.

3.2.7. Utilization of Tg-miR-60a family for loss-of-function analysis
3.2.7.1. Rationale
Despite their possible redundancy, most genes are tightly regulated to allow for
their necessary functions to display in a spatial- and temporal-specific manner. In order to
accurately assess the functionality of a gene, the pattern of spatial and temporal
requirements should be taken into consideration. Particularly when the specific gene
silencing was implemented, a natural expression profile of the gene product should be
used as a point of reference.
3.2.7.2. Experimental design
To standardize the silencing effects with a gene’s natural expression profile, the
binding site for the Tg-miR-60a family was introduced into the genomic locus at the
position immediate after the protein coding sequence of the gene of interest via
homologous recombination (Figure 3.5a). Transforming plasmids were constructed using
pSF-TAP-LIC-HX plasmid (obtained from Dr. Vern B. Carruthers, University of
Michigan). First the parental plasmid was modified by site directed mutagenesis to
integrate three binding sites of Tg-miR-60a using miR-60aFWSF and miR-60aRVSF
primers (Table 3.1), and the resultant plasmid was named pSF-TAP MIR603x_LIC-HX.
Both pSF-TAP-LICHX and pSF-TAP MIR603x_LIC-HX were linearized by PacI
digestion prior to the treatment with T4 DNA polymerase to create compatible ends in the
presence of dGTP for a ligation-independent cloning procedure as described by Huynh
and Carruthers (2009). Amplicons corresponding to either of TgLDH1 (1073 bps) or
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LDH1_Fw/LDH1_Rv and HoDI_Fw/HoDI-RV respectively (Table 3.1), and purified
prior to the treatment with T4 DNA polymerase to create compatible ends in the presence
of dCTP. Equimolar concentrations of the prepared plasmid and insert were allowed to
anneal and subsequently used in bacterial transformations. The resultant plasmids were
analyzed to confirm their sequences via restriction endonuclease digestions. The plasmids
were then used in the transformation of T. gondii. Transgenic parasites were selected and
grown in culturing media containing mycophenolic acid (25 μg/mL) and xanthine (50
μg/mL).

3.2.8. Loss-of-functional analysis
Functional analyses were carried out using parasites generated from test or control
plasmids which were cultured and treated under similar conditions. Assessment of growth
profile was performed after the parasites were allowed to infect HFF monolayers for 24
hours. The numbers of parasites per vacuole were counted and calculated to obtain
population distribution. Analyses were performed in triplicate (n = 3), and at least 100
vacuoles were counted for each test.
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3.3. Results and discussion
3.3.1. Evaluating the silencing effect of Toxoplasma gondii miRNAs
A large collection of Tg-miRNAs were identified via a deep sequencing
methodology, from which 14 families were grouped according to their seed sequences (6
nucleotides) and their expression levels (Braun et al., 2010). Two of the highest
expressed Tg-miRNA families, named Tg-miR-60a and Tg-miR-4a, were selected for the
study. The guide strands (26–27 nucleotides) and seed sequences of Tg-miR-60a and TgmiR-4a are shown Table 3.2. A dual reporter system was designed and engineered so
that Renilla luciferase (Rnluc) transcripts carry the complementary nucleotide sequence
to the guide strand, referred to here as a Tg-miRNA binding site(s). Also as part of the
reporter system, the transcripts of Firefly luciferase (Ffluc) were used as an internal
control for transfection efficiency among various experiments (Figure 3.1a). Both
transcripts have the same controlling elements of Tg-Tubulin-5′ UTR and Tg-DHFR-3′
UTR, and expressed under the control of a TgTubulin promoter to ensure equal
expression and stability of transcripts (Crater et al., 2011). The engineered reporter
system was utilized in the first part of the study, which was aimed for gauging the extent
of the silencing effect of Tg-miR-60a and Tg-miR-4a toward reporter transcripts, in
corresponding to (i) their expression levels and (ii) the nature of their complementarity to
their target transcripts.

3.3.2. Extent of Tg-miRNAs to induce a silencing effect
Between the two selected Tg-miRNA families, Tg-miR-60a was found to be about
2.4 times more abundant than Tg-miR-4a (Braun et al., 2010). The Rnluc transcript was
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Table 3.2. Chosen Tg-miRNAs and their predicted gene targets and interactions. The
sequences of TgmiRNAs are in lower case, while their predicted targets are in capital
letters. Underline indicates their seed sequence.
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designed for the assessment of the extent of Tg-miRNA silencing ability in respect to two
factors: (i) the abundance of Tg-miRNA species, and (ii) the number of binding sites
found on target transcripts. The resultant Rnluc transcripts carried either one or three
binding sites for Tg-miR-60a or Tg-miR-4a. Forty-eight hours following transfection of
the reporter system (1 μg of each construct) into freshly released T. gondii (106 parasites),
the parasites were collected, and their cell-free extracts prepared and used for the
measurement of relative expression of Rnluc and Ffluc luciferases. At least three
independent experiments were performed for each construct, and the data were
normalized using the reporter system without any binding sites for Tg-miRNAs, for each
independent test and to allow for cross referencing among various sets of experiments.
The presence of one binding site for individual Tg-miR-60a and Tg-miR-4a in the Rnluc
transcripts caused the relative expression to reduce to 20 ± 2.7% and 60 ± 5.3%,
reflecting 80% and 40% silencing effect, respectively (Figure 3.1b). The presence of
three binding sites for individual Tg-miR-60a and Tg-miR-4a in the Rnluc transcripts
decreased the relative expression to 17 ± 2.4% and 39 ± 2.3%, reflecting 83% and 61%
silencing effect, respectively. Notably, the higher abundance of Tg-miR-60a conferred
the higher silencing effect, as detected in the constructs carrying one binding site of TgmiR- 60a. An increasing in the number of binding sites for Tg-miR-60a did not result in a
drastic increase in the silencing effect, suggesting a saturation of the silencing machinery
employing Tg-miR-60a as its effector. On the other hand, when the saturation of the
silencing machinery was not reached by an excess amount of Tg-miRNA, such as those
utilizing a lower abundant Tg-miR-4a, an increase in the number of binding sites, from
one to three, could augment the silencing effect. When the Rnluc transcript carrying three
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Figure 3.1. Gene silencing effect induced by endogenous Tg-miRNAs. A. Graphical
representation of transcripts generated from the dual luciferase reporter system used in
the study. Renilla luciferase (Rnluc) transcripts carry either one (1×) or three (3×)
binding sites for Tg-miRNAs, whose location is indicated by asterisk (*). Firefly
luciferase (Ffluc) transcripts were generated under the control of same promoter and
controlling elements as those of Rnluc transcripts, and were used as an internal control
for the transfection and expression analyses. B. The expression levels of the dual
luciferase reporter system whose Rnluc transcripts carrying either one (1x) or three (3x)
binding site(s) for Tg-miR60a, Tg-miR4a or Hs-let-7a were calculated to obtain relative
expression levels when compared to those without a Tg-miRNA binding site (no sites).
The extent of Tg-miRNAs to induce gene silencing, which was derived from the
reduction of relative gene expression, was plotted to show relative silencing effect (%).
Data was obtained from three independent trials, and plotted as means ± standard
deviations.
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binding sites for Hs-let-7a miRNA was used, and no changes in the relative expression
level and silencing effect were observed. It strongly suggested that T. gondii does not
express any miRNAs closely related to Hs-let-7a miRNA, and/or that the level of Hs-let7a-related Tg-miRNA is much lower than those of Tg-miR-60 and Tg-miR-4 families.
Moreover the findings indicated that the silencing effect occurs only (i) when the
transcripts have the binding site and (ii) when the miRNA is present.
3.3.3. The effect of nucleotide sequence complementarity on Tg-miRNA-induced gene
silencing
It has been demonstrated that miRNAs bind their target transcripts using perfect
or imperfect complementary base-pair interactions (Pillai et al., 2005, Wakiyama et al.,
2007). While no predicted targets for Tg-miR-60a was reported, three potential gene
targets of Tg-miR- 4a were predicted to include three independent loci in the genome of
T. gondii (Braun et al., 2010). These loci, namely (A) TGGT1_203470, (B)
TGGT1_246940, and (C) TGGT1_268390, encode for three hypothetical proteins (Gajria
et al., 2008). The transcripts from these loci were predicted to interact with Tg-miR-4a in
three different complementarity formats; via a perfect match (A), one bulge with two
mismatch bases (B), and two bulges with one mismatch base (C), respectively (Table
3.2). Three binding sites corresponding to these individual interactions were placed into
the Rnluc transcripts. In addition, a similar design with a perfect match was made for TgmiR-60a to allow for an equivalent comparison between the effect of Tg-miR-60a and
Tg-miR-4a. As shown in Figure 3.2a, with a perfect complementarity, we observed a
20% higher silencing effect when Rnluc transcripts carry Tg-miR-60a than those of TgmiR-4a (format A). The levels of silencing effect caused by Tg-miR-4a were not
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Figure 3.2.

Effect of nucleotide complementarity. Rnluc transcripts of the dual

luciferase reporter system were engineered to have three binding sites for Tg-miR60a
with a perfect match, and for Tg-miR-4a mimicking the different base-pair interactions of
its three predicted target genes. Their sequences and interactions are shown in Table 3.2.
A. Relative silencing effect was calculated as compared to those without a binding site.
B. Relative Rnluc mRNA levels were determined for each construct using the (ΔΔCt)
method, where the obtained mRNA levels were normalized and compared to the
construct containing no binding sites. Data was obtained from at least three independent
experiments for each constructed tested, and plotted as means ± standard deviations.
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significantly different with perfect or imperfect complementarity at ~60% silencing
effect. Using RT-qPCR analysis to assess the levels of Rnluc and Ffluc mRNAs in the
evaluation of the different formats of target pairing interactions, it was detected that
perfect and imperfect matches of Tg-miR-4a target pairs gave no significant difference in
the levels of Rnluc mRNA in comparison to those of Ffluc mRNA (Figure 3.2b). The
data indicated that the silencing effect resulted from translational repression following
Tg-miR-4a and target interactions. According to Musiyenko et al. (2012), the imperfect
matched pair of miRNA and target would engage a stronger silencing activity of TSN
than that of levels the perfect match of miRNA to engage Ago slicer activity, both
leading to a directed mRNA degradation. Moreover, we detected a drastic difference in
the relative Rnluc mRNA between the perfect matched pairing by Tg-miR-60a and TgmiR-4a (Figure 3.2b). The reduction of Rnluc target mRNA by Tg-miR-60a strongly
suggested that transcript degradation was a mode of Tg-miR-60a action, while the
unchanged level of Rnluc target mRNA of Tg-miR-4a was indicative of translational
suppression. The findings suggested that T. gondii RISC could be directed by TgmiRNAs and resulted in mRNA degradation as well as translational suppression. The
finding was not surprising because TgAgo, via pull-down and MS analysis, was shown to
associate with various initiation and elongation factors of translational machinery (Braun
et al., 2010). However, further investigation is needed to address how the Tg-miR-4ainduced silencing machinery could silence its target genes without discriminating among
various forms of base-pair interactions. Most importantly the silencing effect was not a
result of the degradation of the transcripts. Until we could identify authentic targets of
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Tg-miR-60a, here it was assumed that the perfect match of Tg-miR-60a caused transcript
degradation.
3.3.4. The effect of exogenous small RNAs on Tg-miRNA-induced gene silencing
Despite the significance of the underlying mechanism of Tg-miRNA-induced
gene silencing, no indication from genome analysis could currently suggest how different
species of Tg-miRNAs could engage different silencing machineries. Here we focused
our effort in making use of the abundant Tg-miRNA species to direct functional analyses
of T. gondii genes. Therefore it was of importance to examine whether the extent of TgmiR-60a-induced gene silencing effect could be altered by exogenous small RNAs. We
generated two species of small RNAs carrying a sequence pertinent to Tg-miR-60a,
including (i) one with exact sequence and structure as Tg-miR-60a, referred to as miR60a mimic, and (ii) the other with only the one strand of Tg-miR-60a, referred to as miR60a inhibitor. Using the Rnluc construct carrying three Tg-miR-60a binding sites, we
monitored the silencing effect following the transfection of various amounts of small
RNAs along with the reporter constructs where the ratio of Rnluc to Ffluc (2 μg Rnluc, 1
μg Ffluc) was altered to ensure the detection of silencing alteration. In the absence of
small RNAs, the reporter expression was reduced by the abundant Tg-miR-60a with the
silencing effect detected at 65 ± 2.2% (Figure 3.3a), confirming (i) a higher amount of
transcripts was generated, and (ii) a larger portion of the transcripts escaped the Tg-miR60a-induced silencing machinery to produce final gene products than when 1 μg of Rnluc
was used (Figure 3.2a, 83 ± 2.5%). Subsequent experiments were carried out with the
increased amount of Rnluc (2 μg) construct to allow for the comparison of Tg-miR-60a
mimic and inhibitor under similar testing conditions. Exogenous supplies of Tg-miR-60a
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Figure 3.3.

Effect of miRNA mimics and inhibitors. The engineered dual reporter

system, whose resultant Rnluc transcripts carry three Tg-miR60a binding sites, was
electroporated into the parasites along with various amounts of small RNAs (μg): A.
Double-stranded Tg-miR60a mimic or B. Single-stranded Tg-miR60a inhibitor. Hs-let-7a
mimic and inhibitor were used as control. Three independent experiments were
performed for each test, and the data were plotted as means ± standard deviations.
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mimic gave rise to an increase in the silencing effects from 65 ± 2.2% in the absence of
small RNAs, to 83 ± 2.5% in the presence of 10 or 20 μg of Tg-miR-60a mimic (Figure
3.3a). The presence of 20 μg Hs-let-7a mimic did not cause any silencing effect. The
results suggested that miRNA mimics could be engaged in the same silencing machinery
as endogenous miRNAs. The saturation of Tg-miR-60a-induced silencing machinery
gave rise to a maximum of ~80% silencing effect, under conditions used with the
engineered reporter system. When an increase amount of Tg-miR-60a inhibitor was
supplied, the silencing effect was diminished in a dose-dependent manner (Figure 3.3b).
The presence of Tg-miR-60a inhibitor as little as 1 μg could perturb the silencing effect
caused by Tg-miR-60a-induced silencing machinery. A maximal disturbance was
observed with 10 - 20 μg of Tg-miR-60a inhibitor, where the silencing effect was
abolished to ~6.2%. When miRNA inhibitors with an unrelated nucleotide sequence,
namely Hs-let-7a-inhibitor (20 μg) was supplied, the relative expression and silencing
effect was unaffected. These findings suggested that small RNAs with nucleotide
sequences identical to one or both strands of miRNA could be exploited as genetic tools
for the moderation of miRNA-directed gene regulation in T. gondii, to gain a better
understanding of the function of gene of interest following a negative regulation at the
post-transcription level.
3.3.5. Effective gene silencing caused by directed Tg-miR-60a
As a proof of principle that the highly expressed Tg-miR-60 family can be
directed to control the expression of any genes of interest, we chose two unrelated target
genes to evaluate (i) the effect of directed gene silencing and (ii) the practicality and
usefulness of this genetic tool in functional analysis. The first chosen target is a less
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studied gene, named DEAD-box RNA helicase (TgHoDI, TGGT1_089230; Cherry and
Ananvoranich, 2014), whose ortholog is dispensable for growth in yeast (Tseng-Rogenski
et al. 2003). The second is a metabolically crucial gene, lactate dehydrogenase (TgLDH1,
TGGT1_232350). Due to (i) the relatively high abundance of Tg-miRNAs and (ii) the
lack of information on authentic targets of Tg-miRNAs, it was possible that any given
transcript species might already be under the control of a Tg-miRNA species. To ensure
that the effect observed here was the result of our Tg-miR-60a-directed silencing
machinery and not from other Tg-miRNA effects, the entire nucleotide sequences of
TgHoDI and TgLDH1 transcripts (pre-mRNA and mature mRNA) were searched for a
possible Tg-miR-60a binding site to partially (at least 50%) or fully interact with the seed
or entire sequence of Tg-miR-60a (Table 3.2, underlined sequence). No potential binding
sites of Tg-miR-60a were found on either transcript.
3.3.5.1. Silencing of DEAD-box RNA helicase (TgHoDI) expression by Tg-miR60a
caused a subtle change, but sufficiently demonstrated its physiological importance during
the re-invasion
TgHoDI is a member of DEAD-box RNA helicase superfamily, which contains
highly conserved proteins and implicated in almost all aspects of RNA metabolism in
organisms ranging from yeast to complex eukaryotes (Hooper and Hilliker, 2013; Carroll
et al., 2011). TgHoDI was reported to be involved in the formation of mRNAribonucleoprotein (mRNP) complexes and granules during stress response (Cherry and
Ananvoranich, 2014). Tseng-Rogenski et al. (2003) showed that a null mutant of DEADbox RNA helicase (DHH1) in yeast is not lethal but exhibits a temperature sensitive
phenotype. Using this Δdhh1 strain, Cherry and Ananvoranich (2014) showed that the
expression of TgHoDI cDNA in the yeast strain under DHH1 promoter could
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complement and partially restore its phenotype. In an attempt to study the physiological
significance of TgHoDI in T. gondii, a ligand-controlled destabilization domain
(ddFKBP) version of TgHoDI was generated. Although stable parasite lines expressing
TgHoDI-ddFKBP fusion protein were obtained, the ligand-induced protein degradation
was not achieved (unpublished data). Indirectly this suggested (i) that the C-terminus of
TgHoDI was not solvent-exposed, and (ii) that TgHoDI could be involved in the rapid
formation of mRNPs similar to other DEAD-box RNA helicase members (Hooper and
Hilliker, 2013). Due to its possibly tight regulation and physiological importance,
TgHoDI was chosen as a target for Tg- miR60a-directed gene silencing.
Stable parasite lines expressing either TgHoDI-SF (control) or TgHoDI-SF-miR (test)
were generated and maintained for the study. Under normal growth conditions the test
strain expressing TgHoDI-SF-miR expressed approximately 50% and 30% less TgHoDI
protein and mRNA, respectively, in comparison to the control strain (−, Figure 3.4, A and
B). The introduction of Tg-miR- 60a mimic (+, Figure 3.4, A and B) enhanced the extent
of Tg-miR60adirected silencing and decreased the levels of TgHoDI protein and mRNA
to approximately 25% and 10%, but did not affect the expression of TgHoDI in the
control strain. TgHoDI was previously shown as a protein marker of mRNP granules
called stress granules (Cherry and Ananvoranich, 2014). The accumulation of
cytoplasmic mRNA granules, including those of stress granules, in extracellular
tachyzoites was showed to be important to the ability of extracellular parasites to survive
and re-establish their infectivity. The higher numbers and larger sizes of the stress
granules formed during the stressful conditions translated to a higher success in
reestablishment of infection (Lirussi and Matrajt, 2011). Using these stable parasite lines,
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Figure 3.4.

TgHoDI expressions under the control of Tg-miR60a-induced gene

silencing. Freshly released transgenic parasites, namely TgHoDI-SF and TgHoDI-SFmiR were electroporated with Tg-miR60a mimic (20 μg, +; 0 μg, −). A. Thirty-six hours
following electroporation, the parasites were released and harvested for the cell-free
lysates which were analyzed for the levels of TgHoDI-SF fusion protein using α-Flag
antisera. The levels of tubulin detected using α-tubulin antisera were used as a loading
control. Relative signals of TgHoDI-SF fusion protein was normalized by those of
tubulin. The data were obtained from three independent tests. B. At a similar time point,
total RNAs were isolated and subjected to RT-qPCR analyses. Daggers (†) represent pvalue ≤ 0.05, while double daggers (‡) represent p-value ≤ 0.01. C. Representative
images of extracellular parasites following incubation in either culturing medium or
Hepes-KOH solution (60-minute treatment), the accumulation of TgHoDI were assessed
using α-Flag antisera in conjunction with α-mouse FITC conjugated antisera. Micrometer
bar represents 5 μm. D. A parallel analyses of those shown in C. An aliquot of treated
parasites were transferred onto HFF monolayers to allow for a reinvasion. Their ability to
reinvade and recover from the treatment was assessed 24 hours later. The number of
parasites per vacuole was counted. Data was collected and calculated from at least three
independent trials, where clear bars represent those from TgHoDI-SF, and hatched bars,
TgHoDI-SF-miR.
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we aimed to validate the function of TgHoDI in re-establishing their infectivity. To
establish a stress condition where the accumulation of TgHoDI and mRNP granules could
clearly be monitored, the extracellular parasites of TgHoDI-SF control strain were
released from infected monolayers and subjected to stressful conditions. We utilized a
Hepes-KOH solution treatment. Use of a buffering solution containing 27 times higher
KCl, and 22 times less NaCl than those of the culturing media was previously shown to
induce a stress response in T. gondii (Lirussi and Matrajt, 2011). The Hepes-KOH
solution (25 mM Hepes-KOH pH 7.2, 142 mM KCl, 5 mM NaCl, 2 mM EGTA, 5 mM
MgCl2, and 1 mg/mL BSA) mimicked the composition of the host cell cytosol ionic
conditions, which the parasites come in contact with during egress. It was observed that
the incubation of extracellular parasites in this Hepes-KOH solution for 60 minutes at 37
°C caused maximal formation of mRNP granules, as observed by the accumulation of
TgHoDI aggregates throughout the cytosol (Figure 3.4c, upper right panel). Subsequently
we silenced the TgHoDI expression to the lowest level possible by introducing Tg-miR60a mimic into freshly released TgHoDI-SF-miR parasites via electroporation. The
parasites were allowed to infect and to grow in HFF monolayers for 48 hours to ensure
that the level of TgHoDI protein was approximately 75% lower than those of the control
untreated parasites (as shown in Figure 3.4a). Extracellular parasites were then released
and subjected to the solution treatment for 60 minutes at 37 °C. It was observed that the
numbers and sizes of TgHoDI aggregates were diminished as compared those of the
control conditions (Figure 3.4c, lower right panel). In parallel, these treated parasites
were allowed to re-invade HFF monolayers after the stressful conditions and were
monitored for their reinvasion ability by microscopic examination 24 hours following an
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infection of HFF monolayers. When the extracellular parasites were kept in their
culturing media for 60 minutes at 37 °C (without the solution treatment), both parasite
strains were able to retain a similar infectivity, namely reinvasion and multiplication
(Figure 3.4d left histogram, clear bars for TgHoDI-SF, control; hatched bars for TgHoDISF-miR, test). The majority (50%) of the intracellular vacuoles contained 8 parasites per
vacuole at 24 hours post-infection. Both stable parasite lines exhibited a similar growth
profile with ~ 6-8 hours doubling time, indicating that the changes in the level of TgHoDI
gene products did not significantly affect the parasite ability to multiply under non-stress
conditions. On the other hand, following the solution treatment, the extracellular parasites
of the test strain with electroporated Tg-miR-60a mimic were slower in progressing
through reinvasion and multiplicity. The majority of the formed vacuoles of the test strain
contained 4 parasites per vacuoles (hatched bars), in comparison to 8 parasites per
vacuoles in those of control strain (clear bars) when subjected to a similar treatment. The
decrease of TgHoDI protein (four times less than the control) was concomitantly detected
along with the slowing down of parasite multiplicity (Figure 3.4d, right histogram). The
changes in growth profiles were not observed in mock or Hs-let-7a- mimic
electroporation, nor were the detectable changes in TgHoDI accumulation and growth
observed in other electroporation reactions in either strain (data not shown). The findings
thus confirmed that the accumulation of stress granules in extracellular tachyzoites is
important to the ability of extracellular parasites to re-establish their infectivity.
3.3.5.2. Expression of lactate dehydrogenase isoform 1 is critical to the parasite cell
biology
Being an obligate intracellular parasite, T. gondii obtains its nutrients from the
host cells. Under anaerobic conditions, the parasite relies on TgLDH which is the last
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committed enzyme of the glycolytic pathway to interconvert pyruvate and lactate, as well
as NAD+ and NADH. Because of the necessity of the NAD+-NADH conversion under
anaerobic conditions, TgLDH is thus considered one of potential drug targets. Two active
TgLDH isoforms, namely TgLDH1 and TgLDH2, are produced in a stage specific
manner. TgLDH1 is detected in tachyzoites, while TgLDH2 in bradyzoites (Yang and
Parmley, 1997). To date, the mechanism underlining the requirement of each specific
isoform is still under investigation. The presence of stage specific TgLDH1 protein is
commonly used as a marker in displaying the tachyzoite development stage Yang and
Parmley, 1997). While no documentation on a TgLDH1 null mutant, one successful
TgLDH1 knockdown was reported using long double-stranded RNA expression
generated from a head-to-head promoter construct (Al-Anouti et al., 2004). The TgLDH1
knockdown strain was documented to grow slower and to convert into bradyzoites in a
lesser degree than the parental strain, indicating its physiological importance. As part of
the proof of principle, the metabolic important TgLDH1 gene was chosen as a second
target to further gauge the level of Tg-miR-60a-induced silencing system toward a critical
and essential gene. Similar to the TgHoDI study, two stably transgenic lines, TgLDH1-SF
and TgLDH1-SF-miR were desirable for the study. While TgLDH1-SF parasite strain
was easily obtained and maintained, we were unable to obtain or maintain the TgLDH1SF-miR strain, despite a number of control conditions tested. It thus indirectly indicated
that the level of TgLDH1 expression was effectively silenced below a threshold level to
allow the parasite to maintain a metabolic requirement for its viability. To further
investigate the cause(s) of our difficulties in the generation and/or maintenance of
TgLDH1-SF-miR line, the transfection reactions were performed to include those with
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pTgLDH1-SF, or pTgLDH1-SF-miR (Figure 3.5a). The electroporated parasites were
allowed to infect HFF monolayers for 36 hours using selective media. Due to the nature
of transfection reactions, the bulk of parasites contained both transformed and nontransformed parasites. The level of TgLDH1-SF fusion protein was thus quantified in
comparison to the total level of TgLDH1 and tubulin background from three independent
experiments by using immunoblot-densitometric analyses (Figure 3.5b). The level of
TgLDH1 protein was drastically decreased in the Tg-miR- 60-induced silencing strain
(T1), whose expression could be restored by the introduction of Tg-miR60a inhibitor
(T2). The silencing effect was also detected by immunocytochemistry (Figure 3.5c).
Using α-Flag antisera, the epitope tagged TgLDH1 protein was detected in CTL, and T2,
respectively. However, no α-Flag signals were detected in T1. Altogether, it indicated
that transgenic TgLDH1-SF-miR parasites can be generated, but the stable clonal line
cannot be maintained for further study. The findings thus reiterated the importance of
TgLDH1 functionality in parasite viability. In addition, the findings also confirmed that
the abundant Tg-miR60a can be directed to silence a target gene, and that Tg-miR60a
inhibitor can be used to restore the parasites from detrimental effect of gene silencing.
3.3.5.3. Versatility and possible limitation of the methodology
The miRNA-directed gene silencing methodology reported here offers an
alternative approach to currently available functional genetic procedures. Due to the
abundance and variety of Tg-miRNAs, necessary reagents could be tailored to the
appropriate gene of interest. The plasmids could easily be modified to introduce the
binding site of another species of Tg-miRNAs, when Tg-miR-60a is not appropriate for
the gene of interest. For example, when the gene of interest is already under the control of
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Figure 3.5. TgLDH1 loss-of-function analyses. Freshly released Δku80 tachyzoites were
electroporated with indicated plasmid construct (20 μg), which was engineered to allow
for a homologous recombination at the TgLDH1 locus. A. Representation of plasmid
constructs aimed for a homologous recombination to incorporate the nucleotide sequence
coding epitope tags of Strep and Flag (SF) to be fused to the coding sequence of the gene
(pTgLDH1-SF, CTL), and for the similar construct with the presence of three binding
sites for Tg-miR60a immediate after the stop codon (as indicated by asterisk (*),
pTgLDH1-SF-miR; test). B. Thirty-six hours following electroporation, the parasites
were released and harvested for the cell-free lysate preparation. The lysates were
prepared from electroporation reactions containing CTL, test construct (T1) and test
construct in the presence of Tg-miR60a inhibitor (20 μg, T2). The levels of TgLDH1 and
TgLDH1-SF fusion proteins were detected using α-TgLDH1 and α-Flag antisera. ΑTubulin antiserum was used as a loading control. Notably, immunoblots probed with αFlag antisera were over-exposed to allow for the visualization of Flag tagged signals from
T2 samples. Densitometric data were obtained from three independent immunoblot
analyses of the samples, and plotted as means ± standard deviations. The light bars
represent those of TgLDH1-SF and the dark bars of TgLDH1. Both were normalized the
signals obtained from TgTubulin. Daggers (†) represent p-value ≤ 0.05, while double
daggers (‡) represent p-value ≤ 0.01. C. The expression of TgLDH1 and TgLDH1-SF
proteins was monitored by immunocytochemistry analyses thirty-six hours following the
electroporation. Micrometer bar represents 5 μm.
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Tg-miR-60a, the introduction of more Tg-miR-60a binding sites will not yield any
significant down regulation effect for the analysis. This possible limitation, however,
could easily be remedied by utilizing or directing other Tg-miRNAs, such as Tg-miR-4a
to the target gene products. It is also possible that the expression profile of Tg-miR-60a is
not suitable for that of the gene of interest or the parasite archetype strain. When such
conditions occur, the reagents could be modified so that the expression profile and strain
are suitable and compatible.
3.4. Conclusion
We showed that Tg-miRNAs, at least the two most abundant Tg-miRNAs, namely
Tg-miR-60a and Tg-miR-4a, are functional effectors to alter the expression of a reporter
gene, Rnluc of the dual luciferase reporter system. The extent of their silencing effect was
influenced by (i) the number of binding sites and (ii) the abundance of Tg-miRNA
species. A higher silencing effect was observed (i) when the transcripts carry multiple
binding sites, and (ii) when the levels of Tg-miRNA effector are present in a higher
concentration. The nature of the interactions between target transcripts and the TgmiRNA species directed the mode of gene silencing, either mRNA degradation or
translational suppression. It remains to be investigated how the complementarity and
specific Tg-miRNA species dictate the mode of reactions, as unexpectedly we observed
that perfect matches of Tg-miR-60a and Tg-miR-4a had a different mode of silencing
despite their similar end point. Moreover, we could take advantage of Tg-miR-60a
miRNA mimics and inhibitors to modulate the silencing effect. As a proof of principle,
we successfully demonstrated that the endogenously abundant miRNAs can be directed
to down regulate the expression of two model targets, TgHoDI and TgLDH1. The extent
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of gene silencing can be further enhanced by miRNA mimics or diminished by miRNA
inhibitors, as needed. In conjunction with recent and powerful CRISPR technology, the
binding site(s) of Tg-miRNAs can easily be introduced into any ectopic sites to cause
specific gene silencing, when a knockdown, but not knockout, of the target gene is
needed. Nonetheless, the most important consideration should be placed on developing of
an effective readout of the gene silencing. Naturally to maintain cellular activities,
various regulatory systems work in concert. Gene and functional redundancy would allow
the expression of genes to be temporarily compromised. While TgHoDI knockdown was
effective, it required an effective measurement to detect the subtle changes. In the case of
an essential gene, such as TgLDH1, a gene knockout would be lethal and difficult for
gaining further information. By having a gene knockdown protocol, the information
could be extracted and deduced.
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CHAPTER 4
Antisense technologies in the studying of Toxoplasma gondii
4.1. Toxoplasma gondii, a model organism
T. gondii is one of the most successful intracellular parasites which is reported to
infect any warm-blooded animals, and an estimated one third of the world’s population
(Kim and Weiss, 2008). As a member of the phylum Apicomplexa, Toxoplasma has a
unique non-photosynthetic apicoplast organelle, similar to that found in other important
and pathogenic microorganism members, including Plasmodium which is the cause of
malaria, Cryptosporidium a waterborne parasite, as well as Eimeria, Neospora, and
Theleria all can cause disease in animals. These pathogenic microorganisms share a
remarkable evolutionarily relationship. Using Toxoplasma as a study model, we review
various types of non-coding RNAs which have emerged and could be effectors in the
regulation of gene expression (Radke et al., 2005; Hassan et al., 2012; Ramaprasad et al.,
2015). Recent research shows that Toxoplasma contains a “mix-and-match” of plant- and
animal-like machinery used to direct RNA for gene regulation (Braun et al., 2010;
Musiyenko et al., 2012). Toxoplasma can be easily cultured using any nucleated cell
cultures and has proven previously to be a very useful model to develop a number of
molecular and genetic tools (Roos et al., 1994; Kim and Weiss, 2004). Taken together,
Toxoplasma is an important model organism, and a fascinating system for exploring the
progress in antisense technologies.
4.2. History of antisense RNAs and other regulatory RNAs
The term “antisense RNA” was coined in the early 1970s, and first used in
describing “RNA repressors” in prokaryotes. Spiegelman et al. (1972) showed that
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antisense RNA molecules can hybridize with complementary sense RNA to render it
inactive. This experiment was among the first to define the function of regulatory RNA
as a highly specific repressor or inhibitor of gene expression. Coleman et al. (1985)
showed that antisense RNA could be used to target foreign genes in an experiment, in
which resistance to bacteriophage SP infection could be conferred to Escherichia coli.
They achieved this by creating plasmids coding for RNA sequences which targeted genes
coding for bacteriophage coat protein and/or replicase. By the time that Green et al.
(1986) published a review on antisense RNA technologies, it was widely accepted that
antisense RNA can perform a repressor function, and that the 5′ end of the messenger
RNA (mRNA) was the key target sequence. Antisense RNA which did not include
sequences complementarity to the 5′ end of the target mRNA required much higher
concentrations to achieve an effective repression. Additionally, some genes remained
resistant to repression by antisense RNA. It was suggested that mRNA with a high degree
of secondary structure was resistant to hybridization with antisense RNA. Pioneer work
on antisense RNAs in prokaryotes has provided us with fundamental knowledge on
various aspects of RNA directed gene regulation, both inhibition and activation of
replication, transcription and translation.
The applications of antisense technology in eukaryotic systems began as early as
1978. Zamecnik and Stephenson (1978) were able to temporarily inhibit the production
of Rous sarcoma virus (RSV) in chick embryo fibroblast tissue cultures. This study
targeted the intermediate provirus DNA, and as such used antisense DNA rather than
RNA. As with antisense RNA, hybridization between the provirus DNA and the injected
antisense DNA was believed to prevent the normal function of the oligonucleotide, in this
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case the necessary circularization and/or incorporation of the viral genome. By 1984
artificial antisense RNA was successfully used to regulate the expression of a eukaryotic
gene, named thymidine kinase in murine cells (Izant and Weintraub, 1984). Bunch and
Goldstein (1989) developed a system for generating antisense RNA in vivo with cultured
Drosophila melanogaster cells. The methodology used by Bunch and Goldstein (1989)
offered an alternative to the commonly used microinjection as a method by which
artificial antisense RNA was introduced into the eukaryotic cells. The study also
suggested that hybridization activity between sense and antisense RNA in eukaryotes
occurred primarily in the nucleus with un-spliced mRNA. However, it was later shown
by Vanhee-Brossollet and Vaquero (1998) that antisense RNA molecules have regulatory
function both in the nucleus and cytoplasm, and at any step of gene expression. It has
more recently been found that this multi-level expression control is possible due to
several different types of antisense RNA.

4.3. Application of antisense technologies and their progress in Toxoplasma
After decades of the discovery of antisense RNAs and other regulatory RNAs,
underlining mechanisms and functions are still being investigated and appear to vary
greatly among organisms and various types of regulatory RNAs. These RNAs are nonprotein-coding transcripts and referred to as non-coding RNAs (ncRNAs). Due to the
varied structures and mechanisms, regulatory RNAs or ncRNAs are generally categorized
based on their sizes: (i) small ncRNAs, whose lengths range from ~20 nucleotides to
~200 nucleotides, include siRNA, miRNA, and piwiRNA. (ii) Long ncRNAs are varied
from over 200 nucleotides to a few thousands nucleotides and include natural antisense
transcripts (NAT), intra- and inter-genic ncRNAs, and intronic RNAs. Both small and
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large regulatory ncRNAs could inhibit gene expression and be exploited as target specific
genetic tools (Wahlestedt, 2013; Krishnan and Mishra, 2014; Miller, 2014). It is clear that
the modes of inhibition are different depending on the type of ncRNAs. First, siRNAs
and miRNAs affect mRNA stability mostly through the involvement of the RNA-induced
silencing complex (RISC) in the cytoplasm and cause mRNA degradation and/or
translational repression, while long ncRNAs primarily affect chromatin regulators, which
suppress transcription, and thus act in the nucleus. Their spatial requirement could be a
limiting factor, if we aim to perturb the natural function(s) of these regulatory RNAs.
Second, small ncRNAs, miRNAs in particular, can affect the stability of multiple mRNA
targets, while long ncRNAs, particularly cis-acting NAT, are locus specific. When target
specificity is critical, the use of miRNAs and their derivatives require proper controls to
discern between targeted-inhibition and an off-target effect. Thirdly, the abundance of
small ncRNAs is likely to be higher than that of large ncRNAs. This could be an
important factor in considering for their dose-to-efficacy property. In the following
sections, we summarize genetic silencing tools and technologies used in Toxoplasma
according to their capability related to naturally found regulatory RNAs. Table 4.1 shows
the representative structures, relative sizes, and targets of antisense technologies
summarized here.
4.3.1. Small non-coding RNAs
The Toxoplasma transcriptome contains a large repertoire of small ncRNAs,
including the most prominent group of miRNAs (Braun et al., 2010; Wang et al., 2012;
Xu et al., 2013). Two of the most abundant miRNAs families, namely miR60a and miR4a
of parasite strain GT1 (Braun et al., 2010), were tested using engineered dual luciferase
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Table 4.1. Representative structures and relative sizes of regulatory ncRNAs used in
Toxoplasma gondii. The dash lines represent the antisense strands which will pair with
their targets.
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reporter system (Crater et al., 2015). The expression of engineered transcripts harboring
binding sites of either miR60a or miR4a was repressed in a sequence specific manner,
clearly indicating that Toxoplasma harbors miRNA-inducing silencing machinery (Crater
et al., 2015). Also the silencing effect detected using the reporter system indicated that
the extent of silencing effect is dependent on the abundance of miRNA present and the
number of miRNA binding sites on a target transcript. It was noted in the same study that
the nature of silencing effect could depend on the miRNA species. While miR60 was
detected to induce mRNA degradation, miR4a was found to induce translational
repression. The findings indicated that Toxoplasma silencing machinery could differ from
those of other organisms. Musiyenko et al. (2012) showed that Toxoplasma-Argonaute
(Ago) displays a weak RNA cleavage activity and requires an association with a Tudor
staphylococcal nuclease (TSN) and Arginine methyl transferase for its activity. The study
also strongly suggested that the RNA- induced silencing complex of Toxoplasma utilizes
the slicer activity of TSN for partially mismatched miRNA target pairs, and that of Ago
for perfect match targets.
4.3.1.1. siRNA and miRNA
It has been demonstrated that exogenous supplies of miRNAs or siRNA could
enhance or induce an inhibition of gene expression. We here referred to the short dsRNA
(20–25 nt) with perfect-matched central bases as “siRNA”, and that with mismatched
central bases as “miRNA” (Table 4.1). Yu et al. (2008) successfully showed that
commercially designed and synthesized Stealth™ RNAi duplexes (25-mer dsRNA,
Invitrogen) against Toxoplasma adenosine kinase can inhibit the gene expression. When
individual siRNAs of the Stealth™ RNAi duplexes were introduced into the parasite by
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transfection, it was detected that each siRNA exhibited varied efficacy depending on the
target locations, and the dosage used. The findings are in accordance with other RNAtargeted gene silencing methodologies in that not all target regions of an mRNA are
equally accessible. Wahlestedt (2013) stated that only 10–15% of designed antisense
oligonucleotides will reduce the expression of the target. To enhance the inhibition effect,
a common practice is to make a cocktail of siRNA, as suggested and used with the
commercial Stealth™ RNAi duplexes (Invitrogen).
The capability of siRNA and miRNA to inhibit gene expression was systemically
compared using engineered dual luciferase reporter system (Crater et al., 2012). By in
vitro transcription, but not by chemical synthesized as those of Stealth™ RNAi system,
siRNAs and miRNAs were made, and three binding sites for either siRNA or miRNA
were placed onto the 3′-UTR of Renilla luciferase transcripts. Both siRNA and miRNA
were shown to exhibit a similar silencing ability, and their effect appeared to be enhanced
with longer incubation time (24 h vs. 48 h). In the same study, the effect of these small
regulatory RNAs was compared to that of long double-stranded RNAs (~600 bp) which
are specifically targeted Renilla luciferase transcripts. The silencing effect of long
dsRNAs is lower than those of siRNA and miRNA. It is suggested that an additional
processing step for the long dsRNA might be necessary, although we cannot exclude the
possibility that it might be due to the different site of action of long and short RNA
regulators.
The above mentioned studies clearly indicate that small regulatory RNA, in the
form of siRNA and miRNA can be designed and effectively used as a target-specific
silencing tool. With the aid of reliable software’s algorithms, effective siRNA and/or
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miRNA cocktails can be chemically or enzymatically synthesized. Most companies that
commercialize the production of siRNA or miRNA provide designing services. Although
we cannot advocate for a particular company or software to be superior to others, the best
practice is to use multiple sites to confirm and re-confirm the design of siRNA and
miRNA whenever possible.

4.3.1.2. miRNA inhibitors
miRNA inhibitors are short single stranded RNA (~20–30 nucleotides) with
sequence complementary to intercept the interaction of miRNA and its target mRNA or
gene. While it is a challenge to identify the target gene of a miRNA species in an
organism, due to the nature of perfect or impartial base-pairing of these small regulatory
RNAs to their targets, Braun et al. (2010) identified a number of potential targets by
allowing up to 3 mismatches between their identified miRNA and their targets. It was
stated that more than 80 putative target transcripts were identified for miR-60a alone, and
that an average of 25 cellular targets could be retrieved for each of the other identified
Toxoplasma miRNAs. The effect of miR-60a inhibitor was investigated using an
engineered dual luciferase reporter system (Crater et al., 2015). It was reported that the
silencing effect of miR60a on the reporter system was diminished in a dose–response
manner, when an increasing amount (1–20 μg) of miR-60a inhibitor was used. To
evaluate the global effect of miR60a inhibitor on Toxoplasma infectivity, miR-60a
inhibitor (20 μg) was introduced into freshly released extracellular parasites. The
parasites electroporated with miR-60a inhibitor exhibited 80% less ability to form
plaques than those electroporated with unrelated single stranded RNA of a similar length
(Figure 4.1, A and B). The data indicates that the early process of Toxoplasma infection
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Figure 4.1. Effects of miR60a inhibitor. Freshly lysed parasites (~1 × 106) were
resuspended in electroporation buffer (400 μl of 120 mM KCl, 0.15 mM CaCl2, 10 mM
K2HPO4/KH2PO4. pH 7.6, 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione in
a 4 mm-gap cuvette (Roos et al., 1994). Twenty micrograms of single-stranded RNAs,
either miR60a inhibitor or an unrelated RNA with similar size and structure (CTL), were
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in vitro synthesized, purified and added to the parasite suspension as described in Crater
et al. (2015). The mixtures were then pulsed with 1500 V, 25 Ω, and 25 μF in a BTX
ECM 630 (Roos et al., 1994). To allow for the antisense effect to take place, the
transfected parasites were grown on confluent monolayers of human fibroblasts (60 × 15
mm) for 48 h. Transfected parasites were released, and approximately 1000 parasites
were used to re-infect a new plate (35 × 10 mm) and incubated for 72 h. Plates were then
fixed with cold methanol and stained with 0.5% crystal violet blue and examined for the
formation of plaques, as an indicator of successful invasion and infection. (A)
Representative images of CTL and miR60a inhibitor plaque assays. Images were
acquired using a Leica DMIRB with C PLAN 10×/0.22 LMC objective, and Northern
Eclipse software. Micrometer bar represents 40 μm. (B) The number of plaques formed
were counted from 50 random fields of view, and calculated from three independent
experiments. This data indicates that miR60a inhibitor interfered with the infection
process. In addition, 200 released parasites were transferred onto confluent monolayers
grown on coverslips (22 × 22 mm) and incubated for 24 h. The coverslips were then fixed
by 3% paraformaldehyde and stained with Hoechst (10 μM). (C) From three independent
experiments, the numbers of parasites in 100 random vacuoles were counted to monitor
multiplicity. Hatched bars represent those electroporated with miR60a inhibitor, and
dotted bars are for control experiments. This indicates that miR60a inhibitor can also
affect the parasites ability to multiply once entering.
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was impaired. This impairment could be due to direct or indirect disturbance effect of
miR-60a inhibitor on attachment and/or invasion. When the electroporated parasites were
allowed to multiply for a limited period (24 h) without reaching their lytic phase, it was
detected that the parasite multiplied at a slower rate than those of the control
electroporation. Majority (60%) of vacuoles of parasites electroporated with miR-60a
inhibitor contained 2 parasites/vacuole (hatched bars, Figure 4.1c), where those of control
(40%) carried 8 parasites/vacuole (dotted bars, Figure 4.1c). Considering an average
doubling time of the parasite is 6 h (CTL), the presence of miR-60a inhibitor clearly
increased the doubling time. This finding confirms the global effect of miR60a inhibitor,
which could be direct effects on the predicted 80 target genes (Braun et al., 2010) and/or
indirect effects of these genes partaking in various steps of parasite pathogenesis.
4.3.1.3. Antagomir
The term ‘antagomirs’ is used for a specific group of antisense single-stranded
RNAs that have a phosphothioate backbone with 3′- cholesterol-conjugation and
nucleobases complementary to miRNAs. Antagomirs first appeared and were
successfully used by Krützfeldt et al. (2005) to inhibit the effect of miR-122-directed
gene regulation in mice. With the success and relatively high stability of antagomirs,
these antisense molecules have been extensively exploited for therapeutic uses in various
diseases whose pathogenesis and/or prognosis involve miRNAs, such as cancers and
cardiovascular diseases (Kaboli et al., 2015; Romaine et al., 2015). Although at the time
of this manuscript preparation we did not find any reports on antagomirs in Toxoplasma,
we present and include it here because antagomirs and miRNA inhibitors are closely
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related both structurally and functionally. In addition we anticipate greater use of
antagomirs in molecular microbiological and parasitological studies.

4.3.1.4. Morpholino oligomer
Morpholino oligomer is a common name for phosphorodiamidate morpholino
oligomer (PMO) which is used in an antisense silencing of a gene expression at
translation step. Although the name “PMO” is telling more about its structure, which is
composed of nucleobases bound to morpholine rings (instead of deoxyribose rings)
linked through phosphorodiamidate groups (instead of phosphodiester linkage),
morpholino oligomers is a more widely used name. Because of their chemical
constituents, morpholino oligomers are less negatively charged than natural
oligonucleotides, while still having high hydrophilicity and ability to form canonical
base-pairing with target mRNA. Generally, morpholino oligomers are ~25 nt in length,
which is similar to that of other small regulatory RNAs described above, but their binding
location on the mRNA is preferably near the translational start site spanning the 5′-UTR.
Most morpholino oligomers are used as research tools for reverse genetics by knocking
down gene function. It was noted that the ability of this antisense technology to cross
multiple cellular membranes is drastically increased when the 3′-terminus of morpholino
oligomers is conjugated to transductive peptides (Lai et al., 2012). In the same study, the
transductive peptide conjugated morpholino oligomers were shown to successfully block
the translation of three genes encoding for Toxoplasma’s dihydrofolate reductase, enoylACP reductase and apetela 2 domain transcription factor XI-3. Witola et al. (2014) used a
similar design of peptide-conjugated morpholino oligomer, but with nucleobases specific
to interact with Toxoplasma mRNA encoding a major secretory protein, named GRA10
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and showed that this antisense technology caused a reduction in growth and development
of intracellular Toxoplasma.
4.3.1.5. Ribozymes
Ribozymes are catalytically active RNA molecules. Thus far, naturally discovered
ribozymes catalyze either the transfer of peptidyl or phosphoryl bond for nucleotide
cleaving (Zhang et al., 2010). Those with catalytic ability to perform sequence-specific
destruction of phosphoryl bonds of mRNA have been the most exploited for their
potential as disease-specific therapeutics tools, and stretched further into our possible
personalized medicine. Similarly, in the development of genetic tools and technologies
various natural types of ribozymes (i.e. hammerhead, delta ribozymes), and artificial
types (i.e. RNA ligase, RNA kinase) have been tested for gene sequence specific activity.
Based on their mechanistic reactions, most ribozymes employ a step-wise reaction,
whose initial step involves a nucleotide base-pairing or an “antisense” interaction to
recognize their substrate whose final step yields destruction of their targets, for the
purpose of knock-down or silencing of gene expression. The antisense pairing or
substrate recognition often requires a short span of nucleobases ranging from 7 to ~20
nucleotides (Table 4.1.). On this basis, we summarize the application of ribozymes in
Toxoplasma under antisense technology related to small ncRNAs. Sheng et al. (2004)
successfully used engineered delta ribozymes (antisense or substrate recognition
sequence of 7 nt in length) to simultaneously down regulate the expression of uracil
phosphoribosyltransferase (UPRT) and hypoxanthine guanine phosphoribosyltransferase
(HXGPRT). These trans-acting ribozymes were engineered to express independently
from the target gene, and multiple targets can be silenced simultaneously. More
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elegantly, a self-cleaving hammerhead ribozyme, called Sm1, was engineered to perform
specific nucleolytic activity in an inducible manner (Agop-Nersesian et al., 2008). In the
study, toyocamycin-responsible hammerhead ribozymes were shown to control the
expression of adenosine kinase, when the sequence of the ribozymes was placed onto the
upstream sequence within the transcriptional units, called “cis-acting”. The self-cleaving
or cis-acting riboyzmes, such as those of toyocamycin-responsive hammerhead
ribozymes, have a possible drawback in that the sequence encoding the ribozyme has to
be integrated into transcription unit of the gene of interest. As a consequence, it requires
effective knock-in genetic manipulation. However, it also offers the advantage of
maintaining the level of natural expression as the transcriptional unit is expressed by its
own or endogenous promoter.
It is important to note that although the genome of Toxoplasma contains no
sequence encoding hammerhead-like or delta-like ribozymes, both ribozymes can
effectively execute their desirable action of nucleolytic activity in a sequence specific
manner. Thus it is of importance to point out that Toxoplasma actually has a naturally
found ribozyme, called RnaseP (Mack et al., 1994). RnaseP has been used in other
system and organisms to perform effective nucleolytic activity (Kim and Liu, 2007). The
presence of natural RnaseP activity in Toxoplasma should be explored for the
development of genetic technology.

4.3.1.6. Small guide RNAs
In recent years, one of the most talked about regulatory RNA-derived
technologies is that of the guide RNA of the CRISPR (clustered regulatory interspaced
short palindromic repeats) system, originally identified as an adaptive immune system
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found in bacteria. Since numerous reviews and commercial sites discuss the use of the
CRISPR system, it is thus more appropriate here to limit our scope to those used in
Toxoplasma to serve our aims in comparing various antisense technologies. A simplified
version of the system involves an engineered plasmid expressing (i) a nuclease-directing
guide RNA, and (ii) Cas9 nuclease (Sidik et al., 2014). The nuclease-directing guide
RNA contains nuclease bases (i) acting as an antisense recognition sequence to pair with
genomic DNA target, and (ii) directing the Cas9 nuclease to the desired location, which
subsequently causes double stranded DNA breaks. Sidik et al. (2014) showed that the
CRISPR/Cas9 system can be used to induce homologous recombination in the parasite to,
for example, introduce point mutations without the need for antibiotic selection. The
study also indicated that a non-homologous end-joining (NHEJ) pathway is required for
the prevention of chromosomal instability and to achieve the best efficiency of
CRISPR/Cas9 genetic modulation system. The system was shown to cause 100-fold
increase in gene disruption, in comparison to traditional methods used via homologous
recombination (Sidik et al., 2014). A similar study performed by Shen et al. (2014),
showed that CRISPR/Cas9 not only disrupts genes by insertion but is also capable of
deleting full genomic regions using homologous recombination. Shen et al. (2014) noted
that the CRISPR/Cas9 system can be used to insert selectable markers without the need
for homology arms. These reports show that gene disruption is most effective in wildtype strains of Toxoplasma because of the functional NHEJ; however, genome editing in
processes such as epitope tagging has superior success in ΔKU80 strains that lack NHEJ
capability and therefore rely on homologous recombination (Sidik et al., 2014). The
CRISPR/Cas9 system has many promising applications in Toxoplasma as well as a wide
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variety of other organisms (Shen et al., 2014); however, there is still room for
improvement in efficiency and off targeting (Sander and Joung, 2014) which will likely
be addressed as it continues to come to the forefront of genome editing research.

4.3.2. Long non-coding RNAs
Not only because of their sizes, are lncRNAs constituted as an interesting class of
regulatory RNAs. lncRNAs, not mainly depending on sequence or structure, can function
both by sequence complementarity to bind other nucleic acids and/or by structure to form
molecular scaffolds for assembly of macromolecular complexes to result in either
repression or activation of gene expression (Yoon et al., 2013; Krishnan and Mishra,
2014). When the genome of Toxoplasma was surveyed using SAGE methodologies, more
than 50% of the Toxoplasma genome was shown to transcribe during various stages of
parasite development (Radke et al., 2005). Among polyadenylated transcripts analyzed
by SAGE tags, 21.5% of total SAGE tags observed were annotated as antisense
polyadenylated transcripts. Based on the average density of SAGE tags detected
throughout 14 chromosomes of Toxoplasma, an average antisense polyadenylated
transcripts is ~4000 nucleotides and derived from the opposite strands of the transcripts.
It is interesting to note that the expression of antisense transcripts are inversely
proportional to those of the sense transcripts and there are a number of intergenic regions
(~ 2000 base-pairs in length) to be explored (Radke et al., 2005). Hassan et al. (2012)
using high throughput RNA-sequencing data analysis showed that the Toxoplasma
genome has a number of ncRNAs. Ramaprasad et al. (2015) used a manual evaluation of
strand-specific RNA sequencing and shotgun proteomics to identify cis-natural antisense
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transcripts and long intergenic ncRNAs. Also, in this study a set of long antisense
polyadenylated transcripts and sense coding transcript were reported, and the reverse
correlation between the levels of the antisense noncoding transcripts and coding (sense)
RNAs reported by Radke et al. (2005) was confirmed. However the length of long
antisense polyadenylated transcripts is reported to be ~1300 nucleotides (Ramaprasad et
al., 2015), instead of ~2000. The presence of cis-natural antisense RNA and other forms
of long ncRNAs are indicative of the existence of a possible mode of gene regulation via
long ncRNAs in Toxoplasma.

4.3.2.1. Long antisense RNAs
The first report on utilizing long antisense RNA to regulate gene expression in
Toxoplasma was by Nakaar et al. (1999). In the study, antisense RNA (~2 kb)
corresponding to the coding sequence of nucleoside triphosphate hydrolase (NTPase) was
expressed under the control of its own promoter to yield antisense transcript, whose 3′UTR was tailored by a cis-acting hammerhead ribozyme to ensure its nuclear retention.
Resulting antisense NTPase transcripts subsequently pair with the mRNA with perfect
matches to cause mRNA degradation in the nucleus. The silencing of NTPase was
detected by immunoblotting to show the diminished level of target gene product. The
same strategy was used to down regulate selectable markers, called HXGRPT and CAT
(Nakaar et al., 2000). Both studies not only showed the silencing effect of nuclear
antisense RNA, but also showed that catalytically active hammerhead ribozymes are able
to silence the target without relying on endogenous machinery. Without a compartmentdirected expression, the over-expression of antisense RNA transcripts against the gene
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encoding uracil phosphoribosyltransferase (UPRT) was shown to effectively silence the
gene expression (Al-Anouti and Ananvoranich, 2002). Although these studies did not
offer an insight into the silencing mechanism, the reported silencing effect strongly
suggested that the basic mechanism of antisense-directed gene silencing must be
conserved between Toxoplasma and other eukaryotic organisms.

4.3.2.2. Long double-stranded RNA
Since the discovery of RNA interference mechanism, it is very well accepted that
siRNA and long double-stranded RNA can be used in silencing gene expression.
LaCount et al. (2000) showed that the overexpression of a transcript with promoters
arranged in a head-to-head fashion causes a gene-specific knockdown of gene expression
in Trypanosoma brucei. Al-Anouti and Ananvoranich (2002) adopted a similar strategy
for Toxoplasma. Despite the lack of mechanistic evidence to show the presence of
functional RNA interference in Toxoplasma, a similar expression system was used to
down regulate a number of genes, including marker, metabolic and growth-related
essential genes (Al-Anouti and Ananvoranich, 2002; Al-Anouti et al., 2003, 2004; Adams
et al., 2005; Al Riyahi et al., 2006; Ananvoranich et al., 2006; Yu et al., 2009 and Holmes
et al., 2010). It was noted that the silencing effect of double-stranded RNAs is better than
that of antisense RNAs (Al-Anouti and Ananvoranich, 2002). The superior effect of
double-stranded RNA could be due to (i) a higher stability of double stranded RNA
and/or (ii) fewer processes involved in the double stranded RNA induced gene silencing.

116

4.4. Future of antisense technologies
This review summarizes a limited set of our ever-expanding toolbox for
Toxoplasma, based on regulatory ncRNAs. With that in mind, using conventional genetic
tools and the various mix-and-match technologies, antisense technologies could yield an
array of valuable information. Two examples should be mentioned to encourage future
development of genetic tools via mix-and-match of known methods. By taking advantage
of homologous recombination system offered by ΔKU80 strains that lack NHEJ
capability, the binding sites of miR60a can be placed onto the 3’UTR of the gene of
interest in Toxoplasma (Crater et al., 2015). The resultant system was used to direct the
endogenous miR-60a-directed machinery to silence Toxoplasma genes encoding for
DEAD-box RNA helicase, and lactate dehydrogenase. In a more complex system,
endogenous tagging with DiCre-mediated DNA recombination system can be used to
insert U1 recognition sites at the last exon of the gene of interest to induce pre-mRNA
degradation (Pieperhoff et al., 2015). As a concluding remark, it is definitely an exciting
time to witness the expansion of genetic tools and technologies. More effective
technologies will be developed and realized using a combination of approaches and
methodologies.
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CHAPTER 5
Ubiquitin-like protease 1 (Ulp1) as a model for the study of miRNA-induced gene
regulation in Toxoplasma gondii
5.1. Introduction
Toxoplasma gondii is an intracellular parasitic protozoan and a member of the
phylum Apicomplexa whose members also include important pathogens such as
Plasmodium, the cause of malaria; Cryptosporidium, a water borne parasite; and
Neospora and Eimeria, important zoological parasites (Kim and Weiss, 2004). T. gondii
is able to infect any warm-blooded mammal, and has been reported to infect up to one
third of the world’s population. The life cycle of Toxoplasma consists of two stages; a
sexual reproduction stage that occurs only in the gut of its feline definitive hosts, and an
asexual reproduction stage in other warm-blooded hosts. The asexual stage contains two
distinct forms: a rapidly growing form called tachyzoite, and a latent cyst encapsulated
form called bradyzoite. Although the tachyzoite form is easily removed by the host’s
immune system, the parasites are able to convert to the bradyzoite form and evade the
host’s immune response.

When the host’s immune system becomes weakened, the

bradyzoites are able to reconvert to their rapidly growing tachyzoite form.
One of our research focus is to study a mechanism of post-transcriptional gene
regulation directed in Toxoplasma by small interfering RNAs, including siRNAs and
miRNAs. We showed that the abundance of Tg-miRNAs and the number of binding sites
within a transcript can influence the levels of silencing effects (Crater et al., 2015). The
presence of miRNA mimics and inhibitors altered the silencing effects. To gain a better
understanding of miRNA roles in the regulation of gene expression and parasite cellular
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biology, we endeavored to establish a model gene to facilitate the study. It was shown
previously that Toxoplasma small interfering RNAs were generated by plant/fungal-like
machinery (Braun et al, 2010). In Toxoplasma type I strain, the most abundant miRNAs
are members of Tg-miR-60 family, and predicted to have approximately 80 putative
target genes. Using this information as our starting point, we used the seed sequence
(CACAGT,

6

nts)

of

the

Tg-miR-60a

guide

strand

(ACACAGTCGGTACGAAATCCATACT, 25 nts) as a query in a blast search.
Seventy-five genes were identified to have at least one location with six consecutive
nucleotides to base-pair with the seed sequence. To ensure strong interactions between
Tg-miR-60a and the transcripts, we filtered out any genes with less than 18 nucleotides
complementarity, including those to the seed sequence. The transcripts of eight genes
were found to have at least one location with at least 18 nucleotides complementary to
Tg-miR-60a guide strand. Among these genes, three genes were annotated to have a
putative function in the Toxoplasma database (Gajria et al, 2008). Sorting based on the
number of probable Tg-miR-60a binding sites, we selected the locus containing a gene
with the highest number of probable Tg-miR-60a binding sites. Seven probable sites were
identified in a locus encoding ubiquitin-like protease 1 (TgUlp1, TGGT1_214470); four
sites locate on the non-coding strand, and three sites on the coding strand of the gene
encoding TgUlp1 (Figure 2a, Table 5.1.). This identification prompted us to investigate
and explore whether TgUlp1 could offer a model for the study of miRNA-induced gene
silencing in Toxoplasma.
Prototypic Ulp1, was first identified in baker’s yeast by Li and Hochstrasser
(1999) where it was found to have an essential role in the G2/M phase progression of the
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Table 5.1.

Predicted miR-60a binding sites on TgUlp1-pre-mRNA based on plant

miRNA binding. Predicted base pairing is indicated by *. Seed sequence is highlighted
in orange and target sequence is red.
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cell cycle (Li and Hochstrasser, 1999). Ulp1 is an essential gene in eukaryotes, which
encodes an enzyme involved in a post-translational modification pathway called
SUMOylation. The pathway of SUMOylation is involved in the reversible addition of a
small ubiquitin-like modifier (SUMO) peptide (90-110 amino acids) to a protein
substrate. Unlike ubiquitination, where target proteins are polyubiquitinylated and sent to
lysosomes for degradation, SUMOylation of target proteins aids in the protein’s
localization, stabilization and activity (Hay, 2005; Komander and Rape, 2012).
SUMOylation plays an important role in DNA repair, transcription, RNA processing,
nuclear-cytoplasmic transport, stress response and progression through the cell cycle
(Hay, 2005). The pathway is initiated by Ulp1 in the activation of a SUMO precursor.
Ulp1 is a cysteine peptidase that is highly specific for the SUMO peptide, as it recognizes
the tertiary structure of SUMO rather than an amino acid sequence (Mossessova and
Lima, 2000). Ulp1 cleaves amino acid residues from the C-terminal end of the SUMO
precursor to reveal a di-glycine motif that is required for attachment to target proteins.
The hydrolysis of a peptide bond by Ulp1 involves the thiol group of a cysteine residue as
a nucleophile, a histidine, and an aspartic acid to assist the reaction. The mature form of
SUMO with its revealed di-glycine is subsequently transferred by E1 and E2 enzymes
and ligated to its protein substrate by an E3 enzyme which recognizes the KxE
consensus sequence on the substrate (where  is a large hydrophobic residue and x is any
residue). The catalytic activity of Ulp1 is also responsible for the removal of SUMO
peptide from SUMOylated proteins (Watts 2013).
In Toxoplasma, a study was undertaken to explore the biological significance of
SUMOylation (Braun et al., 2009). The cDNA coding for the SUMO peptide was
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identified (TGME49_266460). Since a knockout or over-expression of TgSUMO was
found to be lethal, a N-terminal HA-Flag tagged version was generated under the control
of its endogenous promoter. Affinity purification of HA-Flag-TgSUMO expressed in
tachyzoites coupled to mass spectrometry identified 120 putative SUMOylated proteins.
The majority of identified SUMOylated proteins (~27 %) were found to be involved in
protein translation and folding. Other identified proteins were involved in (i) metabolism
and post-translational modification and (ii) degradation, which makes up 19 and 11 % of
the total identified proteins, respectively (Braun et al., 2009). Using an anti-HA antisera,
HA-Flag-TgSUMO was found to localize to the nucleus of transgenic parasites. They
next developed a polyclonal antibody raised against a recombinant TgSUMO protein
expressed from bacteria. To confirm the specificity of the new antibody for TgSUMO,
the HA antisera signal was compared to the TgSUMO antisera signal for localization and
western blot analysis. Since the anti-TgSUMO antisera could recognizes free SUMO and
SUMOylated proteins, localization during the parasite lytic cycle was analyzed. Upon
contact with a host cell during invasion, TgSUMO was found on the parasite membrane
at the point of contact. As the parasite entered the host cell, TgSUMO staining migrated
down the length of the parasite at the moving junction. Once the parasite successfully
invaded, the TgSUMO signal was found within the parasite’s nucleus. Under bradyzoite
conditions a TgSUMO signal was found on the parasitophorous vacuole membrane
(PVM). These studies suggest SUMOylation in T. gondii is a dynamic processes required
for parasite invasion and bradyzoite conversion. SUMOylation orthologs, Ulp1, E1, E2
and E3 have been identified yet their functions remain unknown (Braun et al., 2009).
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5.2. Materials and Methods
5.2.1. Cell cultures
5.2.1.1. Mammalian cell cultures
Human foreskin fibroblasts (HFF; ATCC, #1041) were grown in Dulbecco’s
Modified Eagle Media with high D-glucose and L-glutamine (DMEM; Invitrogen,
#12100046) supplemented with 10% v/v Cosmic Calf Serum (Hyclone, #H3008704N)
and 0.5x Antibiotic–Antimycotic (Invitrogen, #15240-062). Cultures were maintained at
37 C in 5% CO2.
5.2.1.2. Toxoplasma gondii culture
RHHX, T. gondii type I strain, was obtained from NIH AIDS Research and
Reference Reagent Program (#2857); Δku80 strain, which is an RHΔHX-derived strain,
was obtained from Dr. Vern B. Carruthers (University of Michigan). Unless stated
otherwise, both strains were maintained in HFF using Minimum Essential Medium
(MEM, Invitrogen, #61100061) supplemented with 1% v/v dialyzed fetal bovine serum
(ThermoFisher Scientific, Hyclone, #SH3007903) and diluted (0.5x) AntibioticAntimycotic and maintained at 37 C in 5% CO2. Selection of transgenic parasites was
grown in culture media containing either, mycophenolic acid (25 μg/mL) and xanthine
(50

μg/mL)

or

pyrimethamine

(1M),

for

hypoxanthine-xanthine-guanine

phosphoribosyltransferase (HXGPRT) or dihydrofolate reductase (DHFR) resistance,
respectively.
5.2.1.3. Saccharomyces cerevisiae
Wild type strain, MHY500 (MATa his3-200 leu2-3, 112 ura3-52, lys2-80, 1trp11, gal2) and the ulp1 shuffle strain, YOK 40 (ulp1::HIS3, ULP1/URA3) gifts from Dr.
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Oliver Kerscher, (The College of William and Mary, Williamsburg, Virginia) were
grown under their nutrient requirements on YEPD plates.
5.2.2. Plasmid construction
TgUlp1-SF transforming plasmid was constructed using pSF-TAP-LIC-HX
(obtained from Dr. Vern B. Carruthers, University of Michigan). The plasmid was
linearized by PacI digestion prior to the treatment with T4 DNA polymerase to create
compatible ends in the presence of dGTP for a ligation-independent cloning procedure as
described by Huynh and Carruthers (2009). TgUlp1 (1298 bp) amplicon was prepared
using gene specific primer pair of TgUlp1LICFw/TgUlp1LICRv (Table 5.2.), and
purified prior to the treatment with T4 DNA polymerase to create compatible ends in the
presence of dCTP. Equimolar concentrations of the prepared plasmid and insert were
allowed to anneal and subsequently used in bacterial transformations. The resultant
plasmid, pUlp1-SF-TAP-LIC-Hx was analyzed to confirm its sequence via restriction
endonuclease digestions. The plasmid was then used in the transformation of T. gondii
(ΔKu80). Transgenic parasites were selected and grown in culturing media containing
mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL).
CRISPR/Cas9 constructs for TgUlp1 knock out were generated by PCR reaction
using the pU6-universal parental plasmid (obtained from S. Lourido, Whitehead Institute
for Biomedical Research, Cambridge, MA) as a template.

Opposing primers,

gRNAUlp1NsiI and U3upstrem and gRNAUlp1XhoI and U3upstrem were used to
generate gRNAUlp1_1 and gRNAUlp1_2 plasmids (Table 5.1). PCR products were gel
purified using QiaexII Gel Extraction kit (Qiagen #20021) according to the manufacturer
protocol. Purified PCR products were then phosphorylated using T4 PNK (New

129

Table 5.2. Oligo nucleotide primers used in the study.

Primer name

Sequence

Plasmid Construction and verification
TgSUMO-GFP
XbaIRBS5Sumo
AATCTAGAAGGAGATATACCATGTCGGACGACAAGAAG
EcoRI3Sumo
AAGAATTCTGCGCCCCCCGTCTGTT
EcoRISer5eGFP
AAGAATTCTCCATGGTGAGCAAGGGCGAG
HindIII3eGFP
AAAAGCTTCGAACTCCAGCAGGACCA
LIC constructs
TgUlp1LICFw (b)
TACTTCCAATCCAATTTAATgcacgaacaaaacctggttc
TgUlp1LICRv (b’) TCCTCCACTTCCAATTTTAGCgtcgagttcgccgccgacga
FlagRv (e)

TGCGGATGAGACCAAGAACC

GST-TgUlp1
GST_Ulp1_FwCf
GATCTGGTTCCGCGTggatccATGATGTATGTTGACCTC
Ulp1EcoR1_RvCf
CTCGAGTCGACCCGGgaattcTCAGGGGTCGAGTTCGCCGC
Ulp1RvRT
TCAGGGGTCGAGTTCGCCGC
TgUlp1 yeast construction
ScUlp1Fw
GGTACCGGGCCCCCCCTCGAGACACATATATTACACAAGTA
ScUlp1Rv
GTCAACATACATCATATGCATTATTATGATATCCAAAGGTC
TgUlp1Rv
TCCTTTGCTAGCCATGCGGCCGCGGTCGAGTTCGCCGCCGA
TgUlp1Fw
TTGGATATCATAATAATGCATATGATGTATGTTGACCTCCC
CRISPR
gRNAUlp1NsiI
ggacagctcgagtgtctgtaGTTTTAGAGCTAGAAATAGCAAG
gRNAUlp1XhoI

ggacagctcgagtgtctgtaGTTTTAGAGCTAGAAATAGCAAG

TgUlp1DHFRFw

gcgggacagctcgagtgtctGCTTCGCCAGGCTGTAAATC

TgUlp1DHFRRv

aaaatcaaagcttcgtccgtCAGGAATTCATCCTGCAAGTG

U3upstrem
RT-PCR
qGAPDH_Fw
qGAPDH_Rv
qUlp1_Fw (a)
qUlp1_Rv (a’)
Exon6Fw ( c )

aacttgacatccccatttacc

UPRTFw

GGTCACTGCTGCTGTTGACATC

UPRTRv

GGTGTTCCGTGCTGCGAT
GCCTTTCCGCCGACAAT
ACGCGCTCTGGGACAAAA
GAACAGAGGCGAAGTCGTAGGT
AGCTCGAGTGTCTGTACGGCT

TTTTCCAGTCCGCGATTC

In vitro transcription
T7promoterGG
TAATACGACTCATATAGG
antiMIR60a_tpl
ACACAGTCGGTACGAAATCCATACTccTATATGAGTCGTATTA
antiMIR4a_tpl

ATGTTTGCTTGGAAGCTGTAGTCATTccTATATGAGTCGTATTA

Ulp1intron7FwT7

TAATACGACTCACTATAGGacgcgctctgggacaaaa
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England BioLabs #B0201S) according to the manufacturer protocol.

Subsequent

reactions were then ligated by a T4 DNA ligase (Fermentas #02076201) and analyzed by
NsiI and XhoI restriction endonuclease reactions, respectively. A DHFR (dihydrofolate
reductase) selection cassette was prepared by a PCR reaction with primers
TgUlp1DHFRFw and TgUlp1DHFRRv that contained 20-nucleotide homology to
TgUlp1 genomic sequence where Cas9 cleavage would occur.

The resultant PCR

product was extracted with 1 volume of phonol:chloroform then ethanol precipitated.
Parasites were transformed with 50 μg of each CRISPR/Cas9 plasmid, gRNAUlp1_1 and
gRNAUlp1_2, and 20 μg of purified DHFR selection insert. Parasites were cultured in
Ed1 media containing 1 μM pyrimethamine.
For expression of GST-Ulp1 in bacteria, the pGEX-4T-1 plasmid was prepared by
restriction endonuclease reaction with BamHI and EcoR1 restriction endonucleases. For
generation of the 2355 bp TgUlp1 amplicon, cDNA which was generated by
SuperScriptIII reverse transcriptase (Invitrogen #18080-093) with 250 ng of total RNA
and 2 pmol gene specific primer Ulp1RvRT, was used as a template. Amplicons were
produced with primers, GST_Ulp1_FwCf and Ulp1EcoR1_RvCF in a PCR reaction.
Each primer carries an 18-nucleotide homology to the linearized plasmid. Purified vector
and insert were subjected to a Cold Fusion cloning reaction (System Biosciences
#MC010A-1) according the manufacture’s protocol at a 1:1 ratio. Resultant plasmid was
confirmed by EcoRI restriction endonuclease.
Expression of the TgSUMO-eGFP recombinant protein substrate was generated
by linearization of pET28b plasmid by a XbaI and HindIII restriction endonuclease
reaction. To generate a TgSUMO (TGGT1_266460) insert, a PCR reaction with primers
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XbaIRBS5Sumo and EcoRI3Sumo with cDNA was used. The resultant PCR product
was digestion with XbaI and EcoR1 restriction endonuclease reaction and gel purified.
For generation of the eGFP insert, a PCR reaction with primers EcoR1ser5eGFP and
HindIII3eGFP were used with a ptub-mcherryFP-EGFP plasmid (from Dr. Vern B.
Carruthers, University of Michigan) as a template. Resultant amplicon was digested with
EcoRI and HindIII and gel purified. Purified linear plasmid and TgSUMO and eGFP
inserts were ligated at a 2:1:1 ratio using T4 DNA ligase.

Resultant plasmid was

confirmed by restriction endonuclease reactions.
For yeast complementation assays, the parental plasmid pScUlp1-GFP/LEU2 (gift
from Dr. Oliver Kerscher, The College of William and Mary, Williamsburg, Virginia)
was prepared by digested with XhoI and NotI endonucleases to remove the ScUlp1
promoter and coding region. Primers ScUlp1Fw and ScUlp1Rv were used with the
parental plasmid as a template to generate the ScUlp1 promoter insert. The resultant
product was subjected to XhoI endonuclease reaction to create a complimentary end
between the 5’ end of the promoter insert and the linearized plasmid used for ligation.
TgUlp1 coding region was generated in a PCR reaction with primers TgUlp1Fw and
TgUlp1R with the pGEX-TgUlp1 plasmid as a template for TgUlp1. The PCR product
was then digested with NotI endonuclease to create complimentary 3’ end used for
ligation.

Purified components were ligated with T4 DNA ligase at a 2:1:1 ratio.

Resultant plasmid was confirmed by XhoI restriction endonuclease reaction.
5.2.3. Yeast complementation assay
Standard lithium acetate transformation protocol for yeast cultures was used
(Gietz and Schiestl, 2007). YOK 40 strain (referred to as Δulp1 shuffle strain) was grown
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overnight at 30 °C and prepared for transformation. While a parental pAA3 plasmid was
used as a negative control (empty vector), a plasmid expressing Ulp1 from its
endogenous promoter (pUlp1-GFP/LEU2, obtained from Dr. Oliver Kerscher, The
College of William and Mary, Williamsburg, Virginia) served as a positive control
(Elmore et al., 2011). The construct of TgUlp1 cDNA under the endogenous yeast Ulp1
promoter was used in the transformation to monitor the level of functional
complementation. All yeast strains and their transformed cultures were grown to a midlog phase of growth and then subsequently diluted to ~0.5 (OD600). Serial dilutions were
performed using sterile 1x TE.

Each dilution was spotted (3 μL) onto YEPD plates

containing a final concentration of 1 mg/mL of 5-Fluoroorotic acid (5-FOA, Bio Basic
#703-95-7) and 20 g/mL of uracil (Bio Basic #UD0564) at pH 4.5 for induction of Ulp1
knockout. Plates were incubated at 30 °C for 72 hours. Growth analyses were performed
using densitometry (ImageJ 1.44p) for three independent experiments.
5.2.4. RNA isolation and qRT-PCR
Total RNA was isolated from freshly lysed parasites (approximately 106 parasites)
using TRI reagent (Molecular Research Center, Inc., #TR 118) according to the
manufacturer’s protocol, and treated with RQ1 Rnase-Free Dnase (Promega, #M6101)
for 30 minutes at 37 °C. Samples were kept at −20 °C until use. Isolated total RNA
(~500 ng) was annealed with 250 ng of an oligo-(dT) following heating at 65 °C for 5
minutes and slowly cooled. The reactions were then divided in half. A half of each
annealed reaction was used in SuperScript III reverse transcriptase (RT) reaction
(Invitrogen #18080-093), while the other aliquot was used as a negative control reaction
in the absence of SuperScript III RT. For real-time qPCR, the reaction mixtures were
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diluted 1/10, and analyzed by using Kapa Sybr Fast qPCR Kit Master Mix (2x) ABI
Prism (Kapa Biosystems #KR0390) and OneStepPlus thermocycler (Applied
Biosystems). Samples were analyzed in technical triplicates among at least biological
tests. Relative TgUlp1 expression levels in comparison to TgGAPDH expression levels
were measured and calculated using ΔΔCt protocol carried out by the StepOne Software
v 2.1 (Applied Biosystem). To generate a data set, relative TgUlp1 expression from no
addition of RNA was used for normalization of Tg-miR-60a and Tg-miR-4a (control)
inhibitor TgUlp1 mRNA levels.

PCR was performed using Hot Start Taq DNA

Polymerase (New England Biolabs, Inc., #M0495S) according to the manufacturer’s
protocol.
5.2.5. In vitro transcription of effector RNAs
Using partial DNA duplexes as templates, in vitro transcription reactions were
carried out in 50 μL-reaction mixtures in the presence of T7 RNA polymerase (~5 units),
80 mM Hepes-KOH, pH 7.5, 24 mM NaCl, 2 mM spermidine, 40 mM DTT, 10 mM
rNTPs, and ~1 unit pyrophosphatase at 37 °C for 16 hours. Reactions were subsequently
extracted with one volume of phenol-chloroform mixture (1:1), and resultant RNAs were
precipitated and quantified (Thermo Scientific NanoDraop2000). The oligonucleotide
template (2 μM) was annealed with an equimolar of T7promoterGG following mixing
and heating the mixture for 5 minutes at 70 °C and slowly cooled to room temperature to
yield partial DNA duplexes. One fifth of the annealing reaction (or 400 nM of the partial
DNA duplex) was used as templates for the RNA synthesis. Resultant single-stranded
RNA products, which were produced using the oligonucleotides named antimiR-60a_tpl
and antimiR4a_tpl were referred to as miR-60a inhibitor and miR-4a inhibitor,
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respectively. For the production of pri-miR-60, DNA amplicons were prepared using an
oligonucleotide primers containing a gene specific sequence and the sequence of the T7
promoter only on the forward primer, as listed in Table 5.1, under standard conditions for
Hot Start Taq DNA polymerase (New England Biolabs). Isolated genomic DNA from
type I parasites was used as a template with primers: TgUlp1intron7T7 and qUlp1Rv to
produce a 710 bp product and primers: TgUlp1intron7T7 and Ulp1LICRv to produce a
2308 bp product. In vitro transcription reactions were carried out in similar conditions as
described above using 1 g of DNA amplicon. Quality of RNA products were verified
by gel electrophoresis to confirm their expected sizes prior to electroporation into freshly
released parasites.
5.2.6. Dual luciferase assay
For dual luciferase assays, 48 hours post-transfection, freshly lysed parasites were
harvested and lysed with 100 μL of 1x Passive Lysis Buffer (Promega, #E1531) and
incubated for 10 minutes at room temperature. Lysates were cleared of debris by
centrifugation (10,000 xg for 1 minute), and the supernatant was kept on ice and used in
the dual luciferase assay, which was carried out in a 2-step fashion as previously
described by Crater et al. (2015). Luminescence signals were measured with a 20/20n
Luminometer (Turner Biosystems). Rnluc signals were normalized to Ffluc signals for a
direct comparison among different independent experiments. For each experiment, the
reporter plasmid electroporation without tested in vitro synthesized RNA, was carried out
to allow for the measurement of the dual luciferase expression under at least three
independently tested conditions.
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5.2.7. Western blot analysis
Cell-free lysates were prepared by the addition of RIPA buffer to collected
parasites and sonicated for 30 seconds (x3). Protein concentration was measured using
the RC DC Protein Assay according to manufacturer’s instructions (Bio-Rad
Laboratories, #500-0119). Approximately 20-25 μg was used for the analysis, of which
the lysates were denatured using 6x SDS protein loading buffer and resolved on a 10%
SDS-PAGE. The primary antibodies used were α-Flag mouse antisera (1:5,000, Applied
Biological Materials Inc., Richmond, B.C, Canada, #G191), α-tub mouse antisera
(12G10, 1:1,000, Developmental Studies Hybridoma Bank, University of Iowa, USA),
and α-GFP goat antisera (1:2,500, Rockland Immunochemicals Inc., #600-101-215). The
signals were revealed using secondary antibodies: horseradish peroxidase (HRP)
conjugated goat anti-mouse antisera (Rockland Immunochemicals Inc., #610-1319) or
rabbit anti-goat antisera (Rockland Immunochemicals Inc., #605-4302) at a 1:10,000
dilution, and a Chemiluminescent HRP Substrate Kit (Millipore, #WBKLS0500).
5.2.8. Recombinant protein purification
Both GST-TgUlp1 and TgSUMO-GFP fusion proteins were expressed in E. coli,
BL21-codonPlus (DE3)-RIL cells (Agilent #230245), by the addition of 1 mM IPTG and
grown overnight at room temperature. GST-TgUlp1 was purified on glutathione-agarose
beads (Novagen #7044-3) and eluted with 10 mM glutathione and 50mM Tris-HCL, pH
8.0. Freshly purified protein was then used for cleavage assays. TgSUMO-GFP was
purified on Ni-NTA agarose beads (Invitrogen #537735A) and eluted with 250 mM
imidazole, then dialyzed with 50 mM Tris-HCL, pH 8.0, 150 mM NaCl, and 0.2 %
Tween 20 and stored at -80 C for future use.
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5.2.9. TgUlp1 cleavage assays
5.2.9.1. TgUlp1 activity within parasite lysates
For TgUlp1 activity within type I parasites, 48 hours post-transfection with the
indicated concentration of miR-60a inhibitor, parasites were lysed in reaction buffer
containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2 % Tween 20 and 1 mM
dithiothreitol, and no protease inhibitors, and sonicated for 30 seconds.

Total protein

was quantified and 25 g of parasite lysates were combined with 4 M of substrate and
incubated at 37 C for two hours. Aliquots were removed every 30 minutes and reactions
were stopped by the addition of SDS loading buffer and boiled for 10 minutes. Samples
were then resolved by 10 % SDS-PAGE and subjected to western blot analysis.
TgSUMO-GFP amounts were quantified by densitometry for at least three experimental
trials.
5.2.9.2. In vitro TgUlp1 activity
Equal amounts of GST-TgUlp1 and TgSUMO-GFP (4 M) were combined in
reaction buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2 % Tween 20 and
1 mM dithiothreitol, and no protease inhibitors, and incubated at 37 C for 30 minutes.
Reactions were terminated by the addition of SDS loading buffer and boiled for 10
minutes. Samples were then resolved by SDS-PAGE and visualized via coomassie
staining. TgSUMO-GFP amounts were quantified by densitometry for at least three
experimental trials.
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5.2.10. Bioinformatics
Multiple sequence alignments were performed with the Clustal Omega tool
(Sievers et al., 2011) while sequence similarities were performed by GGSEARCH for
global and by SSEARCH for local protein analysis (Pearson 1988).
5.2.11. Statistical analysis
Statistical analysis was completed by the paired-wise student t-test methodology
assuming a null hypothesis. All values were calculated from at least three independent
tests.
5.3. Results
5.3.1. TgUlp1 is the most probable target of Tg-miR-60a
To verify if TgUlp1 expression is controlled by miR-60a, we used a miRNA
inhibitor to alter its expression. The mRNA levels of TgUlp1 were determined by qRTPCR. To confirm the effects of the miR-60a inhibitor on protein levels, we used our
engineered dual luciferase reporter system where our Renilla luciferase transcript (Rnluc)
contains three perfect match sites to miR-60a in the 3’ UTR as previously described
(Crater et al. 2015). Upon the introduction of increasing concentrations of miR-60a
inhibitor (5, 10 and 20 g), relative TgUlp1 mRNA levels increased to 2.4  0.23, 5.15 
0.35 and 10.15  0.60, respectively (Figure 5.1a). When an unrelated miRNA inhibitor
for Tg-miR-4a was used, relative TgUlp1 mRNA levels were 1.28  0.22. To confirm
the sequence specific effects of the miR-60a inhibitor, two unrelated genes (TgGAPDH
and TgUPRT) showed no change in relative mRNA levels (Figure 5.1b). The effects of
the miR-60a inhibitor (5, 10, and 20 g) on relative Rnluc activity increased to 46.6 
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Figure 5.1. TgUlp1 expression is affect by a miR-60a inhibitor. A. qRT-PCR indicates
that the presence of a miR-60a inhibitor can increased relative TgUlp1 mRNA levels in a
sequence specific manor. B. RT-PCR indicates an overall low expression of TgUlp1
when compared to housekeeping genes. TgUlp1 mRNA levels increase in the presence
of a miR-60a inhibitor while transcripts with no miR-60a binding sites remain
unchanged. C. Rnluc activity was also compared in subsequent parasite lysates. (Pvalues from at least three independent trials are, ‡ p≤ 0.001, * p≤0.005 and ● p≥ 0.01)
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3.2, 83.8  2.7 and 90  2.2 %, respectively, when compared to no inhibitor at 17  1.6
(Figure 5.1c).

The unrelated miR-4a inhibitor caused no change in relative Rnluc

activity, 25.0  4.0 %. As a control, the maximal amount of miR-60a inhibitor (20 g)
was also tested with the Rnluc construct with no miR-60a binding sites. Relative Rnluc
activity remained unchanged indicating the sequence specificity of the miR-60a inhibitor
(Figure 5.1c).
5.3.2. TgUlp1 genomic arrangement and miR-60a binding sites
Since miR-60a has a near perfect complementarity to intron 7 of TgUlp1 premRNA we sought to examine the genomic arrangement of this region in relationship to
the predicted miR-60a binding sites. We hypothesized that if miR-60a is able to bind
intron 7, it may cause intron retention. Total RNA was isolated and reverse transcribed
using a poly(T) oligonucleotide (polyA RT).

For polyA generated cDNA, the PCR

reaction using primer set a-a’, which spans exons 7-8, produced two transcript products at
110 and 710 bps. The 110 bp product corresponds to joined exons 7 and 8 of TgUlp1
mRNA, and the 710 bp product would include exon 7, intron 7, and exon 8. The lack of
a product in the no RT reaction suggests the 710 bp amplicon is not the result of genomic
DNA contamination and could be the effect of intron 7 retention (Figure 5.2b). PCR
reactions for primer sets b-b’, a-b’ and c-a’ produced one transcript size each that
corresponds to TgUlp1 mRNA at 281, 538 and 198 bp respectively (Figure 5.2b). As a
control, we also generated cDNA by a gene specific primer for TgUlp1 (primer b’ RT).
Unexpectedly, primer set a-a’ only produced a PCR product at 110 bp. Subsequent
reactions (c-a’and a-b’) produced products of 198 and 281 bp, respectively, which
correspond to TgUlp1 mRNA.
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Figure 5.2. TgUlp1 genomic arrangement. A. Predicted miR-60a binding sites on
TgUlp1 locus are indicated by * and ● on the coding and non-coding strand, respectively.
B.

Primer set a-a’ spans intron 7 where a near perfect match binding to miR-60a is

located. Polyadenylated generated cDNA produced two PCR bands at ~110 and ~710 bp.
The 710 bp product is not present in gene specific generated cDNA (by primer b’), only
the 110 bp from mRNA. C. The 710 bp product is only detected in antisense generated
cDNA by primer a.
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Complementary DNA for the antisense RNA was also generated and tested
(primer a RT). To our surprise, primer set a-a’ produced a product at 710 bp. The lack of
amplicons in the subsequent reactions with antisense cDNA (a-b’, b-b’, and No RT)
could indicate the location for the promoter of the antisense RNA (Figure 5.2c). These
data suggests the 710 bp product is not the effect of intron retention but of a
polyadenylated antisense RNA.
The antisense RNA contains a sequence that resembles the sequence of miR-60a
guide strand. To investigate the ability of the identified 710 nt antisense RNA to confer a
gene silencing effect, we used our dual luciferase reporter assay. The 710 nt nucleotide
sequence of antisense RNA was in vitro transcribed and tested. In the presence of in
vitro synthesized 710 RNA, Rnluc activity decreased when compared to no in vitro
synthesized RNA (Figure 5.3.). When the 710 in vitro synthesized RNA was RNaseIII
treated prior to transfection, Rnluc activity decreased further to 24.8  2.3 % (Figure
5.3.). A longer antisense RNA molecule (2803 nt) from the same locus was used as a
control. In the presence of the 2803 nt RNA and RNAseIII treated RNA Rnluc activity
was 43.6  0.36 and 36.9  1.1 %, respectively, when compared to no RNA added at 47.2
 3.7 % (Figure 5.3.). These data suggest that the expressed antisense RNA could confer
gene silencing and a possible locus is pri-miR-60a.
Taken altogether, our findings suggest that TgUlp1 could be identified as the first
self-regulating gene in T. gondii by miRNAs.

A self-regulating gene could be an

indication of an essential gene. Therefore we sought to determine the function and
importance of TgUlp1 to parasite cell biology and the effects of miRNA-induced gene
regulation of TgUlp1 in the SUMOylation pathway.
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Figure 5.3. Antisense RNA acts as effector RNA. In vitro transcribed antisense RNA
(710) is able to decrease Rnluc activity when the transcript contains miR-60a binding
sites. RNAseIII treatment of antisense RNA (710R) can decrease Rnluc activity further.
To confirm the silencing effect, a 2803 nt RNA corresponding to the antisense region to
the 3’ coding region of TgUlp1 was tested (2803). No alteration in Rnluc activity was
observed even when the RNA was RNAseIII pre-treated (2803R). (P-values compared to
Rnluc activity in the presence of miR-60a binding sites, but no additional RNA from at
least three independent trials are ‡ p≤ 0.001)
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5.3.3. TgUlp1 function by yeast complementation
Due to the conserved catalytic triad and high sequence similarity of the functional
domain of TgUlp1 (TGGT1_214470) with yeast Ulp1 (GenBank:KZV07496.1), we
anticipated TgUlp1 to display similar activities as observed with yeast Ulp1.

To

determine if TgUlp1 could function similarly to ScUlp1, we used a conventional yeast
complementation analysis. A Ulp1 shuffle strain (ulp1::HIS3, Ulp1/URA3), referred to
as Ulp1, which is a conditional knock-out in the presence of 5-fluoroorotic acid (5FOA), was used (Li et al., 2003, Elmore et al., 2011). To determine a background level
of growth, the Ulp1 strain was grown on plates containing 5-FOA and uracil at 30 C
for 72 hours and growth was determined via densitometry. Growth of the Ulp1 strain
was 20.6  2.6 % when compared to the wild-type (WT) (Figure 5.4.). Transfection of
Ulp1 with the pAA3 (LEU2) empty vector displayed a similar growth phenotype to 19.6
 2.5 % as compared to WT. When Ulp1 was transformed with a pAA3 plasmid
containing the yeast wild-type Ulp1 under the control of its own promoter (ScUlp1,
Elmore et al., 2011), growth was restored to 87.4  5.3 % of the wild type phenotype.
When pAA3 plasmid engineered to carry TgUlp1 (cDNA 2316 bp) under the control of
the yeast Ulp1 promoter (TgUlp1) was used, complementation by TgUlp1 was achieved.
Growth was restored to 48.4  3.7 % (1x) and 80.0  4.4 % (2x) as compared to the WT
(Figure 5.4.).

144

Figure 5.4. Yeast complementation analysis in Ulp1 strain. The ability of yeast to
utilize the T. gondii ortholog of Ulp1 was tested by growth analysis in the conditional
ScUlp1 KO yeast strain. Under the ScUlp1 KO conditions, phenotypic growth was only
restored upon transfection of a Ulp1 expressing plasmid. (P-values compared to WT
yeast growth by densitometry from at least three independent trials are ● p≥ 0.01, * p ≤
0.01)
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5.3.4. TgUlp1 peptidase activity
To examine the peptidase activity of TgUlp1, we expressed and purified a
recombinant protein and a SUMOylated recombinant protein substrate for in vitro assays.
TgUlp1 (85 kDa) was N-terminally tagged with a glutathione S-transferase (GST, 26
kDa) that would produce a 111 kDa protein. The peptide of TgSUMO (TGGT1_266460,
10.3 kDa) was joined to the N-terminus of GFP that carries a C-terminal His tag (6x) to
give a 45 kDa protein substrate (Figure 5.5a). Equal amounts (4 M) of purified GSTTgUlp1 enzyme and TgSUMO-GFP substrate were combined and incubated at 37 C for
30 minutes. In the presence of GST-TgUlp1 (+), the amount of TgSUMO-GFP substrate
decreased to 57  6.9 % when compared to no enzyme (-) (Figure 5.5a). A GFP product
at 34.7 kDa was also detected (Figure 5.5a). This indicates TgUlp1 is able to recognize
and hydrolyze the peptide bond from a SUMO conjugated protein.
Separate parasite lysates (~25 g) were prepared 48-hours post-transfection
without or with the miR-60a inhibitor and combined with purified TgSUMO-GFP
substrate. First, mock (no inhibitor) parasite lysates displayed a substrate cleavage rate of
0.21 nM·min-1·µg-1 (Figure 5.5b). Second, the introduction of 5, 10, and 20 µg of
inhibitor increased substrate cleavage rates to 0.58, 0.77 and 1.10 nM·min-1·µg-1,
respectively (Figure 5.5b). These data suggest the presence of the miR-60a inhibitor can
increase TgUlp1 activity in parasite lysates.
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Figure 5.5. TgUlp1 peptidase activity. A. Purified GST-TgUlp1 can remove TgSUMO
from a recombinant protein substrate, TgSUMO-GFP. B. Total TgSUMO-GFP levels
were analyzed by western blot and an anti-GFP antisera within parasite lysates. Parasites
were transfected with the miR-670a inhibitor and allowed to grow for 48 hours.
Extracellular parasites were lysed in reaction buffer (see section 5.2.9.1.) and incubated
with purified TgSUMO-GFP. Activity was calculated by the total amount of TgSUMOGFP substrate present at each time point. (A, p-value compared to GFP signal without
GST-TgUlp1 is p≤ 0.005, B, p-value for all substrate cleavage rates are p ≤ 0.0001
calculated by densitometry from at least three independent trials)
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5.3.5. TgUlp1 localization
To monitor TgUlp1 at the protein level, we generated a tagged version of TgUlp1
by a genetic knock-in strategy. The nucleotides encoding for a Strep/Flag (SF) tag were
introduced immediately before the stop codon for TgUlp1 cDNA to create a ~93 kDa
protein (85 kDa TgUlp1, ~8 kDa SF) (Huynh and Carruthers, 2009). To ensure proper
integration of the SF tag to the TgUlp1 locus, PCR analysis was performed (Figure 5.6a).
Primer set b-b’ spans 1298 bps in exons 10-13 of TgUlp1 and was present in both the
parental (Ku80) and transgenic TgUlp1-SF parasites (Figure 5.6a). Primer set b-e’, spans
1798 bps in exon 10 to the Flag tag sequence and was only present in the TgUlp1-SF
parasites (Figure 5.6a).
SUMOylation could be important for parasite invasion and cyst formation, as
TgSUMO localizes to specific areas during these events (Braun et al., 2010).
Localization of TgUlp1 could suggest its involvement in similar events.

Within

intracellular tachyzoites, TgUlp1 localization is mainly dispersed throughout the
cytoplasm, however, in extracellular tachyzoites, TgUlp1 localizes to distinct structures
in the apical and basal ends of the parasite (Figure 5.6b). Under bradyzoite conditions
(Dolichos stain for cyst walls not shown), the distinct structures do not appear to change
(Figure 5.6b).
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Figure 5.6.

Endogenously tagged TgUlp1 localization.

A. PCR confirmation of

generation of TgUlp1-SF transgenic parasites by genetic knock-in.

B.

TgUlp1

localization changes throughout the different stages of the lytic cycle.

Within

intracellular parasites, TgUlp1 localization is found within the cytoplasm, which changes
to distinct structures in the apical and basal ends of the parasite in extracellular parasites.
Under bradyzoite conditions the distinct structures become more prevalent.
Hoechst, micrometer represents 5 µm.)
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(Hz,

5.3.6. Physiological function of TgUlp1
To determine the function of TgUlp1, we attempted to generate a knockout
parasite strain by using the CRISPR/Cas9 mythology in type I parasites. Two guide
RNAs were designed to target and cleave in the genomic sequence of TgUlp1 at
nucleotide 4162 in exon 6 and nucleotide 7023 in exon 12 to remove a 2880 bp region
that encodes for the catalytic domain of TgUlp1. Using homologous recombination, a
3640 bp DHFR (dihydrofolate reductase) selectable marker was inserted at the cut sites.
Upon selection pressure, transfected parasites would begin to grow normally with an
average of 8 parasites per vacuole at 24-hours post-invasion (data not shown). However,
we noticed at 48-hours post-invasion, vacuole morphology would appear somewhat
abnormal and the parasites remained intracellular (Figure 5.7., vacuole indicated by red
triangle). Generally under our culturing conditions at 48-hours post- invasion, parasites
would require a fresh monolayer of host cells to invade. As the parasites were allowed to
growth further (up to 5 days), vacuole morphology continued to look abnormal and
worsened in appearance and size (Figure 5.7.). A lack in host cell destruction or debris
due to parasite egress, or exit, of the host cell was also observed. The abnormal vacuole
morphology was noted to be similar in parasites with an inability to egress (Heaslip et al.,
2011). The inability to create a stable TgUlp1 KO parasite strain may indicate TgUlp1 is
as an essential gene and may be involved in parasite egress.
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Figure 5.7. Effects of TgUlp1 knockout by CRISPR/Cas9 methodology. After 48-hours
post-infection, TgUlp1KO parasites display abnormal vacuole morphology (indicated by
red triangle). By 72 hours post-infection, parasites display an inability to egress and
remained intracellular.
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5.3.7. Effects of TgUlp1 expression on SUMOylation
The effects of TgUlp1 on total SUMOylated substrates in parasite lysates was
tested by alteration of TgUlp1 expression accomplished by using the miR-60a inhibitor
and in vitro synthesized 710 nt antisense RNA (710as).

Extracellular TgUlp1-SF

parasites were transfected with 20 g of miR-60a inhibitor, 710 antisense RNA (710as),
or a mixture of miR-60a inhibitor and 710as. TgUlp1-SF expression was detected by an
anti-Flag antisera. Densitometry values were calculated based on the expression of an
alpha-tubulin loading control. At 48 hours post-transfection the presence of miR-60a
inhibitor increased Ulp1-SF expression to 232 ± 17 % when compared to WT (Figure
5.8.). Introduction of 20 g of the 710as RNA decreased TgUlp1 expression to 65 ±
13%. When equal amounts of miR-60a inhibitor and 710as RNA were mixed and
introduced to the parasites, TgUlp1 expression was 129 ± 10% (Figure 5.8.).
Subsequent lysates were also analyzed for total SUMOylated substrates with an
anti-SUMO antisera.

The SUMO antisera would recognizes free SUMO and

SUMOylated protein substrates. The presences of the miR-60a inhibitor increased total
SUMOylated proteins levels to 266 ± 13 % when compared to WT (Figure 5.8.). Total
SUMOylated proteins levels decreased to 47 ± 4.1 % in the presences of 710as RNA.
Combined miR-60a inhibitor and 710as RNA restored total SUMO levels to 129 ± 17 %.
Selected individual SUMOylated proteins (A, B, C, and D) were also monitored for an
alteration of expression in the presence of the effector RNAs (Figure 5.8).
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Figure 5.8. Alteration of TgUlp1 expression affects total SUMOylation levels.

A.

Representation of immunoblot for analysis at 48-hours post-transfection with or without
effector RNA molecules. B. TgUlp1-SF parasites were transfected with an effector RNA
or combined effector RNAs and allowed to grow for 48 hours. Changes in protein
expression of TgUlp1-SF and total SUMOylated proteins were observed in the presence
of the miR-60a inhibitor and 710 antisense RNA (710as) when tested independently. (pvalues were calculated by densitometry from at least three independent trials compared
to WT expression relative to Tubulin expression,* p ≤ 0.01)
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5.4. Discussion
For the identification of the most probable target for miR-60a, we used miRNA
target binding criteria based on plant miRNAs, which contain a perfect to near perfect
complementary binding. The identified near perfect miR-60a binding site is located in
intron 7 of the pre-mRNA. Two other putative miR-60a binding sites with only a seed
match complementarity (6 nt) were found in intron 2 (Table 5.1., Figure 5.2a). Since
these three sites were identified in the introns of TgUlp1 pre-mRNA, we sought to
identify possible miR-60a binding sites on the mRNA based on mammalian miRNA
binding criteria. Mammalian miRNAs need as few as 6-nt complementary to bind target
mRNA and can contain a 1 nt mismatch in the miRNA seed sequence (Seok et al., 2016).
Either strand of a miRNA can be used as the “guide” strand therefore we sought to
analyze both the lower and upper strand of miR-60a to target TgUlp1 mRNA. Only the
guide strand sequence of miR-60a has been reported, therefore we used two predicted
upper strands from miR-60b as reported by Braun et al., (2010). These miRNAs come
from the same miRNA family (miR-60), contain the same seed sequence and should
target the same mRNAs. Using these criteria, we identified ten putative binding sites for
Tg-miR-60. Table 5.3. indicates the sequence of the miR-60 strand (lower or upper +)
and their predicted base pair interactions (indicated by *) and location on the TgUlp1
mRNA. The predicted seed sequence base pairing is highlighted. Using the lower strand
of miR-60a, eight putative binding sites were identified. Two of the binding sites are
located in the predicted 5’ UTR, four in the coding region, and one in the predicted 3’
UTR. The miR-60b upper 1 strand has a binding site in the predicted 5’ UTR and exon 6
while miR-60b upper 2 would bind once in the predicted 5’ UTR.
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Table 5.3. Predicted miR-60a binding site on TgUlp1 mRNA based on mammalian
miRNA binding. Seed sequence is highlighted in orange and target sequence is red.
Predicted base pairing is indicated by * (+ indicates upper strand of pridicited miR60).
Location on mRNA
(nt)

Predicted base pairing
5’ UCCCCCCGUUGGAAUUUUCCCUUCU
*
* *******
3’ GUACAUCGUGUAUAUCAUGGGAAGA

3’

mRNA

5’

miR60b+

5’ CCGCUGUUCGUGGUGUCUAAUCGAG 3’
*
* ***** *
3’
CUGAUUUCAGUCGUAUUAGUUAA 5’

mRNA

5’

AAUCGAGGGCGACUUCGCGUCUGUU 3’
**
* * ** ****
UCAUACCUAAAGCAUGGCUGACACA 5’

mRNA

GAGCUUCUGUACACCCACGAGUGUA 3’
** *
*
*** ***
UCAUACCUAAAGCAUGGCUGACACA 5’

mRNA

GAGGAAGGAUUCGAGAGACGGUGUC 3’
*
*
* *** ****
TCATACCTAAAGCATGGCTGACACA 5’

mRNA

CGUCCUGGACACAAGGACGACUAUCU 3’
****
***** * *
UCAUACCUAAAGCAUGGCUGACACA 5’

mRNA

CAGGCCCGUCAAGCGACGAUUGUGC 3’
*
*
*** ****
UCAUACCUAAAGCAUGGCUGACACA 5’

mRNA

5’ CUGGCUGAACGACGAAGUUAUCAAC 3’
*
** * *
* *****
3’
CUGAUUUCAGUCGUAUUAGUUAA 5’

mRNA

5’

mRNA

3’
5’
3’
5’
3’
5’
3’
5’
3’

3’

AGUGGUGCAUCCCCGACGACUUUGC 3’
***
* * *
***** **
UCAUACCUAAAGCAUGGCUGACACA 5’

5’ UGCCAUGCAUGGAAAGAAAUGUGUG 3’
* * *
* *****
3 UCAUACCUAAAGCAUGGCUGACACA 5’
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miR60b

+

Predicted 5’ UTR
-68 to -43

miR60a

Exon 1
681 to 705

miR60a

Exon 2
1165 to 1189

miR60a

Exon 2
1348 to 1373

miR60a

miR60a
mRNA
miR60a

Predicted 5’ UTR
-322 to -297

Predicted 5’ UTR
-304 to -279

miR60a

miR60b

Predicted 5’ UTR
-364 to -339

+

Exon 6
1710 to 1735

Exon 11
2120 to 2145

Predicted 3’ UTR
2700 to 2725

TgUlp1 was identified as the most probable target for miR-60a. The expression
of TgUlp1 mRNA and protein levels can be effected by the introduction of a miR-60a
inhibitor indicating miR-60a acts upon TgUlp1. Antisense RNA produced from the
TgUlp1 locus, which contains a possible miR-60a guide sequence, is able to down
regulated Rnluc activity when the transcript carries miR-60a binding sites and decrease
TgUlp1 protein expression. Based on this data, the locus of TgUlp1 has other regions
that would require investigation. The pre-mRNA of TgUlp1 could be a source of miR60a mirtrons.

Upon splicing, introns 2, 7, and 12 might produce a structure that

resembles a mirtron with sequences similar to miR-60a. These regions would also need
to be tested for their ability to induce gene silencing.
TgUlp1 locus is on chromosome X and composed of 13 exons and 12 introns that
span 7432 bp. The coding sequence is 2316 nucleotides (Gajria et al., 2008). Pairwise
sequence alignment of TgUlp1 from three archetype strains revealed 8 SNPs (Type I,
GT1, Type II, ME49 and type III, Veg) in the N-terminal variable region. Each SNP
results in an amino acid change, but are conservative substitutes. Reported gene
expression profile of TgUlp1 indicates an overall low expression (40th percentile) in the
three strains (Bahl, et al., 2010).

Overall, this indicates that TgUlp1 would have the

same function and activity among the parasite archetypes (type I, II, and III).
The amino acid sequence alignment of TgUlp1 (TGGT1_214470) with reported
homologs, showed a C-terminal cysteine peptidase domain that contains a canonical
catalytic triad, His-Asp-Cys. TgUlp1 sequence also contains a conserved Gln that is
important for stabilizing the acyl intermediate that forms during catalysis (Supplemental
Figure 5.1a). The global sequence similarity among TgUlp1 (771 amino acids), H.
159

sapiens SENP2 (589 amino acids), C. elegan Ulp1 (697 amino acids), and S. cerevisiae
Ulp1 (621 amino acids) is, 31.9, 35.5, and 30.2 %, respectively. The catalytic domains
alone have a 57, 50.6, and 47.4% sequence similarity respectively (accession; SENP2,
NP_067640.2, C. elegan Ulp1, NP_498095.3, yeast Ulp1, GenBank:KZV07496.1).
Global phylogenic tree analysis revealed TgUlp1 to be more closely related to human
SENP2 and C. elegan Ulp1 rather than P. falciparum Ulp1, another Apicomplexan
(Supplemental Figure 5.1b).

Therefore, we would expect TgUlp1 to have similar

function and activity to these identified homologs.
TgUlp1 was only able to complement the growth of yeast to ~50 % (Figure 5.4.).
The level of rescue observed could be due to the longer N-terminal domain of TgUlp1
compared to yeast Ulp1 (~150 amino acids) or the lower sequence similarity between the
functional peptidase domains (47.4 %). The N-terminal domain of yeast Ulp1 has been
shown to be important for nuclear localization (Li et al., 2003), therefore, the differences
in length, tertiary structure and amino acids may have an impact on the ability of TgUlp1
to localize and function in the yeast nucleus. Furthermore, these differences may also
hinder the ability of TgUlp1 to interact with and cleave yeast SUMO-1 and SUMOylated
products.
A recent study used the CRISPR/Cas9 system to perform a genome-wide
screening of T. gondii genes by knockout (Sidik et al., 2016). After three lytic cycles,
parasites were analyzed for their ability to grow and given a score based on their fitness.
Any gene with a negative score was considered to contribute to parasite fitness and
identified as an indispensable gene. Under these criteria, TgUlp1 KO was found to have
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Supplemental Figure 5.1. Amino acid analysis and phylogenic tree for TgUlp1. A.
Sequence alignment of Toxoplasma (TgUlp1) with C. elegan (CsUlp1), H. sapiens
(HsSENP2), and S. cerevisiae (CsUlp1). Catalytic domain in gray while catalytic triad,
H-D-C is highlighted in red (*), conserved Q in purple (#). B. Phylogenic tress analysis
of full length Ulp1 orthologs.
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a score of -2.73 (Sidik et al., 2016). Combining our inability to produce a stable TgUlp1
KO parasite indicates that TgUlp1 is an essential gene.
TgUlp1 has been identified as the first gene target of miR-60a and could be selfregulating gene. TgUlp1 KO and alteration of expression by the miR-60a inhibitor
suggests a tight regulation of TgUlp1 expression is necessary for parasite cell biology.
Overall, these data show the importance of an RNA induced gene silencing mechanism in
T. gondii.
5.5. Acknowledgements
This work was supported by the Natural Sciences and Engineering Research
Council of Canada (NSERC). Also, ACP received an additional financial support, which
was kindly allocated from NSERC to Dr. Lana Lee and from University of Windsor.
5.6.

References

Braun, L.; Cannella, D.; Ortet, P.; Barakat, M.; Sautel, C.F.; Kieffer, S.; Garin, J.;
Bastien, O.; Voinnet, O.; Hakimi, M.A. A complex small RNA repertoire is generated by
a plant/fungal-like machinery and effected by a metazoan-like Argonaute in the singlecell human parasite Toxoplasma gondii. PloS Pathogens, 2010, 6(5), e1000920.
Crater AK, Manni E, Ananvoranich S. (2015) Utilization of inherent miRNAs in
functional analyses of Toxoplasma gondii genes. Journal of Microbiological Methods.
108:92-102.
Elmore ZC, Donaher M, Matson BC, Murphy H, Westerbeck JW, Kerscher O. Sumodependent substrate targeting of the SUMO protease Ulp1. BMC Biol. 2011 Oct 28;9:74.
Gajria B, Bahl A, Brestelli J, Dommer J, Fischer S, Gao X, Heiges M, Iodice J, Kissinger
JC, Mackey AJ, Pinney DF, Roos DS, Stoeckert CJ Jr, Wang H, Brunk BP. ToxoDB: an
integrated Toxoplasma gondii database resource. Nucleic Acids Res. 2008
Jan;36(Database issue):D553-6.
Hay RT. (2005) SUMO: a history of modification. Molecular Cell. 1;18(1):1-12

163

Heaslip AT, Nishi M, Stein B, Hu K. The motility of a human parasite, Toxoplasma
gondii, is regulated by a novel lysine methyltransferase. PLoS Pathog. 2011
Sep;7(9):e1002201.
Huynh MH, Carruthers VB. Tagging of endogenous genes in a Toxoplasma gondii strain
lacking Ku80. Eukaryot Cell. 2009 Apr;8(4):530-9.
Kim, K., Weiss, L.M., 2004. Toxoplasma gondii: the model apicomplexan. Int. J.
Parasitol. 34 (3), 423–432.
Komander D, Rape M. (2012) The ubiquitin code. Annual Review of Biochemistry.
81:203-29.
Li SJ, Hochstrasser M. The Ulp1 SUMO isopeptidase: distinct domains required for
viability, nuclear envelope localization, and substrate specificity. J Cell Biol. 2003 Mar
31;160(7):1069-81.
Montoya, J.G.; Liesenfeld, O. Toxoplasmosis. Lancet, 2004, 363(9425), 1965-1976.
Mossessova E, Lima CD. (2000) Ulp1-SUMO crytal structure and genetic anaylsis reveal
conserved interactions and a regulatory element essential for cell growth in yeast.
Molecular Cell. 5(5):865-76.
Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl
Acad Sci U S A. 1988 Apr;85(8):2444-8.
Seok H, Ham J, Jang ES, Chi SW. MicroRNA Target Recognition: Insights from
Transcriptome-Wide Non-Canonical Interactions. Mol Cells. 2016 May 31;39(5):375-81.
Sidik SM, Huet D, Ganesan SM, Huynh MH, Wang T, Nasamu AS, Thiru P, Saeij JP,
Carruthers VB, Niles JC, Lourido S. A Genome-wide CRISPR Screen in Toxoplasma
Identifies Essential Apicomplexan Genes. Cell. 2016 Sep 8;166(6):1423-1435.e12.
Watts FZ. (2013) Starting and stopping SUMOylation. What regulates the regulator?
Chromosoma. 122(6):451-63.

164

CHAPTER 6
Toxoplasma gondii Argonaute: A core protein of RNA-induced silencing complex
6.1. Introduction
RNA-directed gene silencing mechanisms play a critical role in the control of
gene expression at the transcriptional, post-transcriptional and chromatin remodeling
levels in eukaryotes. Argonaute (Ago) is the core protein found in the RNA-induced
silencing complex (RISC) (Fire et al., 1998, Shabalian and Koonin, 2008, Carthew and
Sontheimer, 2009, Siomo and Siomi, 2009). A member of the Argonaute family is
responsible for guiding small RNAs (siRNAs and miRNAs) to their regulatory target
mRNAs. Subsequent RISC assembly leads to (i) degradation of mRNA target, (ii)
translational repression or (iii) causing chromatin modifications. The Ago protein family
was first identified in plants (Bohmert at al., 1998). Ago proteins were named after a
phenotype of a knockout in Arabidopsis thaliana, as it resembles the tentacles of the
octopus, Argonaute argo (Bohmert at al., 1998). Originally, Ago was called “Slicer”
based on its nuclease activity to hydrolyze phosphodiester bonds of messenger RNA
(mRNA). Based on sequence homology, Ago proteins have been divided into three
subfamilies; (i) Ago subfamily, which resembles A. thaliana Ago1, (ii) Piwi subfamily
(P-element induced wimpy testis) that is related to Drosophila melanogaster Piwi protein
and (iii) WAGO which are specific to C. elegans. Piwi subfamily members only contain
the Piwi domain that includes the canonical catalytic triad, DDH/E and are generally ~40
kDa in size. Members of the Ago subfamily on the other hand, contain two conserved
domains called PAZ (Piwi-Argonaute-Zwille) and Piwi and are typically ~100 kDa in
size. Among species an organism can contain one or many paralogs of Ago. Fission
yeast (Schizosaccharomyces pombe) and budding yeast (Saccharomyces castellii) both
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harbor one gene coding for Argonaute, while fruit fly (Drosophila melongaster), humans
(Homo sapiens), and worm (Caenorhabditis elegans), contain five, eight and 27 paralogs,
respectively. Generally, multiple paralogs of Argonaute within an organism function
within distinct locations (i.e. nucleus or cytosol), vary in nuclease activity or interact with
a specific form of non-coding RNA molecule (siRNAs and miRNAs vs. piRNA). In
organisms that contain a single Argonaute gene, the protein can be found within the
nucleus and cytosol and, participate in transcriptional and post-transcriptional gene
regulation mechanisms (Azlan et al., 2016). Not every eukaryote contains an Argonaute
gene, for example, baker’s yeast (Saccharomyces cerevisiae, Jinek and Doudna, 2009).
Among parasitic protozoans, Trypanosoma brucei has two genes that code for
Argonaute while Toxoplasma gondii, Giardia spp., Entamoeba spp. and Trypanosoma.
congolense are predicted to have only one. The presence of Argonaute and small noncoding RNAs amongst these organisms led to interest in developing a genetic tool to
target and develop new drugs against parasitic infection (Ullu 2004 and Kolev 2011).
Trypanosoma cruzi, Leishmania major, Leishmania donovani, and Plasmodium
falciparum on the other hand, do not harbor Argonaute coding genes (Ullu 2004 and
Kolev 2011).
Our focus is the Apicomplexa parasite T. gondii which has infected up to one
third of the world’s population.

Infection in humans and mammals often leads to

blindness, encephalitis, severe brain dysfunctions and miscarriages (Kim and Weiss,
2004). The study by Al-Riyahi et al. (2006) showed that T. gondii has one Argonaute
coding gene with a conserved Piwi domain and a partial PAZ domain (Al-Riyahi et al.,
2006).

Using RNA Ligase-Mediated Rapid Amplification of cDNA (RLM-RACE),
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analysis in type I parasites, TgAgo was found to be encoded by a 2265 nucleotide mRNA
which spans five exons that could produce a 58.5 kDa protein. Southern blot analysis
determined a single locus for the expression of TgArgonaute.

Immunofluorescence

assays showed that TgAgo localizes to the cytosol. Despite the smaller size, it was
shown that TgAgo is required for double-stranded RNA induced gene silencing even
though it lacks a canonical catalytic triad (DDH/E) (Al-Riyahi et al., 2006).
In a later study, Braun et al. (2010) identified a larger TgAgo protein in type II
parasites that was predicted to contain additional domains called MID and RGG, and the
protein is ~98 kDa (Braun et al., 2010).

A full-length HA-Flag-tagged TgAgo

overexpression construct composed of the ~7.5 kb genomic sequence was used for the
study. They found that HA-Flag-TgAgo had an affinity for small RNAs and polysomes
by chromatin immuno-precipitation and chromatographic polyribosome fractionation
analysis, respectively. Immunoprecipitation of HA-Flag-TgAgo and mass spectrometry
identified several TgAgo interacting proteins involved in RNA metabolism and
chromatin-repression complexes, indicating that TgAgo may play a role in translational
and transcriptional regulation. HA-Flag-TgAgo was also found to interact with a TudorSN (tudor staphylococcal nuclease) and a PRMT1 (arginine methyltransferase), which
have been found in the RISC complex of C. elegans and D. melanogaster (Caudy et al.,
2003).
Another study by Musiyenko et al. (2012) investigated the roles of TgAgo in
RNA cleavage by antisense guide RNA.

A tachyzoite cDNA library from type I T.

gondii parasites (provided by the AIDS reagent bank), was used as starting material for
generating cDNA (2841 nt) used to overexpress an N-terminally Myc-tagged TgAgo.
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The construct produced a ~100 kDa Myc-TgAgo. Since TgAgo does not contain the
canonical DDH/E catalytic triad, the roles of the interacting proteins TgTSN and
TgPRMT1 were investigated in target mRNA cleavage. In vitro assays determined that
purified Myc-TgAgo alone displayed a weak nuclease activity. When purified MycTgAgo and Myc-TgTSN were combined, a greater target mRNA cleavage was achieved
(Musiyenko et al., 2012).

By in vitro methylation assays, it was discovered that

TgPRMT1 is required for methylation of the RGG domain of TgAgo, which is used for
protein stabilization in addition to recruitment of TgTSN.
The three versions of TgAgo protein are reported in the NCBI protein database
(GenBank: ACZ73654.1, ABA70456.1 and ABB05350.1) predicting three possible
translational starts sites. Gene ACZ73654.1 identified by Braun et al (2010), contains the
first predicted translational start codon in exon 1 (Figure 6.1., ATG1). The predicted
coding region spans 7 exons and would produce a ~100 kDa protein which would contain
a RGG, PAZ and PIWI domain (protein 1). The second predicted TgAgo, ABA70456.1
identified by Andrews, et al. (2006), has a start codon in exon 3 (ATG 2). Protein 2
would span 5 exons and produce a ~ 82 kDa protein and would contain a PAZ and PIWI
domain (Figure 6.1.). The third predicted TgAgo, ABB05350.1 identified by Al-Riyahi
et al. (2006) has a start codon in exon 6 (ATG 3). Protein 3 would span 2 exons and
produce a ~58 kDa protein and only contain the PIWI domain (Figure 6.1.).

The

discrepancy could be due to the methodologies used; genomic expression (TgAgo1), a
cDNA library (TgAgo2) and RLM-RACE (TgAgo3) or the parasite strains (type I for
TgAgo 2 and 3 and type II).
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Figure 6.1. TgAgo isoforms could be expressed by multiple start codons to produce three
different TgAgo proteins of different sizes.
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for TgAgo 1). This study was initiated in an attempt to resolve these discrepancies by
determining the expression of the three isoforms of TgAgo and their roles in gene
silencing. The role of each TgAgo in gene silencing and the small RNAs they would
interact with, could be suggested by the unique domains they contain.
6.2. Materials and Methods
6.2.1. Cell cultures
6.2.1.1. Mammalian cell cultures
Human foreskin fibroblasts (HFF; ATCC, #1041) were grown in Dulbecco’s
Modified Eagle Media with high D-glucose and L-glutamine (DMEM; Invitrogen,
#12100046) supplemented with 10% v/v Cosmic Calf Serum (Hyclone, #H3008704N)
and 0.5x Antibiotic–Antimycotic (Invitrogen, #15240-062). Cultures were maintained at
37 C in 5% CO2.
6.2.1.2. Toxoplasma gondii culture
RHHX, T. gondii type I strain, was obtained from NIH AIDS Research and
Reference Reagent Program (#2857); Δku80 strain, which is an RHΔHX-derived strain,
was obtained from Dr. Vern B. Carruthers (University of Michigan). Unless stated
otherwise, both strains were maintained in HFF using Minimum Essential Medium
(MEM, Invitrogen, #61100061) supplemented with 1% v/v dialyzed fetal bovine serum
(ThermoFisher Scientific, Hyclone, #SH3007903) and diluted (0.5x) AntibioticAntimycotic and maintained at 37 C in 5% CO2. Selection of transgenic parasites was
grown in culture media containing either, mycophenolic acid (25 μg/mL) and xanthine
(50

μg/mL)

or

pyrimethamine

(1

M),
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for

hypoxanthine-xanthine-guanine

phosphoribosyltransferase (HXGPRT) or dihydrofolate reductase (DHFR) resistance,
respectively.
6.2.2. Plasmid construction
Transforming plasmids were constructed using pSF-TAP-LIC-HX and pChFPTAP-LIC-DHFR (obtained from Dr. Vern B. Carruthers, University of Michigan). Each
plasmid was linearized by PacI digestion prior to the treatment with T4 DNA polymerase
to create compatible ends in the presence of dGTP for a ligation-independent cloning
procedure as described by Huynh and Carruthers (2009). TgAgo (1565 bp) amplicon was
prepared using gene specific primer pair of TgAgoLICFw/TgAgoLICRv (Table 6.1.), and
purified prior to the treatment with T4 DNA polymerase to create compatible ends in the
presence of dCTP. Equimolar concentrations of the prepared plasmid and insert were
allowed to anneal and subsequently used in bacterial transformations. The resultant
plasmids, pAgo-SF-TAP-LIC-Hx and pAgo-ChFP-TAP-LIC-DHFR were analyzed to
confirm their sequences via restriction endonuclease digestions. The plasmids were then
used in the transformation of T. gondii. Transgenic parasites were selected and grown in
culturing media containing mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL) or
pyrimethamine (1M).

6.2.3. Dual luciferase assay
For dual luciferase assays, 48 hours post-transfection with 20 g of Ago
expression plasmid, freshly lysed parasites were harvested and lysed with 100 μL of 1x
Passive Lysis Buffer (Promega, #E1531) and incubated for 10 minutes at room
temperature. Lysates were cleared of debris by centrifugation (10,000 xg for 1 minute),

171

Table 6.1. Oligonucleotide primers used in the study of TgAgo. Lower case nucleotides
were used for LIC cloning.

TgAgoLICFw
TgAgoLICRv
a
a’
b
b’
c
c’

Nucleotide sequence
tacttccaatccaatttaatgcCTCCCCGAAATCGCGTGG
tcctccacttccaattttagcACAGAACACCATCGGGGTCACC
ATCTGGTATTCCG
CGAACACCATCGG
ATGGCGTCCAAACCCATTGAA
ACCGGTGTCGACGTCCTC
ATGGAGGGATACCAAATGTTCC
CGG GGC TGAATGTCCCTG
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and the supernatant was kept on ice and used in the dual luciferase assay, which was
carried out in a 2-step fashion as previously described by Crater et al. (2015).
Luminescence signals were measured with a 20/20n Luminometer (Turner Biosystems).
Rnluc signals were normalized to Ffluc signals for a direct comparison among different
independent experiments. The measurement of the dual luciferase expression was tested
under at least three independently trials.
6.2.4. Western blot analysis
Cell-free lysates were prepared by the addition of RIPA buffer to collected
parasites and sonicated for 30 seconds (x3). Protein concentration was measured using
the RC DC Protein Assay according to manufacturer’s instructions (Bio-Rad
Laboratories, #500-0119). Approximately 20 μg was used for the analysis, of which the
lysates were denatured using 6x SDS protein loading buffer and resolved on a 10% SDSPAGE. The primary antibodies used were α-Flag mouse antisera (1:5,000, Applied
Biological Materials Inc., Richmond, B.C, Canada, #G191). The signals were revealed
using secondary antibodies: horseradish peroxidase (HRP) conjugated goat anti-mouse
antisera (Rockland Immunochemicals Inc., #610-1319) at a 1:10,000 dilution, and a
Chemiluminescent HRP Substrate Kit (Millipore, #WBKLS0500).
6.2.5. Immunocytochemistry
HFF monolayers were cultured on coverslips until confluent, infected with ~1 x
106 freshly lysed parasites and incubated at 37 °C and 5% CO2. Infected monolayers on
the cover slips were rinsed three times with 1x phosphate buffer saline (PBS), fixed with
3% paraformaldehyde for 5 minutes. Cells were then incubated with Hoechst staining
solution (10 μM) at room temperature for 5 minutes, washed twice with 1x PBS and
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mounted on glass slides. Image acquisition was carried out using a Leica DMI 6000B
inverted fluorescent microscope using HCX PL Apo 100×/1.40–0.70 objective and a
Leica DFC 360FX camera with Leica Advanced Fluorescence Application Software
V.2.3.0. Post-acquisition image processing was performed with Adobe Photoshop 7.0.
6.2.6. Statistical analysis
Statistical analysis for TgAgoKO gene silencing rescue was completed by the
paired student t-test methodology assuming a null hypothesis. All values were calculated
from at least three independent tests.
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6.3. Results
6.3.1. Multiple proteins from one locus
To begin our investigation whether T. gondii expresses multiple TgAgo
proteins, we generated transgenic parasites by homologous recombination to have the Cterminus of TgAgo linked to a Strep/Flag (SF) epitope or a cherry fluorescent protein
(ChFP). These parasite lines would express TgAgo at the endogenous level and at its
natural regulation. To verify TgAgo-SF expression and identify multiple isoforms, SFtagged parasites were monitored by western blot analysis using anti-Flag antisera (Figure
6.2a). TgAgo-SF expression was monitored over culturing passages to ensure only
transgenic parasites were studied.

At passages one and two post-transfection with

pTgAgo-SF-TAP-LIC-Hx, a band appears at ~58 kDa as reported by Al Riyahi et al.
(2006). By passage three another band at ~97 kDa appears, as reported by Braun et al.
(2010). A band also appears at ~34 kDa in all passages and in WT parasite lysates
(Figure 6.2a). The 58 and 97 kDa proteins are not revealed in WT lysates, which
suggests two forms of TgAgo-SF could be produced from the same locus. Localization
of TgAgo-ChFP, after at least three passages, was found to be primarily cytosolic, which
was in agreement with previous reports (Figure 6.2b. Al Riyahi et al., 2006, Braun et al.,
2010, Musiyenko, et al., 2012).
6.3.2. TgAgo is required for gene silencing
To study the effects of TgAgo in gene silencing mechanism, a TgAgo knockout
parasite strain from Dr. JC Boothroyd (Stanford University School of Medicine, Stanford,
California) was used. The coding region of TgAgo was replaced with the hypoxanthinexanthine-guanine-phosphoribosyltransferase (HXGPRT) gene, and selected for by
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Figure 6.2. Multiple TgAgo proteins. A) Western blot analysis of TgAgo-SF expression
at progressive culturing passages (p). Total parasite lysates were analyzed for Flag
expression up to 6 days post-transfection. B) TgAgoChFP localization in intracellular
parasites. (Hz, Hoechst, Texas red for cherry fluorescent protein.
represents 5 m.)
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Micrometer bar

mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL).

Gene replacement was

confirmed by PCR analysis using primers in Table 6.1. Based on their annealing sites,
primer sets, a-b’, b-a’, and b-b’ would only produce a PCR product if the HXGPRT gene
was properly integrated into the TgAgo locus at 1, 1.4, and 0.5 kb, respectively. Primer
set c-c’ would anneal within the coding region of TgAgo and was only present in WT
parasites (Figure 6.3.).
We used our dual luciferase assay where binding sites for the endogenous miR-4a
were located in the 3’ UTR of the Rnluc transcript, as described by Crater et al., 2015.
Three perfect match sites to miR-4a were used in reactions labeled A, while three
mismatch sites were used in reactions labeled B. Rnluc activity decreased to (A) 39 
2.0 and (B) 35  4.0 % when normalized to Rnluc activity without binding sites in WT
parasites. The same reactions were carried out in TgAgoKO parasites, Rnluc activity was
(A) 110  11 and (B) 70  4.0 % (Figure 6.4).

Plasmids that could express an Ago

protein were introduced via electroporation with the dual luciferase plasmids in an
attempt to decrease Rnluc activity within the TgAgoKO parasites. When human Ago 2
(HsAgo2) was introduced, Rnluc activity decreased to (A) 67  4.0 and (B) 36  9.0%.
Transfection of the plasmid that would express the 58 kDa, (TgAgo1) decreased Rnluc
activity to (A) 87  5.0 and (B) 70  6.0 %. Upon transfection with the construct that
contained the genomic sequence of TgAgo (TgAgo2) slightly deceased Rnluc activity to
(A) 69  11 and (B) 67  6.0 %. As a control to ensure the decrease in Rnluc activity
was due to the introduced plasmid, a GFP expressing plasmid was also tested, Rnluc
activity was (A) 110  9.0 and (B) 92  7.0 % (Figure 6.4.).
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Figure 6.3. Confirmation of TgAgo knockout parasite strain. The coding region of
TgAgo was replaced with the HXGPRT gene. Proper gene replacement was confirmed
by genomic RNA PCR analysis in TgAgoKO parasites compared to wild-type (WT).
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Figure 6.4. Argonaute gene silencing rescue. TgAgo silencing capability was tested with
a dual luciferase reporter assay within WT and TgAgoKO parasites.

The Rnluc

transcripts tested would carry either a perfect match (A) or mismatch (B) interaction for
miR-4a (Crater et al., 2015). Rnluc activity in TgAgoKO parasites remained unchanged
when compared to Rnluc activity when no miRNA binding sites were tested. A rescue of
a silencing effect was observed upon transfection of a plasmid that would express the
catalytic active human Ago2 (HsAgo2). When any of the TgAgo expressing plasmids
were tested (TgAgo1, TgAgo3), a decrease of Rnluc activity was achieved. A plasmid
that would express GFP did not affect Rnluc activity in TgAgoKO parasites. (p-values
are the change in TgAgoKO silencing when complemented by a form of Ago for each
miRNA binding format from three independent trials, * p ≤ 0.01 and ** p ≤ 0.02)
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6.4. Discussion
Argonaute is a central protein for which RNA directed gene regulation occurs. It
has the ability to confer gene regulation at the transcriptional and post-transcriptional
level. Within T. gondii, the roles and functions of TgAgo have yet to be fully eluded.
Previously, our lab tested the TgAgoKO parasite line for its ability to (i) convert to
bradyzoites, (ii) its effects on RNAseIII protein expression and (iii) knockdown a gene of
interest (Liwak, 2009). First, TgAgoKO parasites were grown under alkaline conditions
for 5 days to induce bradyzoite formation.

The cyst walls were detected by

immunofluorescence with a Dolichols-FITC antibody and at least 100 random vacuoles
were counted. Under these conditions, ~70 % of the TgAgoKO parasites formed cysts
while only ~14 % of the WT (RH) parasites formed cysts. This suggests TgAgo may
play a role in tachyzoite to bradyzoite interconversion. Using an anti-RNAseIII antisera
and western blot analysis, it was found that the expression of RNAseIII containing
proteins was decreased in the TgAgoKO parasites when compared to WT. Finally,
dsRNA for the gene UPRT (uracil phosphoribosyltransferase) was used to test the gene
silencing ability in WT and TgAgoKO parasites. UPRT is responsible for the uptake of
uracil in the parasites; therefore a radio labeled uracil was used to detect UPRT activity.
In WT parasites, the maximal amount of knockdown was ~60 %, however, the TgAgoKO
parasites showed no ability to knockdown UPRT. Overexpression of TgAgo3 in these
parasites was unable to rescue a knockdown effect (Liwak, 2009). The inability to rescue
a gene silencing effect in the TgAgoKO parasites may be related to the type of dsRNA
used as an effector. In these experiments the dsRNA was ~ 600 bp. As previously
described in Chapter 2, the amount of an induced gene silencing effect could be related to
the length or type of RNA. Although a gene silencing effect can be achieved with long
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dsRNA, a greater silencing effect was observed when a small dsRNA with a mismatch
interaction to the mRNA target was used (Crater at al., 2012).
The presence of two forms of Ago expressed from the same locus in T. gondii
suggests TgAgo1 and TgAgo3 may be the result of two translational start sites. To
determine if ATG1 and ATG3 are translational start codons, we could first use the
CRISPR/Cas9 methodology to disrupt each predicted start codon separately in TgAgo-SF
parasites. TgAgo-SF expression could be determined by western blot analysis. If ATG1
and ATG3 are bona fide translational start sites, we would expect to see only one isoform
expressed (from the site that was not disrupted). An increase in protein expression from
the TgAgo isoform could also be possible under these conditions. Next, we could use our
dual luciferase reporter system with Tg-miRNA binding sites to monitor gene silencing
by (i) Rnluc activity and (ii) qRT-PCR analysis. TgAgo expressed from ATG1 would
have the RGG domain required for TSN association. Upon TSN association to TgAgo,
we would expect gene silencing to occur by mRNA degradation. TgAgo expressed from
ATG3 has only a PIWI domain and we would expect gene silencing to occur by
translational repression.
Overall, these data are the first to suggest that T. gondii expresses at least two
isoforms of Ago that could be required for gene silencing. The mode of gene silencing,
mRNA degradation or translational repression, could be determined by the TgAgo
isoform.

Further investigations into the roles of TgAgo are thereby necessary to

understand this unique gene.
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CHAPTER 7
Discussion and Future goals
7.1. Mechanism of RNA induced gene silencing
7.1.1. Roles and mechanism of miRNAs
These studies have been conducted to understand RNA directed gene regulation
mechanism in Toxoplasma. The effectiveness of endogenous miRNA is directly related
to (i) the abundance of miRNA and (ii) the number of miRNA binding sites within a
target transcript. The mode of regulation appears to vary among miRNA families. The
miR60 family causes mRNA degradation, while the miR-4 family causes translational
repression. Gene expression can also be manipulated by the use of a miRNA inhibitor or
mimic. This work shows that miRNA-induced gene silencing could also become a
valuable tool in the study of Toxoplasma. By using a combination of known genetic
methodologies, we took advantage of homologous recombination system offered by the
ΔKU80 strain that lack non-homologous end joining (NHEJ) capability to place miR-60a
binding sites within the 3’ UTR of an essential (LDH1) and nonessential (HoDI) gene to
down regulate their expression and monitor the effects. With the use of the miRNA
inhibitors and mimics the gene silencing capabilities of miR-60a could be altered and the
effects evaluated.
In order to further elucidate the mechanism for RNA induced silencing in
Toxoplasma, we would need to also investigate the factors involved and underlying
mechanism. The presences of putative Dicer and RdRp gene have been predicted in
Toxoplasma (Braun et al., 2010). The silencing activities of Argonaute, Tudor and
PMRT1 have been studied (Musiyenko et al., 2012). However, the interactions among
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these proteins, small effector RNAs (siRNA and/or miRNA) and target transcripts
collective roles and functions have not yet been studied. Since protein-protein and RNAprotein interactions are vital for a functional gene silencing mechanism, we could employ
a BioID and RNA aptamer methodology to examine these factors. BioID is a method to
identify proximal and direct protein-protein interactions in a cell system.

This is

accomplished by the fusion of a biotin ligase enzyme (BirA) to a protein of interest to
either the N- or C-terminus.

Addition of excess biotin to the cell system leads to

biotinyation of proteins either adjacent or directly interacting with the protein of interest
(Kim et al., 2016). Biotinyated proteins are then purified on streptavidin-conjugated
agarose beads. Interacting and proximal proteins can be identified via fluorescence
microcopy, western blot analysis or by mass spectrometry (Fairhead and Howarth, 2015).
A methodology to study protein-RNA interactions is by use of the MS2 RNA
aptamer to purify RNA-protein complexes (Slobodin and Gerst, 2010). A transcript that
contains two MS2 loop repeats would bind to a recombinantly expressed coat protein
(CP).

The MS2-CP is linked to a streptavidin binding protein that would bind to

streptavidin-conjugated beads (Figure 7.1.) similarly to the BioID method, interacting
proteins could be identified via mass spectroscopy. Since previous results indicate that
miR-4a causes translational repression, this methodology could be used with the Rnluc
transcripts that contain the different miRNA binding formats (perfect vs. mismatch).
This would also allow for us to compare the possible different or similar proteins
involved in silencing when a perfect match or mismatch interaction is involved. We
could expect to find translational machinery proteins as well as RISC components such as
TgAgo. Since target mRNA cleavage is not the cause of silencing we would not expect
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Figure 7.1. A possible approach for determining RNA induced gene-silencing factors by
MS2 RNA aptamer. The Rnluc transcript would contain the sequence for the MS2 loop
following three Toxoplasma miRNA binding sites (miR-60a or miR-4a) in the 3’ UTR.
The secondary structure of the MS2 loops would bind to a MS2 coat protein linked to a
streptavidin binding protein that would allow for complex purification by streptavidinconjugated beads.

186

to find TgTudor interactions as it appears to be involved in transcript degradation
(Musiyenko et al., 2012). Furthermore, the isoform of TgAgo involved could also be
identified. As TgTudor is not expected to be involved in translational repression we
would expect the smaller isoform of TgAgo to be involved as it does not possess the
RGG domain required for TgTudor interaction (Al Riyahi et al., 2006). One possible
limitation of the MS2 aptamer would be to elude the proteins involved in mRNA
degradation. The transcripts may not be sustained long enough to purify the interacting
complex. To test this, we could use the Rnluc transcript that contains miR-60a binding
sites as previous reports indicate target mRNA degradation occurs for this interaction.
7.1.2. Self-regulating genes and TgUlp1
The most well defined example of a self-regulating gene is the Xist gene involved
in cellular differentiation in female mammalians. Tsix is the non-coding RNA gene that
is transcribed antisense to the Xist RNA to induce random x inactivation by binding to
Xist RNA (Chow et al., 2005). Another example is the hok/sok system in E. coli during
cell division. Expression of the hok gene creates a toxic protein that causes cell death by
depolarization of the cell membrane. To prevent accumulation of this deadly protein
the sok RNA is transcribed from antisense strand to the hok gene. Sok regulates hok
expression by binding within the hok transcript open rereading frame to induce
translational repression. The subsequent RNA duplex is recognized by an RNAseIII
enzyme and is degraded (Gerdes et al., 1990). These examples of self-regulating genes
are both important for cellular differentiation and development. Self-regulating genes
are also advantageous when a fast response to external signals is required during stress
response (Shimoni et al., 2007).

Most self-regulating genes are regulated by a
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transcription factor by either a negative or positive feedback loop. For example, human
miR-483 has been shown to activate its expression via promoter activation through the
up-regulation of a transcription factor, USF1 (Emmerling et al., 2016). Self-regulating
genes by non-coding RNAs has been observed in other Apicomplexans. For example,
the var gene family in Plasmodium, which is responsible for host cell immune evasion, is
regulated by an RNA transcribed from the antisense strand of a conserved intron within
the var genes (Amit-Avaham et al., 2015). However, at the time of this dissertation, no
reports of self-regulating genes by miRNAs have been identified in Apicomplexans. As
a self-regulating gene, and as evident by the parasite’s inability to complete its lytic cycle
asexually, suggests TgUlp1 is likely also important for parasite development and immune
response.
7.1.3. Alternative translational starts sites of TgAgo
Initiation of protein translation is initiated by the recruitment of a ribosome at a
specific nucleotide sequence called the ribosomal-binding site (RBS). RBS recruitment
can be mediated by the 5’ cap of mRNAs or in a cap independent mediated mechanism
via internal ribosome entry sites (IRES). In eukaryotes, the region upstream of the start
codon on the mRNA has a consensus sequence (ACCAUGG) called the Kozak sequence.
Multiple adenines upstream of the RBS can also enhance ribosomal recruitment (Hellen
and Sarnow, 2001, Laursen et al., 2005). Alternative translational start sites within a
single transcript can contribute to proteome diversity.

Preferential translation is

attributed to longer 5’ UTRs that are enriched for transcription factors and leaky mRNA
scanning. Although the functional significance for alternative start sites is controversial,
this mechanism can lead to the production of N-terminal protein variants to promote
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diversity in higher eukaryotes (Bazykin and Kochetov, 2011).

For example in A.

thaliana, the mitochondrial and nuclear form of the DNA ligase 1 (AtLIG1) are both
translated from a single mRNA from two in-frame start codons (AUG). Similarly,
mitochondrial and cytoplasmic isoforms of proteins have been observed in rat with the
ornithine decarboxylase-antizyme (Gandre et al., 2003), and the human insulin-degrading
enzyme (Leissring et al., 2004) and neuropeptide Y (Kaipio et al., 2005).
The expression of multiple Ago proteins in higher eukaryotes (i. e. human, fruit
fly and worm) function within distinct locations (i.e. nucleus or cytosol), vary in nuclease
activity or interact with a specific form of non-coding RNA molecule (Azlan et al.,
2016).

Organisms that contain a single Ago (baker’s yeast) can participate in

transcriptional and post-transcriptional regulation within the nucleus and cytosol (Jinek
and Doudna, 2009). Although three versions of TgAgo can be found within the NCBI
protein database, the expression of only two forms has been experimentally identified
(GenBank: ACZ73654.1 and ABB05350.1). A ~100 kDa protein that would contain the
RGG, PAZ and PIWI domain and ~58 kDa protein that only contains the PIWI domain
(Braun et al., 2010 and Al Riyahi et al., 2006).
Toxoplasma contains a Kozak-like sequence (gncAaaATGg, Seeber, 1997).
Upon investigation of the TgAgo locus for possible RBS locations, six possible locations
were identified with 4 locations within the predicted exons and 2 in the predicated introns
(Table 7.1.). Based on sequence similarities and location of the predicted sites, the
identified site on exon 6 is the most likely to be a translational start site and corresponds
to the ATG3 start site. The protein that would be produced from this site corresponds to
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Table 7.1. Toxoplasma Kozak-like sequence and possible translational start site on the
TgAgo locus. Nucleotide numbers are based on the reported ATG1 start site. Upper case
indicates essential nucleotides for RBS recruitment and translation.
nucleotides to the Toxoplasma Kozak-like sequence are indicated by *.

Toxoplasma Kozak-like sequence
Location on TgAgo locus
(TGGT1_310160)
Exon 1
-6-4
Intron 4
2418-2428
Exon 6
3490-3500
Intron 6
4313-4323
Exon 7
4593-4603
Exon 7
5058-5068
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gncAaaATGg
Sequence
tctcttATGa
*
***
acgAaaATGg
* *******
gccAaaATGt
*********
gatAaaATGt
** ******
ggaAatATGg
** ** ****
cgcgacATGg
** * ****

Perfect match

TgAgo3 at ~ 58 kDa. The first predicted start site (ATG1) has the lowest sequence
similarity to the Kozak-like sequence and is the least likely possible start site (Table 7.1.).
Although western blot analysis indicates the presence of two isoforms of TgAgo,
predicted translational start sites indicate one likely start site in exon 6. Taken together,
these findings could suggest Toxoplasma contains a leaky translation mechanism that
produces two forms of TgAgo where one could function within the nucleus and the other
in the cytosol.
7.2. MiRNAs as an anti-Toxoplasma therapeutic
During host cell invasion by Toxoplasma, parasite specific secretory organelles
(micronemes and rhoptries) inject effector molecules into the host. These effectors have
been shown to interfere with host cell signaling to block apoptosis and progression of the
host’s cell cycle. Additionally infected host cell expression profiling has shown 15 % of
host mRNAs display an alteration (Blader et al, 2001, Nelson et al., 2008). A study used
microarray profiling to analyze the change in host cell miRNA expression upon
Toxoplasma infection. Primary transcripts for miR-17~92 and miR-106b~25 display an
increased abundance in infected human foreskin fibroblasts.

The mature miRNAs

derived from these primary transcripts target mRNAs that encode for pro-apoptotic
factors and negative regulators of the cell cycle (Zeiner et al., 2010). Furthermore, a
study showed an increase in miRNAs that target immune response factors in Toxoplasma
infected mouse brains (Cannella et al., 2014). The exact mechanism for this change is
not fully understood however, a study by Zeiner et al., (2010) showed the increase the
miR-17 ~ 92 primary transcripts is likely due to an increase in promoter activity. The
fact that parasite or host miRNAs have not been found locationally different may not
infer an exchange of host-parasite miRNAs is not occurring, but the level of change or
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location is not currently detectable.
Although systematic siRNA therapies have been used in the clinic treatment of
cancer, many different barriers can inhibit their delivery due to unfavorable
physicochemical properties and instability of the siRNA (Roberts 2016). To prevent
rapid degradation of the siRNA, modified backbones such as those like locked nucleic
acids, morpholinos and antagmers are preferred.

Non-viral delivery of siRNAs is

preferred to prevent potential toxicities associated with viral vectors. Non-viral siRNA
vectors involve complexing the siRNA with a positively charge polymer or lipid,
conjugation of the siRNA to small molecules such as cholesterol and lipids or
encapsulating the siRNA in a nanoparticle (Roberts et al., 2016, Wang et al., 2010). The
administration depends on the organs targeted. Generally, locoreginal delivery, such as
inhalation is preferred as it has fewer barriers to overcome when compared to systemic
delivery, such as intravenous injection (Wang et al., 2011).
Similar methodologies have been utilized to treat intracellular tachyzoites and
bradyzoites in vitro and in vivo. A transductive peptide conjugated to a
phosphorodiamidate morpholino oligomer (PMO) was used sequence specifically to
inhibit the expression of Toxoplasma dihydrofolate reductase (DHFR) and enoyl-ACP
reducatase (ENR) enzymes, which are involved in folate and fatty acid synthesis,
respectively. Intracellular parasite replication was slowed when either of the mentioned
genes was targeted by the peptide-conjugated morpholino (PPMO) in cell culture. The
methodology also showed parasite burden was reduced in infected mice that were treated
with the DHFR-specific PPMO (Lai et al., 2012). As another possible treatment for antiToxoplasma therapeutics, it would be interesting to investigate the use of the Toxoplasma
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specific miRNAs or inhibitors with this methodology. The experiments discussed found
a maximal amount of miRNA mimic or inhibitor required for an alerted silencing effect
was 20 μg, which translates to 1.23 and 2.35 mM respectively. However, the maximal
concentration of the PPMOs discussed earlier was 5 μM indicating treatment by PPMO
may have a greater effect at lower concentrations, which would be more advantages to
eliminate toxicity and off-targeting effects (Lai et al., 2012). Toxoplasma miRNAs have
no reported mRNA targets or sequence homology to host miRNAs therefore we would
not expect to find an alteration in host gene expression.
7.3. Conclusion and significance
This research has been dedicated to studying the underlying mechanism of RNA
induced gene silencing in Toxoplasma. Gene regulation is vital for our understanding of
the biological processes required for Toxoplasma survival and opportunistic life. The
first goal was to determine the effectiveness of different effector RNA molecules to
induce gene silencing. Next, the roles and effectiveness of endogenous miRNA in
Toxoplasma were examined. The best gene silencing effect was observed based on the
abundance of miRNA present or the number of binding sites on a target transcript.
Lastly, TgUlp1 was chosen as a model gene to study the underlying gene silencing
mechanism and the biological roles of Tg-miRNAs. In fact, TgUlp1 has proven an
excellent model gene to study RNA induced gene silencing. The locus of TgUlp1
contains the highest number of miR-60a binding sites and contains possible precursor
miR-60a. It is very likely that TgUlp1 is a self-regulating gene.

Furthermore, the

expression of TgUlp1 is critical for SUMOylation and parasite egress. Overall, this
dissertation has revealed the importance of proper gene regulation by miRNAs in
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Toxoplasma. An alteration in gene expression can be detrimental to the parasite. With
these studies, exanimation of genes for quick functional analysis for the development of
drugs or use of the Tg-miRNA mimics and inhibitors alone as a drug treatment for
Toxoplasma infection could be within reach.
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APPENDICES
A1. Dual luciferase plasmids for Chapter 2.
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A2. Dual luciferase plasmids with miR-4a binding sites for Chapter 3.
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A3. LIC plasmid for miR-60a binding sites for Chapter 3
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A4. LIC plasmids to create HoDI-SF and HodI-SF-miR60a sites for Chapter 3
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A5. LIC plasmids to generate LDH1-SF and LDH1-SF-miR-60a sites for Chapter 3
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A6. Genomic and cDNA sequences for TgUlp1 (TGGT1_214470) for Chapter 5.
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A7. Plasmids for generation of GST-Ulp1 for Chapter 5.
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A8. pET28b TgSumoeGFP for Chapter 5 as substrate for TgUlp1 activity assay.
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A9. Plasmids used to create TgUlp1 KO for Chapter 5.
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A10. Genomic representation of TgUlp1 KO with DHFR selectable marker insert for
Chapter 5.
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A11. pScUlp1PromoterTgUlp1-GFP/LEU2 used for yeast complementation assays for
Chapter 5.
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A12. pUlp1-SF-TAP-LIC-Hx plasmid was used to generate TgUlp1-SF transgenic
parasites for Chapter 5.
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A13. pAgo-SF-TAP-LIC-Hx plasmid was used to generate TgAgo-SF transgenic
parasites for Chapter 6.
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A14. pAgo-mCherry-TAP-LIC-DHFR plasmid was used to generate TgAgo-mCherry
transgenic parasites for Chapter 6.
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A15. Plasmids to express Argonaute homologs for Chapter 6.
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